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 During early embryonic development in mammals, the initially uniform cells of the 
naïve epiblast generate the structurally diverse and functionally specific tissues of the adult 
organism. The naïve epiblast expresses the cell-cell adhesion molecule epithelial (E-) 
cadherin, which is essential for early embryonic development. During subsequent neural 
differentiation in the ectoderm, E-cadherin becomes downregulated, and neuronal (N-) 
cadherin becomes upregulated in a process known as cadherin switching. Premature loss of 
E-cadherin activity leads to faster, more synchronous neural differentiation in embryonic 
stem cells by an unknown mechanism (Malaguti et al., 2013). Cadherins are mainly classed 
as adhesion molecules, but can also modulate cellular signalling by binding various growth 
factor receptors. This raises the possibility that cadherin switching may modulate signalling 
during early neural induction, thus affecting differentiation.  
This thesis investigates the mechanisms by which cadherin switching can bias 
differentiation decisions during neural induction in mouse embryonic stem (ES) cells . First, 
the spatio-temporal patterns of cadherins were investigated in the post-implantation 
embryo and during differentiation of pluripotent cells in vitro.  The results of this analysis 
suggest that cadherin switching is initiated before the loss of pluripotency and co-occurs with 
lineage priming, consistent with the hypothesis that this process may bias cell fate decisions.  
Next, ES cells in which the N-cadherin gene was knocked in to the E-cadherin locus 
(NcKI) were studied. These cells displayed elevated levels of neural marker genes during 
differentiation, suggesting that forced, premature cadherin switching promotes neural 
differentiation. To determine whether this effect could be ascribed to the loss of E-cadherin 
or to the gain of N-cadherin, an inducible N-cadherin overexpressing ESC line was generated.  
Experiments with this cell line confirmed that N-cadherin alone can promote neural fate.  
Cadherin switching also occurs at a later developmental stage: during the maturation 
of bi-potent neuro-mesodermal progenitors (NMPs). Premature induction of N-cadherin was 
shown to bias immature NMPs towards neural differentiation, similarly to the effect of N-
cadherin on pluripotent cells.  
To establish whether the pro-neural effect of N-cadherin was due to its adhesive 
function, a quantitative image analysis method was used to measure adhesion defects. 
Adhesion phenotypes did not correlate with the pro-neural effect observed in NcKI and N-
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cadherin overexpressing cells, suggesting that adhesion may not be the primary cause for the 
neural bias of these cells.  
 Finally, the signalling effects of cadherin switching were studied. The loss of E-
cadherin in E-cadherin null (EcKO) and NcKI cells was found to correlate with a drop in global 
and nuclear levels of β-catenin, a central component of the canonical WNT signalling 
pathway. However, these cells were found to retain WNT responsiveness, suggesting that 
any neural bias shown during cadherin switching is unlikely to be caused by altered WNT 
signalling.   
An mRNA-based signalling pathway analysis showed that cells overexpressing N-
cadherin had reduced levels of FGF signalling cascade components at days three and four of 
neural differentiation. Subsequent experiments in NcKI cells showed that these cells express 
lower levels of FGF readouts during neural differentiation than WT cells, and that their pro-
neural effect can be erased by adding FGF pathway ligands, or replicated by blocking the FGF 
pathway. These results suggest that the pro-neural effect observed in NcKI cells is caused by 
dampened FGF responsiveness.  
Taken together, the results presented in this thesis support a model in which N-
cadherin promotes neural differentiation by dampening FGF signalling. This mechanism, 
rather than being an instructive cue for neural induction, is likely to contribute to the 







The body of a mammal is made up of trillions of cells, and each of these cells has a 
highly specialised function. All of the diverse cell types found in an adult body once originated 
from just one cell: the fertilised egg. During early development of the embryo, the fertilised 
egg divides, and a subset of its cells will go on to create all the organs in the adult body. These 
cells are called pluripotent cells, and they can be removed from the embryo and grown in a 
dish, allowing researchers to study their behaviour. How these cells make decisions about 
what adult cell type to become is a large field of scientific inquiry.  
This thesis explores the question of how pluripotent cells make the decision to 
become part of the nervous system. Pluripotent cells that have not yet decided on their fate 
are called “naïve”, and their surface contains large amounts of a protein called E-cadherin, 
which is an adhesion molecule that allows cells to stick to each other tightly. In the earliest 
stages of nervous system development, E-cadherin becomes switched off, and the early 
neural cells switch on a very similar cell-surface protein called N-cadherin. This process is 
called cadherin switching.  Previous studies have shown that turning off E-cadherin makes 
pluripotent cells become neural cells faster, raising the possibility that cadherin switching 
may regulate the development of the nervous system in the embryo.  
The experiments summarised in this thesis showed that the cadherin switch was 
initiated before pluripotent cells had made a firm decision on what to become. By using 
genetic engineering to modify the types and amounts of cadherins that cells had on their 
surface, it was shown that forced or premature cadherin switching encouraged the cells to 
commit to the nervous fate faster. Image analysis software was used to show that this neural 
bias was not a result of changes in the ways the cells adhered to one another. Instead, genetic 
analysis and additional experiments were used to show that cadherin switching lowered the 
levels of FGF signalling, a type of chemical messaging taking place in the cells. This signalling 
prevents the pluripotent cells from making a final decision on what cell type to become.  
Thus, by lowering these inhibitory FGF signals, cadherin switching encourages pluripotent 
cells to become part of the nervous system, and may ensure that this organ system develops 
correctly and robustly in the embryo. 
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Chapter I – Introduction 
 
1.1 The interface of developmental and stem cell biology 
 The term “embryonic stem cell” was coined by Gail Martin in the early 1980s, when 
two independent scientific teams successfully cultured these cells in a dish for the first time 
(Evans and Kaufman, 1981; Martin, 1981). Since then, embryonic stem cells (ESCs) have 
captured the imaginations of both scientists and the public alike. ESCs are isolated from an 
early embryo, and have two defining properties: self-renewal, the ability to give rise to at 
least one identical copy of themselves, and pluripotency, the ability to become any cell type 
of the adult organism through the process of differentiation.  
 In 1998, ESCs were derived from a human blastocyst for the first time (Thomson et 
al., 1998). Since then, research on ESCs has been surrounded by both hype and controversy. 
In theory, owing to their ability to generate any cell type, these cells could be used to alleviate 
or even cure a wide range of injuries and diseases. However, their use for scientific or medical 
purposes necessitates the destruction of a fertilised embryo, leading to ethical concerns and 
moratoria on their use in research in several countries. A landmark discovery came in 2006, 
when a team of Japanese scientists developed a method to generate a pluripotent stem cells 
from the skin cell of an adult mouse (Takahashi and Yamanaka, 2006). These cells, termed 
induced pluripotent stem cells (iPSCs), represented a major breakthrough in the field as they 
eliminated the need for the destruction of a fertilised embryo, paving the way for novel stem 
cell treatments without potentially unethical origins.  
 As the field of stem cell biology develops at a great pace, the use of stem cells for 
biomedical applications requires not only the methods for their generation, isolation, and 
culture, but also an understanding of how to differentiate them into the cell types required 
for therapeutic purposes. Protocols exist for the differentiation of ESCs into diverse cell types 
in vitro, but even under standardised culture protocols, individual cells make lineage choices 
that can often be unpredictable or stochastic. This is in sharp contrast to the in vivo context 
of the developing embryo, where an initially identical population of pluripotent ESCs gives 
rise to the diverse and complex cell types of an adult organism with astounding efficiency 
and staggering reproducibility. This leads to a very basic research question: how do 
pluripotent stem cells make decisions about their commitment to diverse lineages?  
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 To try to answer this question, scientists are studying the events of embryonic 
development to inform research on in vitro differentiation of stem cells. The two systems 
complement each other: embryos represent the biological blueprint for the differentiation 
of stem cells into all the lineages of the adult organism, while ESCs cultured in vitro provide 
a platform for diverse experimental manipulations in an easily accessible system that reduces 
the need for animal experimentation. By using a combination of these systems, researchers 
hope to gain a fuller understanding of the decision-making process of pluripotent stem cells: 
both to better understand the events of early embryonic development, and to inform the 
generation of ESC differentiation protocols for use in further research and to generate 
potential therapies.  
1.2 Early embryonic development in the mouse 
1.2.1 Pre- and peri-implantation development 
 Embryonic development begins at fertilisation, when a single sperm penetrates the 
membrane of the egg, delivering its haploid genome to that of the oocyte. Sperm penetration 
triggers the egg to complete its second meiotic division, forming a diploid cell with a 
peripheral polar body (reviewed in Wennekamp et al., 2013). In the next one to two days 
following fertilisation, the conceptus divides to reach the two- and four-cell stages. On the 
most part, these cells are very similar to one another, with small differences in gene 
expression (Goolam et al., 2016).  
 During the subsequent days of development, the conceptus does not grow in size 
but increases in cell number with each mitotic division, resulting in a structure called a 
morula, which is made up of individual cells called blastomeres. At around 2.5 days after 
conception (referred to as embryonic day 2.5, or E2.5), cellular adhesion increases, causing 
the blastomeres to flatten in a process known as compaction (Wennekamp et al., 2013).  
Following compaction, and at around E3.0, the morula consists of a layer of outer 
cells and a cluster of central cells: the outer cells are directed towards the trophectoderm 
(TE) lineage and express the Cdx2 protein, while the inner cells go on to form the inner cell 
mass (ICM) and express Oct4 (Boroviak et al., 2015). This division represents the first lineage 
divergence event in the embryo, as the cells of the TE will go on to develop extraembryonic 
structures such as the placenta, while the ICM will give rise to all tissues of the developing 
embryo (Muñoz-Descalzo et al., 2015). Cdx2 and Oct4 reciprocally downregulate one 
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another, resulting in cells with differential gene expression in the outer and inner layers of 
the morula (Arnold and Robertson, 2009). However, cell fate at this stage remains reversible, 
as single blastomeres isolated from these early embryos can continue to give rise to both 
embryonic and extra-embryonic lineages (Gardner, 1998; Hillman et al., 1972).  
When the conceptus reaches the 16-to-32-cell stage at around E3.5, its outer cells 
mature into an epithelium, with tight junctions, gap junctions and desmosomes forming 
between the cells, enabling the transport of fluids from the outside to the inside of the 
embryo. This build-up of fluids accumulates in a central cavity which slowly increases in size. 
While this cavitation is occurring, the pluripotent cells of the ICM remain closely associated 
with one another (Lanza and Atala, 2014; Wennekamp et al., 2013). The embryo at this stage 
is referred to as the blastocyst.  
Over the next day (E4.0-E4.5), the blastocyst matures, and is composed of four 
distinct structures: the pluripotent epiblast, the primitive endoderm which will give rise to 
yolk sac structures, the TE, and the fluid-filled cavity called the blastocoel. At around the 
same time, the blastocyst implants into the lining of its mother’s uterus (Arnold and 
Robertson, 2009; Lanza and Atala, 2014). At E5.5, a cavity appears in the epiblast, and its cells 
elongate around this cavity to form a cup-shaped epithelium. At this stage, the embryo is 
referred to as the egg cylinder. This is also a time when axis specification occurs, driven by 
morphogen gradients of Nodal and WNT along the proximal-distal and anterior-posterior 
axes, respectively (reviewed in Arnold and Robertson, 2009).  
 An important distinction between the pluripotent cells of the blastocyst and those in 
the egg cylinder lies in their pluripotent state; at E4.5, the pre-implantation epiblast is said 
to be in a naïve ground state, meaning that these cells are equipotent and have no bias 
towards any particular embryonic lineage. By contrast, the pluripotent cells of the E5.5 egg 
cylinder are primed for differentiation towards a certain lineage, however this priming can 
be reversible. The naïve epiblast appears to be a unique mammalian feature (for a review, 
see Nichols and Smith, 2009).  
1.2.2 Lineage specification 
1.2.2.1 Gastrulation 
 Gastrulation is a crucial event in the development of all animal embryos, and is 
defined as the migration, differentiation and division of embryonic cells that leads to the 
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formation of the gastrula, an early embryo with three distinct embryonal germ layers: the 
ectoderm, mesoderm and endoderm (Campbell and Reece, 2004). Gastrulation is driven by 
a conserved set of transcriptional programmes, leading to the emergence of heterogeneous 
gene expression in cells that are otherwise phenotypically similar (Tam and Loebel, 2007). 
The cells of the gastrula are individually fated according to their location within the embryo, 
but they are not yet fully committed to a certain lineage (Lawson et al., 1991; Peng et al., 
2016; Smith, 2017). 
 Gastrulation begins with the formation of the primitive streak (PS) in the posterior 
embryo at around E6.25, when cells of the epiblast converge towards a posterior proximal 
pole (Arnold and Robertson, 2009). Some epiblast cells then ingress through the PS and 
undergo a process called epithelial-to-mesenchymal transition (EMT) to form mesodermal 
and endodermal lineages. Those cells that do not encounter the PS become confined to the 
anterior side of the embryo and give rise to the ectoderm (Li et al., 2013; Tam and Loebel, 
2007).  
1.2.2.2 Epithelial-to-mesenchymal transition 
 EMT is a highly conserved cellular program in which polarised, immobile epithelial 
cells lose their polarity and disassemble their cell-cell junctions to become migratory, motile 
mesenchymal cells. This process takes place at various stages of embryonic development, 
and also during cancer metastasis (reviewed in Yang and Weinberg, 2008). Cells undergoing 
EMT progress through discrete stages (reviewed in Lamouille et al., 2014): the dissolution of 
epithelial cell-cell junctions (including adherens junctions), loss of apical-basal polarity and 
acquisition of front-rear polarity, reorganisation of the actin cytoskeleton, changes in gene 
expression, increased motility, remodelling of the extracellular matrix, and, in the case of 
metastising cancer cells, the acquisition of resistance to senescence and apoptosis.  
 EMT is regulated by a set of transcriptional master regulators, such as Snail, Twist 
and Zeb. They are activated early in EMT, and their expression produces many of the hallmark 
features of EMT; one of these is the loss of the cell-cell adhesion molecule and early 
pluripotency marker E-cadherin, which is replaced by an analogous adhesion molecule, N-
cadherin, whose expression is characteristic of mesodermal and neural cells (Lamouille et al., 
2014; Radice et al., 1997).  
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1.2.2.3 Neural differentiation 
 From gastrulation onwards, cells of the anterior epiblast that do not ingress through 
the primitive streak go on to form ectodermal tissues, giving rise to neurectoderm, which 
generates the nervous system, and surface ectoderm, which will go on to generate epithelial 
and dermal structures (Lawson et al., 1991; Quinlan et al., 1995). Neural development begins 
at around E7.5 with the formation of the anterior neural plate, which is initially a monolayer 
of thickened neuroepithelial cells opposite the PS. As development progresses, the cells 
multiply, causing to neuroepithelium to thicken and stratify, and the neural plate gradually 
folds in on itself to create the neural groove, and, later on in development, the neural tube 
(Aaku-saraste et al., 1996; Henrique et al., 2015).  
The fate and potency of the early neurectoderm has been investigated using fate 
mapping studies. At E6.5, the anterior epiblast retains pluripotency and can give rise to all 
three germ layers. Within half a day however, the anterior neurectoderm loses its 
pluripotency, and is fated to either epidermis of neurectoderm, depending on the presence 
of absence of bone morphogenetic protein (BMP) 4, respectively (Li et al., 2013). At E7.5, the 
proximal region of the ectoderm is restricted towards the surface ectodermal fate, while the 
remaining parts of the anterior neurectoderm have been mapped as progenitor regions for 
the developing central nervous system: the forebrain, midbrain, hindbrain and spinal cord 
(Tam, 1989; Tam and Quinlan, 1996).  
In vivo, neural fate specification is an autonomous process that occurs in the absence 
of inhibitory signals, such as BMPs or WNTs (Muñoz-Sanjuán and Brivanlou, 2002; Zhu et al., 
2014). This has led researchers to propose a “neural default model”, which argues that 
pluripotent cells adopt a neurectodermal fate unless specified otherwise by additional 
morphogens.   
1.2.2.4 Neuro-mesodermal progenitors 
 Gastrulation is traditionally viewed as the stage where the pluripotent cells of the 
epiblast undergo their first lineage specification, becoming committed to one of three germ 
layers that give rise to defined organ systems. However, in 2009, a single-cell clonal analysis 
revealed a distinct population of cells arising during early gastrulation that could give rise to 
both neural and mesodermal lineages (Tzouanacou et al., 2009). These neuro-mesodermal 
progenitors (NMPs) are a transient population of cells that emerge at head-fold stage 
(around E7.5) and persists throughout axis elongation until E13.5 (Gouti et al., 2017; Lawson 
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and Wilson, 2016; Wymeersch et al., 2016), long after other organ systems become specified. 
The existence of NMPs therefore challenges the paradigm of cell fate assignment from the 
three germ layers. 
In vivo, NMPs are found in three different regions of the developing mouse embryo: 
at the early stages (E8.5-E9.5), they are located in the node-streak border (NSB), the area 
where the PS meets the node, and in the caudal lateral epiblast (CLE), the region of epiblast 
flanking the rostral PS. At later stages (E10.5-13.5), they are also found in the chordoneural 
hinge (CNH), a region in the tail bud comprising cells of the posterior-most ventral neural 
tube and underlying notochord (Wilson et al., 2009). NMPs act as a progenitor pool for the 
elongation of both the neural tube and the paraxial mesoderm during the extension of the 
body axis (Brown and Storey, 2000; Cambray and Wilson, 2007; Tzouanacou et al., 2009).  
In several vertebrates – including mouse, chick, and zebrafish –  NMPs can be 
identified by the co-expression the transcription factors T (Brachyury) and Sox2 (Martin and 
Kimelman, 2012; Olivera-Martinez et al., 2012; Tsakiridis et al., 2014; Wymeersch et al., 
2016). Cells that subsequently differentiate into neural lineages downregulate T but maintain 
Sox2 expression (Gouti et al., 2014; Gouti et al., 2015; Tsakiridis and Wilson, 2015), while 
those committing to mesoderm downregulate Sox2 and upregulate Msgn1 and Tbx6 
(Chalamalasetty et al., 2014; Gouti et al., 2017). Indeed, gene expression analysis has 
revealed that T and Sox2 play antagonistic roles in NMP lineage specification, with T being 
essential for NMP maintenance and promoting mesodermal fate, while Tbx6 commits cells 
to paraxial fate (Koch et al., 2017)  
The induction, maintenance and differentiation of NMPs involves the convergence 
of predominantly two cellular signalling pathways: the “Wingless-related integration site” 
(WNT) and the fibroblast growth factor (FGF) pathways. Embryonic regions containing NMPs 
express ligands for both of these pathways, and interfering with either of these signalling 
cascades results in the depletion of NMPs and premature truncation of the body axis (Takada 
et al., 1994; van de Ven et al., 2011; Wilson et al., 2009; Yoshikawa et al., 1997). In the 
absence of specific components of the WNT or FGF signalling pathways, the embryo becomes 
truncated and ectopic neural tissue forms in place of posterior paraxial mesoderm, showing 
that both WNT and FGF signals are required for mesoderm specification and axis elongation, 
but are dispensable for neural commitment (Boulet and Capecchi, 2012; Chal and Pourquié, 
2017; Ciruna and Rossant, 2001; Takada et al., 1994; Wymeersch et al., 2016; Yoshikawa et 
al., 1997).  
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WNT signalling has sequential (and sometimes contrasting) roles in the induction and 
maintenance of NMPs and in the differentiation of their derivatives (Henrique et al., 2015). 
Premature Wnt3a expression has been found to completely block neural tube formation and 
inhibit mesoderm formation, with the cells remaining in an early epiblast-like state (Jurberg 
et al., 2014). However, in NMP-derived neural and mesodermal tissues, WNT signalling blocks 
the progression of further differentiation (Garriock et al., 2015), while in the established 
neural tube it promotes cell proliferation (Megason and McMahon, 2002). Similarly, FGF 
signalling is regulated differently in NMPs and committed neural progenitors (Olivera-
Martinez et al., 2014), while downregulation of FGFR1 in the chick embryo results in the 
premature exit of NMPs from the progenitor pool (Mathis et al., 2001). These studies 
highlight a complex regulatory signalling network involved in the maintenance and 
differentiation of NMPs.  
 Despite a rapidly growing body of work about NMPs, several open questions remain 
about this unique cell type (Henrique et al., 2015). For example, what, other than FGF and 
WNT signals, influences their cell fate decisions? How can these two pathways act to both 
maintain NMP and induce mesodermal fate? Are there any additional factors that modulate 
the response to these signals? Further research is required to better understand the fate 
decisions occurring in this cell population.  
1.3 Pluripotent stem cells 
1.3.1 Historical perspectives in the study of embryonic stem cells 
 Advances in embryological techniques in the second half of the 20th century set the 
stage for a series of discoveries that have helped shape the field of stem cell biology. In the 
sixties, cells from a testicular tumour, or teratocarcinoma, of a strain 129 mouse were used 
to demonstrate the capacity of single cells to differentiate into multiple lineages for the first 
time (Kleinsmith and Pierce, 1964). When single teratocarcinoma cells were injected into the 
peritoneum of recipient mice, the cells developed into tumours that could contain derivatives 
of all three embryonic germ layers. This experiment was the first demonstration that a single 
cell could give rise to multiple embryonic lineages, introducing the concept of pluripotency 
that would become a defining feature of ESCs.  
 Two decades later, two independent research groups succeeded in the isolation and 
in vitro propagation of pluripotent stem cells from the mouse embryo (Evans and Kaufman, 
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1981; Martin, 1981), and the term “embryonic stem cell” was coined, opening up a world of 
possibility for the study of ESCs in a dish. The same year, the epiblast was established as the 
pluripotent compartment of the early mouse embryo in a series of experiments showing that 
these cells can give rise to multiple embryonic tissues (Beddington, 1981; Beddington, 1982). 
A decade later, fate-mapping studies were used to demonstrate that the fate of an epiblast 
cell in an E6.7 embryo is dependent on its location, demonstrating that during development, 
epiblast cells lose their pluripotency and become committed to a specific embryonic lineage  
based on environmental cues (Lawson et al., 1991).  
 Since these seminal works, the field has continued to expand and garner attention 
owing to high-profile publications that have generated a buzz in the scientific community and 
in popular media. In the fifties, a team of researchers in Oxford clones a frog by using the 
nucleus from a somatic cell of a tadpole, showing that the somatic cell retains all the 
components required for the development of clonal offspring (Gurdon et al., 1958).  In the 
nineties, Dolly the sheep was born at the Roslin Institute near Edinburgh as a result of somatic 
nuclear transfer, demonstrating the same principle in a mammal for the first time (Wilmut et 
al., 1997). Ten years later, the same principle was used by a group of Japanese scientists who 
were the first to reprogram a mouse fibroblast into a novel type of artificially derived stem 
cell: the iPS cell (Takahashi and Yamanaka, 2006), and the significance of this discovery was 
recognised with a Nobel Prize for Physiology or Medicine for the researchers. The finding was 
reproduced in human cells a year later by two different groups (Takahashi et al., 2007; Yu et 
al., 2007), ushering in a new age of potential therapeutic uses of stem cells that circumvented 
their major ethical drawbacks.  
1.3.2 Stages of pluripotency 
As the field of stem cell research continues to expand, knowledge surrounding the 
phenomenon of pluripotency has developed in incremental steps. This has led the 
identification of several distinct stages of pluripotency in early development, and to the 
establishment of in vitro culture conditions for their study in the lab. 
1.3.2.1 Naïve pluripotency 
 Naïve pluripotency is defined as a state of broad developmental plasticity in which 
cells can go on to develop into any of the three germ layers, and subsequently any cell type 
of the developing embryo, but not into extraembryonic tissues such as the placenta. In vivo, 
this state is characteristic of the pre-implantation epiblast at around E4.5 (Nichols and Smith, 
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2009). Both in the embryo and in the dish, naïve pluripotency is characterised by the 
expression of general pluripotency factors, such as Oct4, Sox2, and Sall4, and distinguished 
from other pluripotent states by the expression of naïve factors such as Nanog, Klf4, Tfcp2l1, 
Tbx3, Esrrb and Rex1 (Boroviak et al., 2014; Guo et al., 2010; Kalkan and Smith, 2014; Ohnishi 
et al., 2014).  
 In vitro, ESCs are propagated in a naïve state in medium called 2i-Lif, which contains 
two pharmacological inhibitors of differentiation and the leukaemia inhibitory factor (Lif); 
this medium is discussed in depth later on in this chapter. Exit from naïve pluripotency occurs 
shortly after the withdrawal of these inhibitors, when naïve factor expression is lowered 
within 24h hours and completely eliminated by 48h (reviewed in Kalkan and Smith, 2014).   
1.3.2.2 Formative pluripotency 
 The transitional state of formative pluripotency was first proposed by Kalkan & Smith 
(2014), and later formalised by Smith (2017). This state is proposed to be devoid of either 
naïve factors or lineage specifiers. It occurs after the clearance of naïve factors (in vivo) or 
upon withdrawal of 2i-Lif conditions (in vitro), and involves formerly naïve cells becoming 
receptive to differentiation stimuli. Cells in the formative state have therefore exited naïve 
pluripotency but remain lineage neutral.  
 There are two underlying assumptions of the hypothesised formative pluripotent 
state: first, that naïve cells are not prepared to execute lineage decisions and must undergo 
a process of maturation, and second, that primed cells have initiated a response to inductive 
cues, and already exhibit a bias towards a certain fate; the formative state is therefore 
hypothesised to occur in between these two well-defined stages (Smith, 2017). The existence 
of such a state is supported by several observations: the presence of a 24h interval (both in 
vitro and in utero) between the loss of naïve pluripotency and the overt manifestation of 
lineage priming, a remodelling of gene regulatory newtorks, changes in epigenetic landscape 
and metabolic state between naïve and primed stages, and the fact that germ cell 
competence is acquired between these two pluripotent states (Smith, 2017). However, more 
experimental evidence will be required before the formative state can be recognised as a 
canonical stage of pluripotency similar to the naïve and primed states.  
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1.3.3.3 Primed pluripotency 
 The cells of the post-implantation epiblast exist in a state referred to as primed 
pluripotency (Nichols and Smith, 2009). These cells can self-renew and have the ability to 
form all embryonic lineages, but are also biased towards a particular fate. In the embryo, 
they remain pluripotent until the onset of somitogenesis, or the development of the first 
somites (Beddington, 1981; Beddington, 1982; Osorno et al., 2012).  
Epiblast stem cells (EpiSCs) are the in vitro analogue of the primed epiblast (Brons et 
al., 2007; Nichols and Smith, 2009; Tesar et al., 2007). EpiSCs can generate derivatives of all 
three germ layers in teratoma assays, but fail to contribute to chimera formation when 
injected into recipient blastocysts, and cannot contribute to the germline, unlike earlier-stage 
ESCs (as reviewed in Smith, 2017). EpiSCs can be derived from the embryonic epiblast 
between E5.5 and E8.0, but the transcriptome of EpiSC lines derived from different stages of 
development converges to resemble that of late gastrulation-stage epiblast, regardless of the 
age of the original embryo from which they were derived  (Kojima et al., 2014; Osorno et al., 
2012).  
 EpiSCs are defined by the expression of general pluripotency markers, such as Oct4 
and Sox2, and early post-implantation markers like Fgf5, Otx2 and Oct6 (Kalkan and Smith, 
2014). These cells have been found to exhibit significant levels of heterogeneity on the gene 
expression level, as they contain at least two large and mutually exclusive subpopulations, 
which express markers of either the early PS (such as T) or the neural lineage (such as Sox1). 
The PS-like subpopulation represents a more un-differentiated and dynamic population, 
while the neural-like subpopulation was found to be less dynamic, with some cells in this 
subpopulation appearing to have committed to neural differentiation (Tsakiridis et al., 2014).  
1.3.4 Pluripotent culture conditions for stem cell culture in vitro 
 Several culture systems exist for the recapitulation of established pluripotent states 
in vitro. While these conditions represent a practical model for the study of development, 
some features of these conditions, such as the “iterations” of pluripotency that they produce, 
may be artefacts of the conditions themselves and may not correspond to true 
developmental events in vivo (Morgani et al., 2017).  
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1.3.4.1 Naive stem cell culture in 2i-Lif 
 2i-Lif is a serum-free culture medium used for the culture of ESCs in a state of naïve 
pluripotency. “2i” refers to the use of two pharmacological molecules to inhibit the activity 
of MEK/ERK1/2 and glycogen synthase kinase 3 (GSK3); these inhibitors allow for the 
suppression of FGF and activation of WNT signalling, respectively, to maintain pluripotency 
(discussed in greater detail later in this chapter)(Ying et al., 2008). 2i conditions can be used 
with or without the addition of the cytokine Lif, which is used to activate the STAT pathway, 
conferring additional stability to the naïve condition (Dunn et al., 2014). Cells cultured in 
these conditions are considered to be homogenous, without any obvious subpopulations, 
with some researchers suggesting that these conditions represent a more natural and self-
sustainable pluripotent gene regulatory network than that in cells cultured in Lif-serum 
(Papatsenko et al., 2015) 
1.3.4.2 Mixed stem cell culture in Lif-serum 
 Lif-serum is the oldest and most widely used pluripotent stem cell medium, and relies 
on the use of animal-derived serum and the cytokine Lif for the maintenance of a pluripotent 
state (Smith et al., 1988). This was the standard pluripotency culture medium before the 
introduction of 2i-Lif, but gene expression studies have shown that cells cultured in Lif-serum 
consist of two distinct subpopulations, one resembling the pluripotent epiblast equivalent to 
E3.5, and the other resembling a more mature epiblast at around E5.5. These two 
subpopulations may exist in a dynamic equilibrium with one another, with some authors 
suggesting that Lif-serum may therefore represent a state of stalled differentiation 
(Papatsenko et al., 2015). Others argue that since this dynamic and fluctuating gene 
expression signature has not been convincingly demonstrated in vivo, Lif-serum conditions 
represent a sub-optimal tool for the study of early development because it does not 
accurately recapitulate the behaviour of the embryonic epiblast (Kalkan and Smith, 2014).  
1.3.4.3 Primed stem cell culture in EpiSC conditions 
 EpiSCs are derived from post-implantation epiblast at E5.5-E8.0, and are maintained 
in vitro in basal medium supplemented with Activin and FGF, to stimulate Activin/Nodal and 
FGF signalling, respectively. Optionally, the medium can also be supplemented with KOSR 
(Brons et al., 2007; Tesar et al., 2007). EpiSCs do not tolerate passage as single cells, and must 
instead be passaged as small clumps; this effect has been tied to the hyper-activation of  Rho-
associated protein kinase (ROCK)/myosin signalling which leads to apoptosis in response to 
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changes in cell-cell adhesion (Ohgushi et al., 2010). Additionally, moving EpiSCs to 2i-Lif 
conditions causes the cells to differentiate into neurons, which is linked to the inhibitory 
activity of the pharmacological inhibitor PD on the FGF signalling pathway (Yu et al., 2018).  
1.3.4.3.1 – Post-implantation epiblast-like cells (EpiLCs) 
 An alternative to the use of EpiSCs in vitro is the use of a closely related cell type 
known as post-implantation epiblast-like cells (EpiLCs). Unlike EpiSCs, which can be 
maintained in self-renewing culture, EpiLCs represent a transitional state occurring during 
differentiation from 2i-Lif. They are formed from naïve ESCs cultured in naïve conditions after 
around 48h from the withdrawal from 2i-Lif, and upon supplementation with FGF, Activin 
and KOSR (Hayashi et al., 2011). Transcriptome profiling places EpiLCs close to early post-
implantation epiblast, and they can be efficiently differentiated into primordial germ cells 
and functional gametes: these properties are characteristic of the intermediate pre-
gastrulation epiblast but are absent in EpiSCs (Hayashi et al., 2011; Kalkan and Smith, 2014).   
1.3.4.4 Neural differentiation culture  
 In the embryo, the neural lineage is borne out of anterior epiblast cells that do not 
ingress through the primitive streak (Arnold and Robertson, 2009), and in its early stages 
does not rely on overt extrinsic signals. This has led to the development of the “neural 
default” model for neural differentiation, where it is argued that neurectodermal 
competence is the fate that pluripotent cells are going to adopt unless instructed otherwise 
(Muñoz-Sanjuán and Brivanlou, 2002; Smith, 2017). Monolayer neural differentiation culture 
reflects this idea, as neuro-epithelial precursor cells can be derived by culture in basal 
medium with few additional factors, but with an increased concentration of insulin to 
enhance the efficiency of neural differentiation (Ying et al., 2003a). This is a widely used 
neural differentiation culture protocol that has become standard in the field.  
1.4 WNT and FGF signalling in early development 
 Throughout development and in other biological processes, cells are able to transmit 
information from their environment to their nucleus through chemical cascades known as 
signalling pathways. Typically, these pathways rely on the binding of an extracellular 
molecule (such as a hormone or ligand) to a cell-surface signalling receptor. This binding 
usually then triggers structural or chemical changes (such as phoshorylations) to the 
receptor, prompting an intracellular cascade of pathway components to chemically transmit 
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the message to the nucleus, where it triggers gene expression. A number of complex and 
precisely timed signalling events orchestrate embryonic development (reviewed in Arnold 
and Robertson, 2009). Here, two signalling pathways most relevant to work presented in this 
thesis are discussed: the WNT and FGF pathways.   
1.4.1 WNT signalling 
Early research on WNT (“wingless-related integration site”) signalling emerged 
through the convergence of mouse models of cancer and developmental genetics in the fruit 
fly Drosophila melanogaster (Nusse and Varmus, 2012; Nusse et al., 1991). It is now widely 
acknowledged that WNT signalling plays a crucial role in developmental patterning 
throughout the animal kingdom (Clevers, 2006).  
Upon the activation of a cell-surface WNT receptor, three pathways can be switched 
on: the canonical WNT/β-catenin cascade, which relies on signal transduction through β-
catenin, the non-canonical planar cell polarity pathway, and the Wnt/Ca2+ pathway; the two 
latter signalling cascades do not rely on β-catenin (Clevers, 2006). Of the three pathways, the 
canonical pathway is the best characterised and most relevant for the current project, and is 
discussed in greater detail in the following sections.   
1.4.1.1 The canonical WNT signalling pathway 
 The central player of the canonical WNT signalling cascade is an intracellular protein 
called β-catenin, encoded by the Ctnnb1 gene. When WNT signalling is inactive, two 
serine/threonine kinases, CK1 and GSK3, phosphorylate β-catenin. This phosphorylation 
marks β-catenin for ubiquitination by the ominously named multi-protein “destruction 
complex”, which targets β-catenin for rapid degradation by the proteasome (Stamos and 
Weis, 2013). In the nucleus, the binding of the protein Groucho blocks the transcriptional 
activator T-cell factor (TCF) from transcribing WNT target genes. When WNT signalling is 
activated, Axin2, a scaffold protein of the destruction complex, becomes bound to the 
cytoplasmic side of the cell membrane, protecting β-catenin from phosphorylation and 
degradation. This un-phosphorylated form of the protein is then translocated to the nucleus, 
where it displaces Groucho, binds to TCF and promotes the transcription of WNT target genes 
(Fig. 1.1) (Clevers, 2006).  
 Importantly, the activation of the WNT signalling cascade can occur as a result of 
Wnt-ligand binding to the cell-surface receptor, or independently of receptor binding. This 
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can take place whenever β-catenin from the membrane-bound pool (where it associates with 
cadherin proteins), is released into the cytoplasm and the nucleus (Kam and Quaranta, 2009). 
This may  explain the lack of an “obligate correlation” between the expression of Wnt ligands 
and pathway activation in certain contexts (Howard et al., 2011; Maretto et al., 2003).  
 
Figure 1.1: The canonical WNT signalling pathway. Reproduced from Clevers 2006. For pathway 
details, see text in 1.4.1.1. 
 
1.4.1.2 Canonical WNTsignalling function 
 The canonical WNT signalling pathway plays diverse roles in several biological 
processes, including development and disease (reviewed in Clevers 2006). For the purposes 
of this thesis, its role in pluripotency and neural differentiation in mammals is discussed 
below.  
1.4.1.2.1 – WNT signalling in pluripotency 
 WNT signalling is reported to be inactive during pre-implantation development in the 
mouse (Kemler et al., 2004; Maretto et al., 2003). However, its role in the maintenance of 
pluripotency, especially in the in vitro context, has been widely investigated. Several studies 
have shown that WNT signalling is required, or at least promotes, the self-renewal of mouse 
ESCs (Faunes et al., 2013; Miyabayashi et al., 2007; Ogawa et al., 2006; Sato et al., 2004), and 
inhibits their differentiation into EpiSCs (ten Berge et al., 2011). WNT signalling was found to 
be dispensable for the maintenance of the primed pluripotent state in EpiSCs, but was found 
to be necessary for the induction of a PS-like subpopulation in these cells at the expense of 
an anterior epiblast-like subpopulation (Tsakiridis et al., 2014).  
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1.4.1.2.2 – WNT signalling in neural differentiation 
 In vivo, a WNT gradient exists in the pre-gastrulation embryo, with the posterior 
epiblast expressing high levels of WNT ligands, while the anterior epiblast is negative for 
them (Arnold and Robertson, 2009; Maretto et al., 2003). This is reflected in the role of WNT 
signalling in the induction of different lineages: it is implicated in the formation of the PS, a  
posterior structure, both in vivo and in vitro (Mohamed et al., 2004; Tsakiridis et al., 2014), 
and, conversely, inhibits neural differentiation in the anterior of the embryo (Haegele et al., 
2003). The addition of Wnt3a into neural differentiation culture is enough to prevent ESCs 
from adopting the neural fate (Faunes et al., 2013). Taken together, these studies confirm an 
inhibitory role for WNT signalling in anterior neural induction.  
1.4.2 FGF signalling 
1.4.2.1 The FGF signalling pathway 
 Fibroblast growth factor (FGF) signalling refers to a number of intracellular signalling 
cascades lying downstream of FGF receptors (FGFRs), a class of receptor tyrosine kinases 
(RTKs).  FGF signalling plays a role in diverse cell processes in multiple contexts, including cell 
proliferation, survival and motility (Goetz and Mohammadi, 2013).  
Binding of FGF ligand to its receptor causes autophosphorylation of tyrosine residues 
in the intracellular domain of the FGFR, and the signal is then transduced through one of four 
distinct pathways: (i) mitogen-activated protein kinase/extracellular signal-regulated kinase 
(MAPK/ERK), (ii) phosphoinositide phospholipase C-gamma (PLC-γ), (iii) phosphatidylinositol 
3-kinase (PI3K)/Akt and (iv) Janus kinase/signal transducer and activator of transcription 
(Jak/STAT) (Lanner and Rossant, 2010). The individual branches can have distinct roles in 
different contexts, but for the purposes of the current project, two will be reviewed in more 
detail: the MAPK/ERK branch and the PI3K/Akt branch.  
1.4.2.1.1 – The MAPK/ERK branch of the FGF pathway 
 MAPK/ERK refers to one of the branches of the FGF pathway, and all eukaryotes have 
multiple MAPK pathways with various functions: in mammals, at least five distinct groups 
have been characterised. “MAPK” refers to a generic kinase of the pathway, with different 
species having different MAPK orthologues- in mammals, this orthologue is called ERK. The 
MAPK pathway consists of a set of three evolutionarily conserved, sequentially acting kinases 
(in the nomenclature, each “K” simply refers to kinase): MAPKKK, which phosphorylates, and 
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thus activates, MAPKK, which dual-phosphorylates MAPK, which in turn phosphorylates 
target substrates (Roux and Blenis, 2004).  
 In mammals, the sequence of MAPK activation follows a prescribed order of events: 
signalling is initiated when an extracellular growth factor, such as an FGF protein, binds to a 
corresponding transmembrane FGF receptor. This phosphorylates and activates MAPKKKs 
(for example Raf proteins), which in turn phosphorylate MAPKKs: in mammals, these are 
MEKs 1 through 7. These proteins then phosphorylate MAPKs, such as ERK1/2, which in turn 
phosphorylate MAPK-activated protein kinases (MKs), which execute downstream cellular 
functions. For an exhaustive review of the signalling cascade, see Roux and Blenis, 2004.  
1.4.2.1.2 – The PI3K/Akt branch of the FGF pathway 
 The PI3K/Akt pathway is involved in the regulation of cell cycle and survival, EMT and 
cancer progression (Larue and Bellacosa, 2005). The pathway is activated by ligand binding 
to receptor tyrosine kinases (RTKs) such as FGFR, which phosphorylates a chain of successive 
kinases: the first is PI3K, followed by PDK, followed by Akt, which mediates downstream gene 
expression (Goetz and Mohammadi, 2013).  
1.4.2.2 FGF pathway function   
 The FGF pathway plays very diverse roles during multiple cellular processes, including 
development and in disease. Here, two processes will be highlighted: pluripotency and neural 
differentiation.  
1.4.2.2.1 – FGF signalling in development and pluripotency 
 Different combinations of FGF receptors and cascade components are expressed at 
various stages of embryonic development, and their knockout causes multiple 
developmental phenotypes, including embryonic lethality (summarised in Lanner and 
Rossant, 2010). Cues mediated by the FGF pathway also play important roles at different 
stages of development. For example, in the pre-implantation blastocyst, FGF/ERK signalling 
is involved in the segregation of the primitive endoderm lineage from the ICM: blocking the 
pathway causes all the cells of the ICM to become Nanog-positive epiblast, at the expense of 
primitive endoderm and hypoblast lineages (Nichols et al., 2009; Yamanaka et al., 2010). 
During gastrulation, signalling through the FGF1R receptor has been found to be critical for 
EMT, cell movement through the PS, and consequently for the formation of mesodermal and 
endodermal lineages (Ciruna and Rossant, 2001; Ciruna et al., 1997).  
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FGF signalling has been shown to play distinct roles in ESCs depending on their stage 
of pluripotency. In general, the inhibition of FGF signalling promotes the self-renewal of naïve 
ESCs, while the addition of FGF2 stimulates conversion of naïve ESCs to primed EpiSCs, and 
subsequently promotes self-renewal and maintenance of the primed state (Lanner and 
Rossant, 2010). This is reflected in the ways that these cells are cultured in vitro: naïve ESCs 
are cultured in 2i-Lif medium containing PD, a MEK/ERK inhibitor (Hamilton et al., 2013; Ying 
et al., 2008), while the derivation and propagation of EpiSCs involves the addition of FGF2 to 
the culture medium (Brons et al., 2007; Tesar et al., 2007).  
However, the exact role for FGF signalling (and especially the MAPK/ERK branch of 
the pathway) for pluripotency remains somewhat controversial. Most studies have shown 
that MAPK/ERK signalling is not required for self-renewal, and that pharmacological 
inhibition of ERK promotes pluripotency (Burdon et al., 1999; Hamilton and Brickman, 2014; 
Hamilton et al., 2013). However, Chen et al., (2015) argue that most studies on the topic have 
either focused on pharmacological inhibition of ERK signalling, or on the knockout of one of 
two ERK proteins, and point out that this may not be a valid approach since the two proteins 
have redundant roles and one can rescue the function of the other (Hamilton et al., 2013; 
Pages et al., 1999; Saba-El-Leil et al., 2003).  Instead, these researchers used an ERK1/2 
double knockout approach to show that these mutant cells suppress pluripotency genes, 
display increased rates of apoptosis, and cannot be maintained in pluripotency conditions 
(Chen et al., 2015a). Therefore, more research may be required to pin down the exact role 
for FGF/ERK signalling in the maintenance of naïve pluripotency.  
By contrast, FGF signalling is required for the derivation and maintenance of EpiSCs 
in a primed pluripotent state. FGF signalling has been shown to inhibit both the reversion of 
EpiSCs back into a Lif-serum-like ESC state and their differentiation down the neural lineage 
(Greber et al., 2010; Sterneckert et al., 2010). It is therefore proposed that FGF signalling, and 
especially FGF1R, plays a role in stabilising the “metastable” state of primed pluripotency in 
EpiSCs (Lanner and Rossant, 2010; Takehara et al., 2015).  
1.4.2.2.2 – FGF signalling in neural differentiation 
 The role of FGF signalling in the neural differentiation of pluripotent cells has yielded 
contrasting findings in the past ten years, leading to some controversy in the literature on 
the topic. Earlier findings showed that FGF signalling promotes neural induction from Lif-
serum (Kunath et al., 2007; Stavridis et al., 2007). However, subsequent reports have shown 
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that blocking FGF signalling in EpiSCs promotes their neural differentiation (Greber et al., 
2010; Jaeger et al., 2011), and in vivo findings have shown that FGF signalling does not act as 
a neural inducer in the post-implantation embryo (Di-Gregorio et al., 2007).  
While these findings may appear contradictory, they can be explained by viewing 
neural differentiation as a progression through discrete stages of pluripotency, priming and 
commitment: naïve ESCs must become primed for the neural lineage, and must subsequently 
exit primed pluripotency to undergo neural differentiation. In this progression, FGF signalling 
promotes the conversion of naïve cells into primed cells, while inhibition of the pathway 
promotes exit from the primed state and entry into the neural lineage (Stavridis et al., 2010; 
Sterneckert et al., 2010). It appear that FGF signalling therefore has stage-dependent 
functions during pluripotency, priming and neural commitment.  
1.5 Cadherins in early development and pluripotency 
1.5.1 The cadherin protein family  
 The cadherins are a large, evolutionarily conserved superfamily of cell-surface 
proteins (Hulpiau and van Roy, 2009). Their main function is in facilitating cell-cell adhesion, 
which is usually accomplished by the proteins preferentially binding to cadherins of their own 
type on the surface of neighbouring cells, forming adherens junctions (Schäfer et al., 2014). 
Intracellularly, cadherins bind to cytoskeletal proteins such as catenin and actin; through this 
function, cadherins are able to bridge the cytoskeletons of neighbouring cells (Stepniak et al., 
2009). Different cadherins are dynamically expressed at different times during development 
and in various adult tissues, and they can also play a role in cell signalling by binding cell-
surface receptors or intracellular mediators of various signalling pathways (Hoschuetzky et 
al., 1994; Williams et al., 1994).  
 Epithelial (E-) cadherin is highly expressed in the cells of the early embryo, and 
becomes downregulated in favour of neuronal (N-) cadherin during EMT and neural 
differentiation; this phenomenon is termed “cadherin switching”. It also occurs when cancer 
cells undergo metastasis to gain a more motile, aggressive cancer phenotype (Wheelock et 
al., 2008). Cadherin switching has been widely studied in the context of EMT and cancer 
biology, though its role during embryonic development, and neural specification in particular, 
is not fully understood. Here, E- and N-cadherin, and their roles in development, adhesion 




1.5.2.1 E-cadherin structure 
 E-cadherin (also called uvomorulin in older literature) is encoded by the Cdh1 gene. 
It is a single-pass transmembrane protein found at the cytoplasmic membrane (extensively 
reviewed in van Roy & Berx 2008). The extracellular domains are mainly responsible for 
forming homotypic interactions with cadherin proteins on neighbouring cells, while the 
intracellular domains bind different catenin species to anchor the cadherin to the actin 
cytoskeleton.  
The N-terminal extracellular portion of E-cadherin is made up of five repeating 
cadherin domains, termed “extracellular cadherin structural domains” and labelled EC-1 
through EC-5, each being around 110 amino acids in size (reviewed in Kim et al 2000). In 
between each of the repeating cadherin domains are calcium binding pockets, which are 
required for calcium-dependent binding to other cadherins on adjacent cells. The C-terminal 
intracellular domain is about 150 amino acids in size and consists of two subdomains: the 
juxtamembrane domain that binds p120-catenin, and the catenin binding domain that 
interacts with the central “armadillo” domain of β-catenin or with γ-catenin (also called 
plakoglobin). Both of these proteins bind α-catenin, which in turn connects the entire 
cadherin complex to the actin cytoskeleton. (Anastasiadis and Reynolds, 2000; van Roy and 
Berx, 2008). E-cadherin and other cadherins lose their adhesive functions if their catenin-
binding domains are deleted (Nagafuchi and Takeichi, 1988; Ozawa et al., 1990). 
Different cadherin species preferentially bind cadherins of their own type on 
neighbouring cells, a process known as homophilic binding (van Roy and Berx, 2008). This 
species specificity is conferred by the N-terminal 113 amino acid region of the extracellular 
domain  (Nose et al., 1990). The classical cadherin family is structurally conserved, with slight 
differences in structure conferring subtle but functionally important differences in their 
behaviour.  
1.5.2.2 E-cadherin expression in early embryogenesis 
 E-cadherin protein is present in the unfertilised egg (Kemler et al., 1977; Ohsugi et 
al., 1997), and significant amounts of E-cadherin are contributed maternally to facilitate 
compaction and adhesion between blastomeres early in development (Stepniak et al., 2009). 
The protein is present in high levels in the embryo until gastrulation, when it begin to be 
downregulated in favour of N-cadherin in cells undergoing EMT and forming mesoderm, 
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allowing the cells to gain a more motile phenotype as they ingress through the primitive 
streak (Larue et al., 1996; Luo et al., 2001; van Roy and Berx, 2008). The same cadherin switch 
occurs in neurulation, during the transition of the neural plate into the neural tube (Aaku-
saraste et al., 1996). In further development, E-cadherin continues to be expressed in various 
tissues, most commonly in epithelia.  
1.5.2.3 E-cadherin function in adhesion 
 E-cadherin can homophilically bind to other cadherins of the same species in two 
ways: through trans-interactions, or binding an E-cadherin protein on an opposing cell, and 
though cis-interactions, or binding to an E-cadherin protein on the surface of the same cell. 
The two processes have distinct mechanisms, so a single E-cadherin molecule may be able to 
participate in both interactions at the same time (summarised in Wu et al 2015).  
 Trans-interactions of E-cadherin are most commonly mediated by a tryptophan 
residue on the first cadherin domain (EC-1) of one cadherin, which is inserted into the 
hydrophobic pocket of another molecule, and vice versa (Harrison, 2005; Shapiro et al., 
1995). By contrast, the cis-interactions are mediated by an EC1-EC2 bond between two 
molecules on the same cell surface. Studies suggest that the cis-interaction is necessary for 
the formation of trans-dimers, ie. that E-cadherin molecules on one cell surface must cluster 
together before they can bind other cadherin molecules on the surface of another cell 
(Tamura et al., 1998; Tomschy et al., 1996).  
 While the extracellular cadherin domains form the structural links of the adherens 
junction, the intracellular domains are also involved in E-cadherin mediated adhesion: 
mutants lacking the intracellular domain exhibit impaired adhesion (Nagafuchi and Takeichi, 
1988). E-cadherin can additionally form heterophilic interactions with other cell-surface 
adhesion molecules, such as integrins or signalling receptors (van Roy and Berx, 2008). While 
E-cadherin is chiefly regarded as an adhesion molecule, it serves many functions in diverse 
cellular contexts, and these functions can be both dependent and independent of its role in 
adhesion.  
1.5.2.4 E-cadherin function in pluripotency and development 
1.5.2.4.1 – E-cadherin function in early embryogenesis 
 E-cadherin plays a critical role in pre-implantation development. Embryos lacking E-
cadherin die during early embryogenesis: they are able to undergo morula compaction with 
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the aid of maternally contributed E-cadherin, but subsequently fail to produce a blastocyst 
cavity or a functional TE epithelium (Larue et al., 1994). Embryos with intact E-cadherin but 
a deletion of the actin-binding domain of αE-catenin display disrupted adhesion in the 
throphoblast epithelium, phenocopying the E-cadherin null embryos and suggesting that the 
lethality is due to defects in adhesion (Torres et al., 1997). Knocking in N-cadherin into E-
cadherin locus (NcKI) is able to rescue morula compaction in the absence of maternally-
contributed E-cadherin, but cannot form a fully polarised TE (Kan et al., 2007). Further studies 
using hybrid cadherin molecules showed that the extracellular domain of E-cadherin is 
required to activate integrin growth factor 1 receptor (IGF1R)-mediated signalling, which is 
indispensable for TE formation (Bedzhov et al., 2012). These studies highlight critical roles for 
E-cadherin during peri-implantation development that are both dependent and independent 
of its role in cell-cell adhesion.  
 E-cadherin is also critical at later stages of development. When the NcKI mutation is 
induced after implantation, gastrulation progresses as normal and all three germ layers are 
formed, but the embryos die at around E8.5 due to severe morphological defects in the 
epiblast, extra-embryonic compartment, amnion, and ectoderm. These defects were 
ascribed to defects in adhesion, but also in cellular signalling, where E-cadherin is required 
to facilitate a feedback loop stabilising BMP expression (Basilicata et al., 2016). Taken 
together, these studies underscore the crucial role of E-cadherin at multiple stages of 
development in both cell-cell adhesion and signal transduction through various pathways.  
1.5.2.4.2 – E-cadherin function in pluripotency 
 Several studies have implicated E-cadherin as an important pluripotency marker and 
a key player in the pluripotent gene regulatory network. E-cadherin overexpression allows 
EpiSCs to have a higher reprogramming efficiency back into naïve ESCs, and can replace Oct4 
in the “Yamanaka cocktail” of factors supporting efficient reprogramming of somatic cells 
(Murayama et al., 2014; Redmer et al., 2011). The repression of E-cadherin using shRNA is 
enough to cause rapid differentiation of blastocyst-derived stem cells, while the forced 
overexpression of E-cadherin is enough to induce teratoma-forming ability in EpiLCs that 
previously lacked this capacity (Chou et al., 2008). One study has suggested that E-cadherin 
binds Oct4 at the cytoplasmic membrane to titrate the nuclear availability of this 




 E-cadherin appears to play a role in the upregulation of naïve pluripotency genes: E-
cadherin-null ESCs have an altered gene expression profile similar to that of EpiSC, including 
lower levels of naïve pluripotency genes such as Nanog, Esrrb and Klf4 (Hawkins et al., 2012; 
Soncin et al., 2011), and elevated levels of T/Brachyury (Larue et al., 1996). These results 
suggest that E-cadherin may inhibit the transition of cells from the naïve to the primed state.  
The loss of E-cadherin is also a hallmark of exit from pluripotency. A drop in the levels 
of E-cadherin was shown to be a limiting requirement for neural differentiation, and the 
levels of E-cadherin and Oct4 were found to decrease in synchrony upon the onset of 
differentiation (Malaguti et al., 2013). However, one study using embryoid body aggregates 
concluded that E-cadherin is necessary for lineage commitment of mESCs, as knock-out cells 
failed to upregulate lineage markers even after 30 days in differentiation culture conditions 
(Pieters et al., 2016). The role of E-cadherin in differentiation is therefore not completely 
understood.  
1.5.2.5 E-cadherin function in cellular signalling 
1.5.2.5.1 – E-cadherin and WNT signalling 
 E-cadherin binds β-catenin at adherens junctions, and due to β-catenin’s central role 
in canonical WNT signalling, the effects of E-cadherin on WNT signal transduction have been 
extensively studied. Cadherins have been generally regarded as negative regulators of the 
WNT pathway, since they reduce the amount of β-catenin available for signalling by 
sequestering it at the cytoplasmic membrane. However, this effect can be very context 
dependent (Howard et al., 2011; Murayama et al., 2014). There has been much speculation, 
and some contradictory reports, on whether β-catenin molecules can be freely exchanged 
between the cadherin-bound and transcriptionally-active pools (Gottardi and Gumbiner, 
2004; Kam and Quaranta, 2009). In fact, one study showed that binding to E-cadherin at the 
membrane “primes” β-catenin for transcription, as β-catenin that never bound E-cadherin 
exhibited significantly reduced transcriptional efficiency (Howard et al., 2011). As discussed 
above, another study went as far as suggesting that E-cadherin and β-catenin exist in a 
cytoplasmic membrane-bound complex with Oct4; the authors propose that the complex 
titrates nuclear Oct4 levels for the optimal maintenance of pluripotency (Faunes et al., 2013).   
Knockdown or loss of E-cadherin has been linked to a drop in levels of β-catenin in 
diverse cell types (Hendriksen et al., 2008; Wetering et al., 2001), including mouse ES cells 
(Orsulic et al., 1999). However, these studies also report that despite a massive re-
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arrangement of the cellular β-catenin pool in cells lacking E-cadherin, WNT signalling activity 
remains comparable to that in control cells. These results suggest a lack of correlation 
between fluctuating β-catenin availability (caused by changes in levels of E-cadherin) and 
WNT pathway activation.  
1.5.2.5.2 – E-cadherin and FGF signalling 
 E-cadherin can form membrane-bound complexes with diverse RTKs, allowing signal 
transduction through the FGF/MAPK cascade. Upon the formation of homophilic adherens 
junctions, E-cadherin can bind to epithelial growth factor receptor (EGFR) (Pece and Gutkind, 
2000); this E-cadherin/EGFR interaction has been shown to be mediated through a conserved 
binding site on β-catenin (Hoschuetzky et al., 1994), but can also occur independently of β-
catenin interaction (Qian et al., 2004). Similarly, the extracellular domain of E-cadherin has 
been shown to bind IGF1R, which was found to be critical for pre-implantation embryonic 
survival (Bedzhov et al., 2012). 
1.5.3 N-cadherin 
1.5.3.1 N-cadherin structure 
 N-cadherin is a single-pass transmembrane protein encoded by the Cdh2 gene that 
has a very similar domain architecture to E-cadherin. Its N-terminal extracellular portion is 
made up of five cadherin-binding domains (EC-1 through EC-5) separated by calcium binding 
pockets. The protein is embedded in the cytoplasmic membrane through a transmembrane 
helix, and its C-terminal cytoplasmic domain functions as a scaffold for intracellular binding 
partners like catenin proteins, similarly to E-cadherin (Shapiro et al., 1995; Tamura et al., 
1998).  
The classical cadherins share highly conserved residues in their binding pockets 
(Tamura et al., 1998), but their specificity for their own type maps to the most N-terminal 
EC-1 domain (Nose et al., 1990; Shan et al., 2000). Additional functional specificity of N-
cadherin lies in a unique 69-amino acid portion of the EC-4 domain, which is both necessary 
and sufficient to confer a motile phenotype in squamous carcinoma epithelial cells (Kim et 
al., 2000). E- and N-cadherin therefore represent similar molecules with subtle differences in 
structure, leading to refined differences in their function.  
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1.5.3.2 N-cadherin expression in embryogenesis 
 N-cadherin expression begins on the mRNA level during gastrulation in the posterior 
epiblast of the E6.0 mouse embryo (Peng et al., 2016). Expression of N-cadherin in early 
embryonic tissues is accompanied by cadherin switching, where E-cadherin is downregulated 
and N-cadherin is expressed in its place. The first such cadherin switch, and the first 
expression of N-cadherin protein, is in the primitive streak, allowing EMT and the formation 
of the migrating mesoderm (Butz and Larue, 1995; Luo et al., 2001; Nagafuchi and Takeichi, 
1988; Radice et al., 1997). The next cadherin switch occurs at around E8.0 in the ectoderm 
during neurulation, when the neural plate invaginates to form the neural tube (Luo et al., 
2001; Yang and Weinberg, 2008). At E8.5, N-cadherin is present in the neural plate, the neural 
tube and in the somites (Lee et al., 2007; Radice et al., 1997). Further on in development, it 
is present in the neural tube, non-neural ectoderm derivatives, and mesoderm derivatives 
such as the heart (Luo et al., 2001; Moore and Walsh, 1993; van Raamsdonk and Tilghman, 
2000). 
1.5.3.3 N-cadherin function in adhesion 
 E- and N-cadherin have similar functions in mediating homophilic adhesion through 
the same intracellular binding partners (Bedzhov et al., 2013). Like E-cadherin, N-cadherin 
forms cis-dimers on the surface of one cell before forming homophilic trans-interactions with 
cadherins on adjacent cells (Koch et al., 2004). Mutations of certain key residues in the 
calcium binding pockets, the donor strand, or the acceptor pockets of the extracellular 
domains of N-cadherin result in the abrogation of adhesion, between both mutant-mutant 
and mutant-WT cadherin pairings (Martinez-Garay et al., 2016; Tamura et al., 1998). These 
mutations have been used to study the effects of N-cadherin-based adhesion on cell 
migration and signalling (Martinez-Garay et al., 2016). 
 While E- and N-cadherin-mediated adhesion is achieved through similar 
mechanisms, junctions formed by the two molecules give rise to different strengths of 
adhesion. Atomic force microscopy studies have shown that E-cadherin has three times the 
adhesive strength of N-cadherin (Chu et al., 2004; Chu et al., 2006).  
1.5.3.3.1 – N-cadherin function in early embryogenesis 
 N-cadherin is essential for embryonic survival; embryos lacking the protein die by 
E10.0 due to multiple developmental defects caused by faulty adhesion, most notably in the 
heart, but also in the somites, neural tube, and yolk sac (Radice et al., 1997). The lethality 
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caused by heart defects can be rescued by knocking-in E-cadherin, suggesting that the 
phenotype is caused by faulty adhesion, and not a specific role of N-cadherin signalling (Luo 
et al., 2001). In other developmental contexts, N-cadherin regulates the migration of 
neuronal progenitor cells and the organisation of internal cortical structures of the brain 
(Kadowaki et al., 2007; Nguyen and Mège, 2016).  
1.5.3.3.2 – N-cadherin and WNT signalling 
N-cadherin can also interact with β-catenin, though this interaction has been less 
studied than that between β-catenin and E-cadherin. In HEK293 cells, siRNA knockdown of 
N-cadherin was shown to lead to a significant decrease in the transcriptional activity of β-
catenin, showing that N-cadherin can promote WNT signalling in certain contexts. In the 
same study, embryos lacking N-cadherin exhibited an attenuation of WNT signalling in 
posterior and midline epiblast and laterally migrating mesoderm, showing that N-cadherin 
may play a role in WNT-driven induction of mesoderm (Howard et al., 2011).  
N-cadherin can also interact with β-catenin in a WNT-independent manner. In 
cortical neural precursor cells, N-cadherin knockdown was shown to cause premature 
migration and neuronal differentiation. The authors showed that blocking N-cadherin led to 
a reduction in β-catenin mediated signalling, but that this signalling was likely to take place 
through a WNT-independent mechanism; indeed, they went on to show that N-cadherin 
mediates β-catenin signalling through the activation of Akt signalling. The study concluded 
that cortical neural precursors maintain their own niche by signalling to one another through 
homotypic adhesion via N-cadherin (Zhang et al., 2010).  
1.5.3.3.3 – N-cadherin and FGF signalling 
 In contrast to E-cadherin, which binds EGFR and IGF1R (Bedzhov et al., 2012; 
Hoschuetzky et al., 1994), N-cadherin binds FGFR and promotes signal transduction through 
this receptor (Williams et al., 1994), suggesting the existence of cadherin species-dependent 
interactions with different members of the RTK family (Fedor-Chaiken et al., 2003). N-
cadherin has been shown to bind FGF receptors via a functional motif on its fourth 
extracellular cadherin domain (EC4) (Williams et al., 2001).  
 N-cadherin-based stimulation of FGF signalling has been demonstrated in many 
additional contexts. In EpiSCs, blocking N-cadherin causes a decrease in pluripotency marker 
expression and promotes differentiation while simultaneously inhibiting phosphorylation or 
ERK and Akt, a phenotype that could not be rescued by the overexpression of E-cadherin. 
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The authors concluded that N-cadherin promotes the primed pluripotent state in EpiSCs by 
stabilising FGF1R and promoting signalling through the MAPK/ERK and Akt pathways 
(Takehara et al., 2015). Similarly, in breast cancer cell lines, N-cadherin binding to FGFR was 
found to stabilise the receptor and protect it from ligand-induced internalisation, thus 
causing sustained activation of the MAPK/ERK pathway and leading to the acquisition of 
metastatic properties (Suyama et al., 2002). N-cadherin has been shown to play a role in 
promoting neurite outgrowth independently of its role in adhesion (Doherty et al., 2000; 
Utton et al., 2001), and ectopically expressed N-cadherin in the epithelial cells of the 
mammary gland was enough to induce constitutively active FGF signalling in these cells (Kotb 
et al., 2011). These studies highlight a functional link between N-cadherin and FGF signalling 
in multiple biological contexts.  
1.6 Regulation of cadherin expression 
There has been considerable study of the regulatory mechanisms of E- and N-
cadherin expression in EMT and cancer metastasis (reviewed in van Roy and Berx, 2008; and 
Wheelock et al., 2008). In most cellular contexts, E- and N-cadherin are expressed in mutually 
exclusive patterns, suggesting that the two proteins may co-repress each other.  In neural 
stem cells, for example, E- and N-cadherin have been shown to reciprocally downregulate 
one another (Chen et al., 2015b).  
E-cadherin expression is negatively regulated during EMT by several zinc finger 
transcription factors, such as Snail, Slug, Twist, various E-proteins, Zeb1 and Zeb2; E-cadherin 
protein is additionally stabilised by p120-catenin (Wheelock et al., 2008). Conversely, some 
of these transcription factors also function to upregulate N-cadherin expression; for example, 
Twist has been identified as an activator of N-cadherin transcription in prostate carcinoma 
cells, human breast epithelial cells, and in gastric cancer cells (Alexander et al., 2006; 
Wheelock et al., 2008). However, it is acknowledged that the negative regulation of the Cdh1 
promoter and the positive regulation of the Cdh2 promoter are both complex processes, and 
the details of their function in other contexts, including neural differentiation, remain to be 
established (Wheelock et al., 2008). 
1.6.1 E- and N-cadherin function in cancer metastasis 
 In addition to EMT, neural differentiation, and other stages of development, another 
context in which cadherin switching is of great importance is in cancer metastasis. In general, 
E-cadherin is associated with the suppression of invasiveness, while in contrast, N-cadherin 
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is linked to more aggressive, invasive and motile metastising cancer phenotypes (Hazan et 
al., 2000; Seidel et al., 2004). The effects of cadherin switching in cancer, and the regulatory 
mechanisms by which it is driven, appear to be similar to that occurring during EMT, and is 
therefore not fully relevant to the current project. For reviews on the topic, see Hazan et al., 
2004; and Larue and Bellacosa, 2005.  
 
1.7 Aims of the thesis 
 As discussed in this introduction, E- and N-cadherin play diverse roles during early 
embryogenesis through their functions in both adhesion and signalling. Previous research in 
our lab has shown that blocking the function of E-cadherin promotes faster and more 
synchronous neural differentiation, raising the possibility that cadherin switching may play a 
role in regulating this process (Malaguti et al., 2013). It is therefore hypothesised that the 
switch from E- to N-cadherin during early neural induction modulates signalling and 
differentiation competence, with the WNT and FGF pathways proposed as two candidate 
pathways through which such an effect may be achieved. Specifically, the research 
summarised in this thesis aims to answer three broad questions:  
1. Is cadherin switching initiated before neural differentiation?  
2. If so, does cadherin switching help regulate neural differentiation?  
3. If so, is this due to effects on adhesion or effects on signalling?  
Answering these questions should shed more light on how neural differentiation 
proceeds robustly in the embryo, and provide novel insights that can be applied to further 









2.1.1.1 – Biosafety cabinets 
 Labculture® Class II Type A2 biological safety cabinet - Esco  
 UV3 HEPA PCR Workstation – UVP  
2.1.1.2 – Centrifuges 
 Centrifuge 5702 – Eppendorf  
 FisherbrandTM Standard Mini centrifuge – Fisher Scientific 
 Heraeus Biofuge 13 – Sepatech  
 Shandon CytoSpin III Cytocentrifuge, 8358-30-0001 – Shandon  
2.1.1.3 – Electrophoresis power packs 
 PowerPacTM Basic power supply – BioRad  
2.1.1.4 – Flow cytometers 
 BD AccuriTM C6 – BD Biosciences 
 BD FACSAriaTM II – BD Biosciences 
2.1.1.5 – Specialist Freezers 
 Ultra low temperature freezer U725 – New Brunswick Scientific  
 Liquid nitrogen storage tank – Statebourne Biostytem 100+ 
2.1.1.6 – Incubators 
 CO2 UV Incubator, MCO-19AICUV – Sanyo/Panasonic 
 HerathermTM Compact microbiological incubator – Thermo Scientific 
2.1.1.7 – Microscopes 
 AE2000 inverted microscope – Motic  
 Leica SP8 3- and 5-detector confocal microscope – Leica  
 Olympus BX61 widefield upright metallurgical microscope – Olympus  
 Olympus IX51 inverted microscope – Olympus  
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 Operetta® High Content Imaging System - PerkinElmer 
2.1.1.8 – Nucleofectors 
 4D-Nucleofector™ System – Lonza  
2.1.1.9 – Plate readers 
 GloMax®-Multi Microplate Multimode Reader, E7061 – BioRad 
2.1.1.10 – Spectrophotometers 
 NanoDropTM Lite – Thermo Fisher, ND-LITE 
2.1.1.11 – Thermocyclers 
 LightCycler® 480 Instrument II – Roche  
 TProfessional thermocycler – Biometra 
2.1.1.12 – Thermal mixers and shakers 
 Incu-Shaker Mini – Benchmark Scientific 
 ThermoMixer® F – Eppendorf  
2.1.1.13 – Transilluminators 
 Dark Reader blue light transilluminator – Clare Chemical Research 
 GeneFlash gel documentation system – Syngene  
2.1.2 Supplies and Reagents 
2.1.2.1 General reagents 
Table 2.1: List of general reagents used in the thesis. 
Reagent Manufacturer Catalogue number 
1kb DNA ladder New England Biolabs N3232L 
2-Mercaptoethanol, 50mM (1000x) Life Technologies 31350010 
7AAD viability staining solution eBioscience 00-6993-59 
Accutase® solution Sigma-Aldrich A6964 
Activin-A (Human/murine/rat raised in E. 
coli) 
Peprotech 120-14E 
Ampicillin sodium salt Calbiochem 171254 
Apo-transferrin, human Sigma-Aldrich T-1147 
B-27® Supplement Gibco 17504-044 
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BactoTM Agar BD 214010 
BamHI-HF® (100,000 U/mL) New England Biolabs R3136T 
Benzyl alcohol Sigma-Aldrich 8421 
Benzyl benzoate Sigma-Aldrich B6630 
Boric acid, solid Fisher Scientific BP168-1 
Bovine serum albumin (7.5%) Gibco 15260-037 
Bovine serum albumin (solid) Sigma-Aldrich A3059 
Brilliant III Ultra-Fast qPCR Master Mix, 2x Agilent 600880-51 
Chick serum Sigma C5405 
Chiron / CHIR 99021 Axon 1386 
Complete™, EDTA-free Protease Inhibitor 
Cocktail 
Roche 05056489001 
CutSmart® Buffer (10x) New England Biolabs B7204S 
DAPI Sigma D9542 
Dimethyl sulphoxide, dehydrated VWR 23500.260 
DMEM/F-12  Gibco 21331-020 
dNTP Mix (10mM) Invitrogen 18427-013 
Donkey serum Sigma D9663 
Doxycycline Hyclate Sigma D9891 
Dulbecco’s Phosphate Buffered Saline 
(PBS) 
Sigma-Aldrich D8537 
EDTA Fisher BP2482 
EDTA (for tissue culture) VWR 20301.186 
Ethanol absolute 100% VWR Chemicals 20821.330 
FGF2, recombinant human basic protein R&D 233-FB 
Fibronectin from bovine plasma Sigma-Aldrich F1141 
Foetal calf serum  APS S-001B-BR 
Foetal calf serum  Life technologies 10270106 
Formaldehyde solution, 37-41% Fisher Chemical F/1501/PB08 
Gelatin, powder Sigma G1890 







Giemsa stain  VWR 350864X 
Glasgow minimum essential medium  Sigma G5154 
Glycerol CalBiochem 356350 
High QC Enhancer (5x) New England Biolabs B9028S 
HyCloneTM Water, molecular biology 
grade 
Fisher Scientific SH3053802 
Insulin from bovine pancreas Sigma-Aldrich I-1882 
Kanamycin sulfate Calbiochem  420311 
KaryoMAX™ Colcemid™ Solution in HBSS Gibco 15210040 
KnockOutTM Serum Replacement Gibco 10828028 
Laminin, 1-2mg/mL Sigma-Aldrich L2020 
LightCycler® 480 Probes Master (2X) Roche 04887301001 
L-glutamine, 200mM Invitrogen 25030-024 
M2 Medium Sigma M7167-100mL 
MEM non-essential amino acids, 100x Invitrogen 11140-036 
N-2® Supplement Gibco 17502-048 
Neurobasal® Medium Gibco 21103049 
NotI-HF (100,000 U/mL) New England Biolabs R3189M 
Orange G Sigma-Aldrich O3756 
Paraformaldehyde (PFA) Sigma-Aldrich P6148 
PD 0325901 Axon 1408 
Penicillin (10,000 U/mL) / streptomycin 
(10,000 µg/mL)  
Invitrogen 15140-122 
Pertex® HistoLab 00801-EX 
Phosphate buffered saline tablets Sigma-Aldrich P4417-100TAB 
PhosSTOPTM tablets Roche 04906837001 
Poly-L-ornithine solution, 0.01% Sigma-Aldrich P4957 
Progesterone Sigma-Aldrich P8783 
ProLongTM Gold Antifade Mountant Thermo Fisher 
Scientific 
P36930 
Protein assay dye reagent concentrate BioRad 500-0006 
Putrescine dihydrochloride Sigma-Aldrich P5780 
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Q5® DNA Polymerase (2000 U/mL) New England Biolabs M0493S 
Quick StartTM bovine serum albumin 
standard 
BioRad 500-0206 
Random Primers Invitrogen 48190-011 
rAPid Alkaline Phosphatase (1000U) Roche 04-898-133-001 
RNAseOUTTM Recombinant Ribonuclease 
Inhibitor (40 U/µL) 
Invitrogen 10777019 
RNAseZap® RNAse decontamination 
solution 
Ambion AM9780 
Sodium pyruvate, 100mM Invitrogen 11360-039 
Sodium selenite Sigma-Aldrich S5261 
Subcloning EfficiencyTM DH5αTM 
Competent Cells  
Invitrogen 18265017 
SYBR® Safe DNA gel stain Thermo Fisher 
Scientific 
S33102 
T4 DNA Ligase (400,000 U/mL) New England Biolabs M0202S 
T4 DNA Ligase reaction buffer (10x) New England Biolabs B0202S 
Tris Base, solid Fisher Scientific BP152 
TritonTM X-100 Sigma X100-100ML 
Trypsin 2.5%, 100x Invitrogen 15090-046 
Tryptose phosphate broth solution Sigma T8159 
UltraPureTM Agarose Invitrogen 16500-500 
Universal Probe Library probes Roche Variable 
X-Gal (50mg/mL) Promega V394A 









2.1.2.2 Plastics, glassware and supplies 
Table 2.2: List of standard plastics, glassware and supplies.  
Name Supplier Catalogue number 





Cell scrapers, small Corning 3010 
Centrifuge tubes, 15mL clear polypropylene Corning 430790 
Costar® multiple well plates, 6-well Corning 3516 
Costar® multiple well plates, 12-well Corning 3513 
Costar® multiple well plates, 24-well Corning 3524 
Costar® multiple well plates, 96-well Corning 3595 
Cover glasses, 12 mm diameter Marienfeld-
Superior 
0111520 
CryoTubeTM Vials, 1.0mL Thermo 
Scientific 
377224 
Falcon® 5mL round bottom polystyrene test 
tube with cell strainer snap cap 
Corning 352235 
Fast Read 102® hemocytometer system Kova 
International 
BVS100H 
ImmEdge Hydrophobic Barrier PAP Pen Vector 
Laboratories 
H-4000 
LightCycler® 480 Multiwell Plate 384, white Roche 04729749001 
Microscope slides VWR ECN 631-1553 
Micro tubes with screw cap, 1.5mL Sarstedt 72692005 
Multiply® µStrip Pro PCR tubes Sarstedt 72.991.002 
Polysine® adhesion slides, white VWR 631-0107 
Round bottom polypropylene test tube with 
snap cap, 14mL 
Falcon 352059 
Shandon™ Single Cytofunnel™ Thermo Fisher 
Scientific 
5991040 







SterilinTM standard 90mm petri dish Thermo Fisher 
Scientific 
101VR20 
Syringe filter unit, 0.22µm, Millex-GP Millipore SLGP033RS 
TC-treated culture dish, 100mm Corning 430167 
Transfer pipettes, 3.5mL Sarstedt 86.1172.001 
U-shaped canted neck cell culture flask,  75cm² Corning 430720U 





 Table 2.3: List of standard kits used in thesis. 
Name Supplier Catalogue number 
Absolutely RNA Miniprep Kit Agilent 400800 
M-MLV Reverse Transcriptase Kit Invitrogen 28025 
P3 Primary Cell Nucleofector™ Kit L (12 RCT) Lonza V4XP-3012 
QIAprep Spin Miniprep Kit Qiagen 27104 
QiaQuick Gel Extraction Kit Qiagen 28704 
Zero Blunt® TOPO® PCR Cloning Kit Invitrogen K2800-20SC 
 
2.1.3 Compositions of standard solutions 
Table 2.4: Standard solution compositions. All solutions made up in Milli-Q filtered and deionised 
water unless otherwise stated. 
Solution Components 
Activin A solution, 
20µg/mL 
100µg/mL Activin A (Peprotech) diluted to 20µg/mL in sterile-
filtered 0.1% BSA (Sigma-Aldrich) in PBS 
BABB 1:2 solution of benzyl alcohol : benzyl benzoate 
Blocking solution (for 
ICC) 
3.33% Donkey serum (Sigma), 0.1% TritonTM X-100 (Sigma), 
0.001% sodium azide in PBS 
DNA loading dye, 6x 0.25% Orange G (Sigma), 30% glycerol (CalBiochem) 
FACS buffer (FB), 2% 2% FCS (Life technologies) in Dulbecco’s PBS (Sigma) 
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FACS collection buffer, 
50% 
50% FCS (Life technologies) in Lif-serum medium 
FGF2 solution, 
10µg/mL 
Lyophilised FGF2 powder (R&D) reconstituted to 10µg/mL in 
sterile-filtered 0.1% BSA (Sigma-Aldrich) in PBS 
Formaldehyde fixative 
solution, 4% 
1:10 dilution of 40%  Formaldehyde solution (Fisher chemical, as 
supplied) in PBS 
Gelatin, 0.1% 1% gelatin (Sigma) in water and autoclaved, then diluted to 0.1% 
in PBS (Sigma) 








Prepared in-house by TC staff by transfecting Cos7 cells with 
plasmid to make them produce LIF. The concentration was then 
assayed by using indicator cells, diluted in PBS to final 
concentration.  
PBS, non-TC One PBS tablet (Sigma-Aldrich) dissolved in 200mL water yields 
0.01M phosphate buffer, 0.0027M KCl and 0.137M NaCl, pH7.4 
at 25°C 
PBST PBS (Sigma-Aldrich) with 0.1% Triton X-100 (Sigma) 
TBE Buffer, 10x 40mM Tris Base (Fisher) 450mM boric acid (Fisher), 10mM EDTA, 
pH 8.0 
Trypsin (1:5) 0.186g of EDTA (VWR) added to 500mL PBS (Sigma) and filter-
sterilised. 5mL chick serum (Sigma) and 20mL 100x Trypsin 
(Invitrogen) added. Prepared by TC service. This solution was 





2.1.4.1 Primary antibodies 
Table 2.5: Primary antibodies used for ICC and flow cytometry. All primary antibodies were diluted in 
blocking solution prior to ICC staining or in FACS buffer prior to staining for flow cytometry.    






β-catenin (total) Polyclonal Rabbit 1:1000 Sigma  C2206 
β-catenin (active), 
dephosphorylated on 
Ser37 or Thr41 
8E7 Mouse 1:1000 Millipore 05-665 
Brachyury Polyclonal Goat 1:200 R&D AF2085 
E-cadherin DECMA-1 Rat 1:200 Sigma U3254 
E-cadherin, eFluor660-
conjugated 
DECMA-1 Rat 1:300 eBioscience 50-3249-
82 
GFP Polyclonal Chicken 1:1000 Abcam 13970 
HA HA-7 Mouse 1:1000 Sigma H3663 
Laminβ1 Polyclonal Chicken 1:1000 Abcam Ab90169 
Laminβ1 Polyclonal Rabbit 1:1000 Abcam Ab16048 
N-cadherin 32  Mouse 1:200 BD 610920 
N-cadherin, 
AlexaFluor488-conjugated 
Polyclonal Sheep 1:50 R&D FAB6426G 
 
Oct4 N-19 Goat 1:200 Santa Cruz SC-8628 
Sox1 N23-844 Mouse 1:200 Pharmigen 560749 





2.1.4.2 Secondary antibodies 
Table 2.6: Secondary antibodies for ICC. All secondary antibodies were diluted at 1:1000 in blocking 
solution prior to ICC staining unless stated otherwise.  
Host species  Species 
recognised 
Alexa Fluor excitation 
wavelength (nm) 
Company Cat. number 
Donkey Chicken 488 Jackson Labs 703-545-155 
647 Merck AP194SA6 
Goat 488 Invitrogen A11055 
568 Invitrogen A11057 
647 Invitrogen A21447 
Mouse 488 Invitrogen A21202 
568 Invitrogen A10037 
647 Invitrogen A31571 
Rabbit 405 Abcam AB175651 
488 Invitrogen A21206 
555 Invitrogen A31572 
647 Invitrogen A31573 
Rat 488 Invitrogen A21208 
568 Abcan AB175475 
Sheep 488 Invitrogen A11015 
Goat Rat 405 Biolegend 405412 
488 Invitrogen A-11006 
 
2.1.5 Plasmids 
Table 2.7: Plasmids used in the thesis.  
Plasmid name Generated by 
p2Lox-eGFP Iacovino et al., 2009 
p2Lox-Ncad-HA Karolina Punovuori 
pCRTM-BluntII-TOPO®  Thermo Fisher Scientific, Cat. No. K28002 
pCR-BluntII-Topo-Ncad-HA Karolina Punovuori 
pPYCAG-3xFlag-eGFP-IP Ian Chambers lab 
pPYCAG-Ncad-HA-IRES Karolina Punovuori 
62 
 
2.1.6 PCR primer sequences 
2.1.6.1 qPCR primer sequences 
Table 2.8: qPCR primer sequences. Forward (F) and reverse (R) primers used to recognise each gene 
shown together with UPL probe they were used with.  
Target Names (F, R) Forward sequence Reverse sequence UPL probe 
number 













































































































2.1.6.2 Cloning primer sequences 
Table 2.9: Cloning primer sequences. “F” and “R” refer to forward and reverse primer orientation, 
respectively.  
Name Target Additional features Sequence 
KP01 N-cadherin (F) - ATGTGCCGGATAGCGGGAGC 
KP02 N-cadherin (R) - TCAGTCGTCACCACCGCCGT 




KP04 N-cadherin-HA (R) Flanked by a NotI 
restriction site, contains 








2.1.6.3 Sequencing primer sequences 
Table 2.10: Sequencing primer sequences. “F” and “R” refer to forward and reverse primer orientation, 
respectively.  
Name Target Sequence 
CAGF CAG vector (F) TGCTGGTTGTTGTGCTGT 
CAGR CAG vector (R) CGCACACCGGCCTTATTCCA 
KP05 N-cadherin (F) GCCTTTCAAACACAGCCACAG 
KP06 N-cadherin (F) TCATCCTGCTGATCCTTGTTCTC 
KP07 N-cadherin (F) CCAGCTCCAGCAACCAGATAC 
KP08 N-cadherin (F) AGTCTTTGACTACGAGGGCAGC 
M13F Blunt II Topo vector (F) GTAAAACGACGGCCAG 
M13R Blunt II Topo vector (R) CAGGAAACAGCTATGAC 
p2LoxF p2Lox vector (F) GCTGTTCTCCTCTTCCTCATCTC 
p2LoxR p2Lox vector (R) TCCCCCTGAACCTGAAACAT 
 
2.1.7 Software packages & databases 
2.1.7.1 – Cloning and sequencing 
 ApE, A plasmid Editor – M. Wayne Davis, University of Utah 
2.1.7.2 – Data processing and statistical analysis 
 GraphPad Prism 6 – GraphPad Software Inc.  
 Microsoft Excel 2013 – Microsoft Corporation 
 R version 3.4.1 – R Foundation for Statistical Computing  (R Core Team, 2017) 
2.1.7.3 – Flow cytometry 
 FlowJo – LLC 
2.1.7.4 – Image analysis 
 ColumbusTM image data storage and analysis system – PerkinElmer  
 ImageJ/Fiji – (Schindelin et al., 2012) 
 PickCells – Guillaume Blin, University of Edinburgh 
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2.1.7.5 – Nanostring RNA expression analysis 
 nSolverTM 4.0 – NanoString Technologies, Inc 
2.1.7.6 – qPCR analysis 
 LightCycler® 480 – Roche Life Sciences 
2.1.7.7 – qPCR primer design 
 UPL assay design centre – Roche Life Sciences 
2.1.7.8 – Referencing 
 Mendeley – Elsevier  
2.2 Methods 
2.2.1 DNA methods 
2.2.1.1 DNA cloning methods 
2.2.1.1.1 – Restriction enzyme digestion 
DNA digestions were performed with 0.2-100µg DNA with 2-100 units of selected 
restriction enzymes, using digestion conditions and buffers recommended by the 
manufacturer (New England Biolabs). Digestions were typically performed for 1-3 hours at 
37°C, with heat inactivation performed (where appropriate) according to the manufacturer’s 
recommendations.  
2.2.1.1.2 – DNA fragment ligation 
Linear DNA fragments were ligated using T4 DNA Ligase (New England Biolabs). 
Reactions were prepared with 50ng of vector backbone and a 1:1 vector:insert molar ratio. 
Ligation reactions were performed in a 10µL total reaction volume with 400U of T4 DNA 
ligase and T4 Buffer (New England Biolabs) at a final concentration of 1x. For each 
vector/insert combination, a no-insert control was prepared as a ligation control for 
subsequent transformations into bacteria. Ligation reactions were performed for 1h at 37°C 
or overnight at 4°C.  
For problematic ligation reactions where a re-ligation of the vector backbone was 
suspected, the backbone was treated with rAPid Alkaline Phosphatese (Roche) following the 
manufacturer’s protocol. Briefly, 100ng of vector backbone was incubated in a 10µL reaction 
with 1µL each of supplied buffer and enzyme. The reaction was incubated at 37°C for 30min 
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and heat-inactivated at 75°C for 15min. The alkaline phosphatase-digested backbone was 
then used in a ligation reaction as usual.  
2.2.1.1.3 – Preparation of agarose gels 
Gels were prepared by mixing UltraPureTM agarose powder (Invitrogen) into 1x TBE 
to a final concentration of 0.5-2% (mass/volume), dependent on application. The solution 
was heated in a standard microwave at full power until the agarose was fully dissolved. After 
briefly cooling the solution, SYBR® Safe DNA Gel Stain (Invitrogen) was added at 1:10,000 
dilution. The solution was then poured into a gel mould with a well comb of desired size and 
allowed to set at room temperature.  
2.2.1.1.4 – Gel electrophoresis 
Before loading onto gels, DNA samples were mixed with DNA loading dye at 1:6 
dilution. An agarose gel was covered in 1x TBE in a gel mould, with the well comb removed. 
The samples were then loaded into individual wells alongside a well of 1kb DNA ladder (New 
England Biolabs). The gel mould was then connected to a PowerPacTM Basic power supply 
(BioRad), and gels were electrophoresed at 80V for 40-90 minutes depending on the size of 
the DNA samples.  After the run was complete, gels were visualised under a blue-light 
transilluminator (Clare Chemical Research), or visualised and photographed under a UV 
transilluminator (SynGene) to verify band sizes.  
2.2.1.1.5 – DNA extraction from agarose gels 
DNA that was to be used in further applications was visualised under a blue-light 
transilluminator (Clare Chemical Research) only to protect it from degradation. DNA bands 
of interest were cut out from the gel using a scalpel. The DNA was subsequently extracted 
using the QiaQuick Gel Extraction Kit (Qiagen). Following gel extraction, DNA concentration 
was quantified using a NanoDropTM Lite scectrophotometer (Thermo Fisher).  
2.2.1.1.6 – DNA sub-cloning into pCRTM-Blunt II-TOPO® vector 
After DNA purification from agarose gels, blunt-ended PCR products were sub-cloned 
into a pCRTM-Blunt II-TOPO® vector by using a Zero Blunt® TOPO® PCR Cloning Kit (Invitrogen). 
This method allows the insertion of a PCR product into the TOPO vector without the need for 
a separate ligation reaction. The resulting DNA mix was transformed directly into competent 
bacteria, with addition of X-Gal (Promega) for blue-white screening.  
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2.2.1.1.7 – Preparation of antibiotic selection plates 
Lysogeny broth (LB) agar was prepared by the institute’s wash staff by dissolving 
1.5% BactoTM Agar (BD) in LB. The solid stock was microwaved at full power until it liquefied, 
and the solution was allowed to cool before addition of antibiotics.  
Stocks of 1000x ampicillin and kanamycin were prepared by dissolving 100mg or 
50mg of ampicillin sodium salt powder or kanamycin sulfate powder (respectively, both 
Calbiochem) in 1mL of nuclease free water (Gibco) and filtering the solution through a 
0.22µm syringe filter unit (Millipore). The appropriate antibiotic was then added at 1:1000 
dilution to the cooled LB-agar solution. In a microbiological UV hood, 15mL LB-agar-antibiotic 
solution was pipetted into 90mm Standard Petri dishes (Sterilin), and allowed to set at room 
temperature.  
2.2.1.1.8 – Plasmid transformation into competent bacteria 
Plasmids were transformed into chemically competent DH5α Escherichia coli 
(Invitrogen) following manufacturer’s instructions. Briefly, less than 200ng of plasmid DNA 
was added to a tube of 50µl of DH5α cells and incubated on ice for 30 minutes. The mixture 
was then heat-shocked by holding the tube in a water bath at 42°C for 45s. The tube was 
then returned to ice for 2min, after which 950µL of LB was added. The solution was then 
incubated in a shaker set to 800rpm at 37°C for one hour to allow the bacteria to start 
expressing antibiotic resistance genes. The solution was then centrifuged at 8000rpm for 
3mins, 800µL of supernatant was removed, and the pellet was resuspended in the remaining 
solution, and 100µL of the resulting bacterial solution was spread onto antibiotic selection 
agar plates. For transformations requiring blue-white screening, 10µL (500µg) X-gal 
(Promega) was added to each plate. Plates were incubated at 37°C overnight.  
2.2.1.1.9 – Preparation and use of bacterial glycerol stocks 
Following overnight incubation, bacterial colonies were picked from selection plates 
using a yellow (200µL) pipette tip, which was used to inoculate 5mL LB supplemented 1:1000 
with appropriate antibiotics in a 14mL Falcon Snap Cap tube (Falcon). The tubes were 
incubated overnight at 37°C, shaking at 225rpm. For long-term storage of bacteria containing  
constructs, glycerol stocks were prepared by mixing 500µL of the bacterial suspension with 
500µL of 50% glycerol (Calbiochem) in a screw-cap 1.5mL micro tube (Sarstedt). The glycerol 
stocks were stored long-term at -80°C.  
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To grow bacterial cultures from glycerol stocks, the tube containing the stock was 
removed from -80°C and kept on dry ice. In a microbiology UV hood, a 200uL pipette tip was 
used to scrape off a small amount of frozen suspension and used to inoculate 5mL of LB 
supplemented with appropriate antibiotic. The culture was incubated overnight at 37°C, 
shaking at 225rpm. The glycerol stock was returned to -80°C for long-term storage.  
2.2.1.1.10 – DNA purification from bacterial cultures 
DNA was purified from the overnight cultures by using a QIAprep spin miniprep kit 
(Qiagen), and DNA concentration was quantified using a NanoDropTM spectrophotometer 
(Thermo Scientific). The resulting DNA stocks were stored at -20°C until further use.  
2.2.1.1.11 – Plasmid sequencing 
Sequencing of DNA plasmids was performed by Edinburgh Genomics at the 
University of Edinburgh via BigDye® Terminator Cycle Sequencing technology (Invitrogen). 
For each construct/primer pair to be used for sequencing, Edinburgh Genomics were 
supplied with a reaction containing 500ng DNA, 1uL primer solution at 3.2µM, with nuclease-
free water (Fisher Scientific) supplemented to 6µL. Returned sequencing reads were analysed 
using ApE software.  
 
2.2.1.2 PCR methods 
2.2.1.2.1 – Q5® Hot Start PCR 
Q5® Hot Start High-Fidelity DNA Polymerase (NEB) was used to amplify genes of 
interest from cDNA in which the given gene was shown to be expressed by qPCR. PCR 
reactions were performed according to manufacturer’s recommendations in a final reaction 
volume of 50µL.  
Table 2.11: Q5® Hot Start PCR reaction components.  
Component Volume per reaction Final concentration 
5x Q5 Reaction Buffer 10 µL 1x 
10 mM dNTPs 1 µL 0.2 mM 
10 µM forward primer 2.5 µL 0.5 µM 
10 µM reverse primer 2.5 µL 0.5 µM 
Template cDNA 4 µL 0.2 ng/µL 
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Q5® Hot Start High Fidelity DNA 
Polymerase 
0.5 µL 1 U/reaction 
5x High QC Enhancer (optional) 10 µL 1x 
Nuclease-free water To 50µL - 
 
PCR reactions were performed in a TProfessional thermocycler (Biometra) using cycling 
conditions listed below:  
Table 2.12: Q5® Hot Start PCR reaction conditions. 
Step Temperature (°C) Duration (min:s) Number of cycles 
1. First denaturation 98 0:30 1 
2. Denaturation 98 0:10 35 
3. Annealing 58 0:30 
4. Extension 72 2:30 
5. Final extension 72 2:00 1 
 
2.2.1.3 qPCR methods 
Quantitative PCR (qPCR) was used to quantify relative gene expression levels of cell 
populations. To this end, mRNA was isolated from cell lysates and was then reverse-
transcribed into cDNA as described in “2.2.2 RNA methods”. The Roche LightCycler® 480 Real-
Time PCR system, coupled with the Universal Probe Library (UPL) from Roche, was used for 
all qPCR measurements. Primers used for qPCR were designed using the online UPL Assay 
Design Centre facility from Roche.  
qPCR reactions were carried out in a 384-well plate (Roche) with a total reaction 
volume of 8µL. Two commercially available qPCR master-mixes were used, depending on 
their availability in the lab. For the two master-mixes, reaction components remained 
unchanged but slight changes were made to the reaction conditions.  
Table 2.13: qPCR reaction components 




Mastermix; either:  
 LightCycler® 480 Probes Master (Roche) 




 2× Brilliant III Ultra-FastqPCR Master Mix (Agilent) 
Nuclease-free water 1.2 µL - 
Forward primer (10µM) 0.36 µL 450 nM 
Reverse primer (10µM) 0.36 µL 450 nM 
UPL probe (10µM) 0.08 µL 100 nM 
Template cDNA 2 µL - 
 
Table 2.14: qPCR reaction conditions for Roche master-mix. 






1. Pre-incubation 95 5:00 4.8 1 
2. Denaturation 95 0:05 4.8 45 
3. Annealing 60 0:10 2.5 
4. Extension 72 0:01 4.8 
5.  Fluorescence 
measurement 
- -  
6. Cooling 40 2:00 2.5 1 
 
Table 2.15: qPCR reaction conditions for Agilent master-mix. 






1. Pre-incubation 95 3:00 4.4 1 
2. Denaturation 95 0:05 4.4 45 
3. Annealing 60 0:10 2.2 
5.  Fluorescence 
measurement 
- -  





For each gene tested, a 10:1 dilution series of a DNA plasmid or PCR amplicon was 
prepared containing the gene of interest. This was used in the LightCycler® 480 software 
(Roche) to determine primer efficiency for each primer pair used. For each experiment, one 
or two housekeeping genes (TBP, SDHA or Ywhaz) were assayed, and the levels of the 
housekeeping gene were used to normalise readings for other genes within each sample. For 
each gene tested, three technical replicates were set up on the qPCR plate to account for 
small-volume pipetting error.  
qPCR data were analysed in Microsoft Excel. The mean concentration and standard 
deviation were calculated for each sample from three technical replicates, with any obvious 
outliers removed manually. Readings were then normalised to the geometric mean of the 
housekeeping gene concentrations. Where primer efficiency calculations could not be 
performed by LightCycler® 480 software, sample concentration was calculated from the 
crossing point (Cp) value using the formula:  
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 = 2(−𝐶𝑝) 
 All qPCR data, unless otherwise stated, are presented either as raw relative 
expression values, or normalised to the mean expression of the first condition of the dataset, 
which is denoted as having an expression value of 1.  
2.2.2 RNA methods 
2.2.2.1 RNA isolation 
RNA isolation was performed using an Absolutely RNA Miniprep Kit (Agilent) 
according to the manufacturer’s instructions. Briefly, cells were plated at least one day 
before lysis for RNA isolation, cells were washed once with PBS (Sigma-Aldrich), and 350µL 
of RNA lysis buffer (containing 2.5µL β-Mercaptoethanol) was added per well – this amount 
was scaled up or down depending on plate confluence and culture volume. When performing 
the spin steps, lab bench surfaces, tube racks and gloves were wiped with RNAse-Zap 
(Ambion) to prevent RNAse contamination. RNA concentration was quantified using a 
NanoDropTM Lite spectrophotometer (Thermo Fisher).  
2.2.2.2 cDNA synthesis from RNA 
cDNA was synthesised from RNA by using Moloney-Murine Leukaemia Virus  Reverse 
Transcriptase (M-MLV RT, Invitrogen) according to manufacturer’s instructions. Briefly, 300-
500ng of RNA, 50ng of random primers (Invitrogen), and 1µL of 10mM dNTP mix (Invitrogen) 
were combined in a nuclease-free PCR tube (Sarstedt), and nuclease-free water (Fisher 
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Scientific) was supplemented to a total reaction volume of 12µL. In a thermocycler 
(Biometra), samples were heated to 65°C for 5mins, and then cooled at 4°C for 5min. Next, 
the following components were added: 4uL First-strand buffer (5x), 2µL DTT (0.1M) (both 
Invitrogen) and 1µL RNaseOUTTM recombinant ribonuclease inhibitor (40U/µL, Invitrogen). 
The reactions were incubated at 37°C for 2min. Next, 1µL (200U) of M-MLV RT was added, 
and the reaction was incubated at 25°C for 10min, then 37° for 50min for the reverse 
transcription, and finally at 70°C for 15min for heat inactivation of the enzymes. The reaction 
was then diluted in 180µL of nuclease-free water and stored at -20°C. 
2.2.2.3 Nanostring analysis 
 Nanostring analysis was used to study the expression levels of genes involved in 
various signalling pathways. RNA samples were generated using the Absolutely RNA Miniprep 
Kit (Agilent), and 8µL of each sample was diluted to 20ng/µL in RNAse-free water. The 
samples were then shipped on dry ice to the Edinburgh Cancer Research Centre at the 
Institute of Genetics and Molecular Medicine at the University of Edinburgh, where 
Nanostring analysis was performed by Alison Munro.  
 Briefly, Nanostring is an RNA microarray platform that uses molecular barcoding to 
detect and count hundreds of unique transcripts in one RNA hybridisation reaction (Geiss et 
al., 2008). Each color-coded barcode is attached to a single target-specific probe 
corresponding to a gene of interest. The first step of the process is hybridisation, where two 
small probes per mRNA hybridise in solution: a reporter probe carrying a detectable signal, 
and a capture probe allowing the mRNA/probe complex to be immobilised for data 
collection. Following hybridisation, excess probes are removed and the probe/target 
complexes are aligned and immobilised in an nCounter cartridge. These cartridges are then 
read using an analyser, where the colour codes on the cartridge surface are quantified for 
each target molecule.  
 The system works by using pre-prepared panels containing a set of hundreds of 
genes of interest for a certain application. For this study, a mouse PanCancer Pathways Panel 
containing 770 genes from 13 cancer-associated pathways was used, due to the fact that it 
measures levels of genes involved in diverse cellular signalling pathways. Once the samples 
were analysed, the raw expression values were processed using Nanostring’s associated 
quantitiative analysis software, nSolver4.0. By using the software’s analysis wizard, the data 
73 
 
were quality controlled and normalised to housekeeping genes before being exported as an 
MS Excel file for downstream data processing.  
2.2.3 Protein methods 
2.2.3.1 Immunocytochemistry  
2.2.3.1.1 – Adherent cell culture on glass coverslips 
 For imaging applications requiring sample mounting onto glass slides, cells were 
grown on glass coverslips in 6- or 12-well plates (Corning). Prior to use, the coverslips 
(Marienfeld Superior) were stored in 100% ethanol (VWR). In a sterile biosafety cabinet 
(Esco), the relevant coating solution was added to the cell culture plate. Glass coverslips were 
then removed from ethanol using sterile forceps and the ethanol was rapidly evaporated by 
passing it through the flame of a lighter. The coverslip was aired for 2-3 seconds and 
immediately dropped into a cell culture well, ensuring that it was completely covered in the 
coating medium. The coverslip-containing wells were then coated for the correct amount of 
time for the coating medium used, and cells were seeded into the well following standard 
protocol.   
2.2.3.1.2 – Fixation of adherent cells 
When cultured cells were ready to be fixed for imaging, the supernatant was 
removed, the cells were washed once in PBS (Sigma), and overlaid with 4% Formaldehyde 
fixative solution for 10-15 minutes at room temperature. The fixative was then removed and 
cells were washed three times in PBS.  
2.2.3.1.3 – Fixation of cells in suspension by Cytospin 
For applications where cells were to be fixed and stained as single cells without 
adhesions to each other or an ECM, cells were prepared for fixation by using a Cytospin 
centrifugation protocol.  
Adherent cells were washed once in PBS and detached by incubation in Accutase® 
(Sigma) for 2-3 minutes at 37°C. Cells were then quenched in ice-cold FACS buffer (FB), 
centrifuged to remove Accutase solution, resuspended in FB and counted. 5 x 104 cells were 
aliquoted into 1.5mL tubes and centrifuged. The cells were then resuspended in 200µL FB 
and stored on ice.  
To assemble the Cytospin clamp units, Polysine® adhesion slides (VWR) were labelled 
and placed onto a metal Cytospin clamp. A white filter card (Thermo Fisher) was placed on 
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top of the clamp, and a ShandonTM single cytofunnelTM (Thermo Fisher) was placed on top, 
making sure that the hole in the card was aligned with the end of the funnel. The whole 
assembled units were locked securely in place and loaded into a Shandon Cytospin III 
cytocentrifuge (Shandon). 200µL of cell suspension were added into each corresponding 
funnel. Programme 2 (7 mins at 1000rpm) was used.  
Following centrifugation, the clamps were quickly disassembled, the spots 
corresponding to cells were circled with an ImmEdge Hydrophobic Barrier PAP pen (Vector 
Laboratories), the glass slides were moved to a humidified chamber in a fume hood, and a 
50µL drop of formaldehyde fixative solution was placed on the cells. The cells were fixed at 
room temperature for 10-20 minutes, after which time the formaldehyde was removed and 
the cell spots were washed three times in PBS. The cells were immediately blocked for 
antibody staining.   
2.2.3.1.4 – Antibody staining for immunocytochemistry 
Prior to antibody staining, fixed cells were incubated in blocking solution for at least 
one hour at room temperature to block any non-specific sites that antibodies may bind to. 
Primary antibodies were diluted in blocking solution to a concentration recommended by the 
manufacturer, with up to four antibodies used simultaneously. Once the blocking step was 
complete, the blocking solution was removed and the cells were overlaid with diluted 
primary antibody solution for at least one hour at room temperature. The antibody solution 
was then removed and stored at 4°C to be re-used. Cells were washed three times in PBS and 
overlaid with diluted secondary antibody solution. Secondary antibodies were diluted 1:1000 
in blocking solution unless otherwise stated. Where applicable, DAPI was added to the 
secondary antibody mixture at a concentration between 1:3000 – 1:10,000. Cells were 
stained with secondary antibody for 1 hour at room temperature and washed three times in 
PBS. Secondary antibodies were not routinely re-used. For cells stained in plastic culture 
plates, the cells were overlaid with PBS for imaging.  
For cells cultured on glass coverslips, all staining steps were performed in a 
humidified chamber. Once staining was complete, the coverslips were mounted onto glass 
slides (VWR) with ProLong Gold Antifade Mountant (Thermo Fisher Scientific). When the 
mounting medium solidified, the coverslips were sealed using clear nail varnish.  
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2.2.3.1.5 – Sample imaging on bright-field and fluorescent microscopes 
 Mounted and stained samples were imaged using various fluorescent and bright-
field systems (See “Microscopes” under instruments). The most appropriate visualisation 
parameters (including microscope type, magnification, exposure, gain, bit-depth, etc) were 
determined by the intended outcomes of each experiment. Where applicable, negative and 
positive fluorescence controls were used to set exposure and gain levels. Images were stored 
as .tiff files or as .lif databases and processed in ImageJ/Fiji image analysis software for 
optimal visualisation of pertinent features.  For all experiments where fluorescence intensity 
was to be compared between samples, samples were stained simultaneously using the same 
antibody solution and then imaged in one session, using the same imaging and visualisation 
parameters across the whole dataset.  
2.2.3.1.6 – Imaging of stained samples on the Operetta® high content imaging system 
The Operetta® high content imaging system (referred to as “Operetta” from now on) 
from PerkinElmer® is an automated fluorescence microscopy system compatible with 
imaging samples both mounted on slides or those fixed in multi-well plates – these were 
overlaid with and imaged in PBS.  
For 2D imaging, the height of acquisition and exposure time were individually 
optimised for each channel to achieve the best focal plane and highest quality fluorescent 
signal. For all analyses in this thesis, samples were imaged using the 20x wide-angle objective.  
2.2.3.1.7 – Quantitative image analysis in Columbus® 
 Images acquired on the Operetta system were analysed using the Columbus® 
software supplied with the system by PerkinElmer®. Using the “Image Analysis” tool, 
individual image analysis pipelines were generated for each experiment. First, flat-field 
correction was set to “Basic” using the Input Image building block. Next, nuclear 
segmentation was performed on the DAPI channel using the Find Nuclei building block and 
selecting the most appropriate segmentation method for the sample. Quality control 
measures were applied to reject incorrectly segmented nuclei using the Select Population 
building block: these included filtering out incorrectly assigned nuclei by size and shape (using 
the Nucleus Area and Nucleus Roundness filters), and rejecting nuclei that were too bright 
(using the Instensity DAPI filter), as these usually represented areas where multiple nuclei 
76 
 
were found on top of each other, resulting in unreliable segmentation and fluorescence 
intensity calculations.  
 Once nuclear segmentation was satisfactory, nuclear intensities in the “Nucleus” 
population were calculated using a Calculate Intensity Properties building block for each 
channel to be quantified. Where necessary, positive and negative populations for a given 
marker were selected using the Select Population building block by empirically studying the 
scatter plots generated to determine positive/negative thresholds.  
 After all desired populations were selected, the Define Results building block was 
used to select all the parameters to be reported for each population. The analysis pipeline 
was then saved and run on the appropriate image files, with results exported and analysed 
further in Microsoft Excel.  
2.2.3.1.8 – Imaging of stained samples by confocal fluorescent microscopy for single-cell image 
analysis 
 For downstream image analysis of stained samples, mounted coverslips were imaged 
using a Leica SP8 confocal microscope, and all images were acquired as 12-bit files using a 
40x oil immersion objective. A sample with the highest expected expression level of a stained 
protein of interest for a given dataset was used to determine optimal laser power, gain and 
exposure parameters: for each fluorophore, laser power was gradually increased until a few 
pixels in the image were saturated, resulting in the optimal dynamic range of pixel intensities 
for a given dataset. Once optimal image parameters were set for all channels, they were kept 
constant for the full dataset. Z-stacks were then set up independently for each sample using 
a 0.5µm step size.  
2.2.3.1.9 – Quantitative single-cell image analysis in PickCells 
 PickCells is a bespoke quantitative image analysis software developed in our lab by 
postdoc Guillaume Blin, and it allows nuclear segmentation – using an inbuilt Nuclear 
Envelope Segmentation System (NESSys) – and subsequent deep analysis of cellular 
properties based on imaging data.  
 To analyse properties of cellular nuclei in PickCells, confocal 3D images were first 
segmented using the NESSys ridge-based segmentation system, which requires nuclei to be 
stained with either a nuclear envelope marker, such as Laminβ1, or with a nuclear content 
marker, such as DAPI. Optimal segmentation parameters were selected empirically for each 
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experiment, and a linear classifier was trained to distinguish between correctly and 




Table 2.16: Sample nuclear segmentation parameters in NESSys  
Pipeline stage Parameter Value 
Initial parameters Segmentation method Nuclear envelope 
Scale 2 
Maxima threshold 2.5 
2D linear classifier Search radius 4 
Delta 0.3 
Minimum radius 10 
Maximum radius  40 
3D segmentation Minimum volume 2000 
Maximum volume 20,000 
Search radius 60 
Minimum overlap 0.7 
Advanced 3D segmentation settings Allowed slice jumps 4 
Split tolerance 4 
 
 Following nuclear segmentation, PickCells was used to analyse nuclear properties in 
3D images. These included nuclear fluorescence intensities in different channels and distance 
between nuclear edges to quantify changes in clustering or adhesion.  
2.2.3.2 Flow cytometry 
2.2.3.2.1 – Antibody staining for flow cytometry 
In the days leading up to flow cytometry analysis or fluorescence-activated cell 
sorting (FACS), cells were cultured to reach 50-90% confluence in an appropriately sized 
culture vessel. FACS buffer (FB) was prepared by adding 2% FCS (Life technologies) to   (Sigma) 
and was maintained at 4°C for all flow cytometry applications.  
To prepare cells for flow cytometry, adherent cells were washed once with PBS 
(Sigma) and detached from the culture dish by incubation in Accutase® solution (Sigma) for 
2-3 minutes at 37°C. The Accutase was then quenched in FB, and cells were pelleted by 
centrifugation at 300g (1300rpm) for 3 minutes.  The pellet was resuspended in FB and cells 
were counted using a FastRead 102® hemocytometer (Kova International). The required 
number of cells was transferred to a SterilinTM universal tube (Thermo Fisher scientific) and 
centrifuged. The supernatant was aspirated and the pellet was resuspended in 100µL flow-
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cytometry compatible antibody solution (made up in PBS) per 5 x 105 cells. The cells were 
incubated in antibody solution on ice in the dark for 15 minutes. After incubation, 10mL of 
FB was added to the universal tube to dilute the antibody, and the sample was centrifuged. 
The supernatant was aspirated and the cells were washed three times by resuspension and 
centrigugation in 5mL FB. Finally, the cells were resuspended in 0.5-1mL FB, and filtered into 
Falcon® 5mL round bottom polystyrene test tubes (Corning) through a filter cap. Samples 
were stored on ice until analysis or sorting.  
2.2.3.2.2 – Flow cytometric analysis 
Antibody-stained and/or fluorescent cells were analysed using a BD AccuriTM C6 flow 
cytometer (BD Biosciences) and accompanying acquisition software. 0.5-1 x 106 cells were 
prepared and stained per sample.  Prior to analysis, 5µL of 7AAD cell viability solution 
(eBioscience) was added per 1 x 106 cells directly into the tube and incubated on ice for 5 
minutes. Cells were sequentially gated using the following axes to yield reliable populations:  
 FSC-A v SSC-A: gating for cells based on size and shape 
 FSC-A v FSC-H: gating for single cells 
 FSC-A v FL-3: gating for live cells. The live/dead marker 7AAD emits in the FL-3 laser 
channel, and 7AAd-negative cells were gated.   
Following gating, 1-2 x 104 events in the final gate were recorded per sample.  
2.2.3.2.3 – Single cell sorting 
To generate clonal cell lines for karyotyping, cloning and other purposes, cultured 
cells were sorted as single cells into 96-well plates (Corning) using a BD FACS AriaTM II flow 
cytometer (BD Biosciences). 96-well plates were pre-coated with 50uL of 0.1% gelatin 
solution per well for 15 minutes. The gelatin was then removed and 180µL of Lif-serum 
medium supplemented 1:100 with penicillin-streptomycin solution (Invitrogen) was added 
per well.  
Adherent cells were washed once in PBS (Sigma) and detached using 1:5 trypsin 
solution and incubated for 2-5 minutes at 37°C. The trypsin solution was then quenched using 
2% FB. The cells were then centrifuged, resuspended in FB, counted, diluted to a 
concentration of 2 x 106 cells/mL and stored on ice until analysis. DAPI (Sigma) was added to 
a concentration of 1µL/mL to be used as a live-dead marker. The population was gated for 
live cells only and one cell was sorted into each well. The cells were returned to TC and 
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allowed to proliferate. The cells were then serially expanded to generate a working stock of 
each clonal cell line and validated for further applications.  
2.2.3.2.4 – Fluorescence-activated cell sorting for gene expression analysis 
Antibody-stained and/or fluorescent cells were sorted using a BD FACS AriaTM II flow 
cytometer (BD Biosciences). In the days leading up to sorting, cells were cultured to 50-90% 
confluence in 75cm2 flasks (Corning). Cells were washed in PBS (Sigma) and dissociated by 
culturing in Accutase solution (Sigma) for 2-3 minutes at 37°C and quenched in 2% FB. Cells 
were centrifuged and counted, and 5 x 105 cells were resuspended for all control populations 
(including unstained and DAPI-only controls), with the remaining millions of cells left for 
sorting. Where applicable, cells were then stained with FACS-compatible antibodies.  
Immediately prior to sorting, the control populations were used to compensate the 
cytometer for all fluorescent channels used. Cells were then sequentially gated to yield a 
population of live single cells for sorting, and additional gates were made that were relevant 
to the fractions to be sorted. Desired cells were then sorted into 15mL polypropylene 
centrifuge tubes (Corning) containing 3mL of FACS collection buffer (50% FCS in Lif-serum 
medium). Upon completion of sorting, the cells were centrifuged and the pellet was lysed in 
RNA lysis buffer (from Absolutely RNA Miniprep Kit, Agilent) for RNA extraction. 
2.2.3.3 Reverse-phase protein array (RPPA) 
Reverse-phase protein array (RPPA) was used to quantify protein expression and 
phosphorylation levels, and was performed in collaboration with the RPPA facility at the 
Institute of Genetics and Molecular Medicine at the University of Edinburgh, managed by 
Kenneth MacLeod. The facility provided the reagents and performed most of the analysis 
once samples were cultured, lysed and delivered to the facility.  
2.2.3.3.1 – RPPA sample collection   
 Cells were cultured in 100mm TC-Treated culture dishes (Corning) under 
experimental conditions. Before lysis, media were removed from the culture plates and the 
cells were washed twice in PBS (Sigma). Next, 400µL of RPPA lysis buffer was added and the 
plates were incubated at 4°C for 20 minutes with shaking every five minutes to evenly 
distribute the lysis buffer.  
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Table 2.17: RPPA lysis buffer composition. The 2x buffer and remaining components (excluding 
glycerol and sterile water) were pre-supplied by the RPPA facility.  
Component Volume Final concentration Supplier  
2x Buffer 5mL 1x Buffer:  
 Triton X-100, 1% 
 HEPES, 50mM, pH 7.4 
 NaCl, 150mM 
 MgCl2, 1.5 mM 
 EGTA, 1mM 
RPPA facility 
Glycerol 1mL 10% CalBiochem 
NaF 1mL 100mM RPPA facility 
Tetrasodium 
pyrophosphate (TSPP) 
1mL 10mM RPPA facility 
Na3VO4 0.1mL 1mM RPPA facility 
H2O, molecular biology-
grade 
1.9mL - Fisher 
Scientific 
PhosSTOP™ tablet - - Roche 
cOmplete™ tablet - - Roche 
 
 Following incubation, cells were scraped off the plates using a cell scraper (Corning) 
and pipettor into 1.5mL centrifuge tubes. The lysates were centrifuged at 14,000 rpm for 
10min at 4°C. The supernatant was collected and stored on ice. The protein level in the 
supernatant was then quantified using a Bradford assay (see below). The protein 
concentration was then adjusted to 1mg/ml with remaining lysis buffer. The samples were 
stored at -80°C and shipped on dry ice to the RPPA facility where all the remaining analysis 
was performed.  
2.2.3.3.2 – Quantification of protein concentration by Bradford assay 
A Bradford assay was used to measure protein concentrations in RPPA lysate 
supernatants. Briefly, a set of dilutions was generated containing between 0-0.6 mg/mL 
Quick StartTM BSA standard (BioRad) diluted in PBS (Sigma) with 5% RPPA lysis buffer. The 
protein supernatant samples were then diluted 1:20 in PBS.  
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Next, 10µL of the diluted standards and diluted samples were loaded into duplicate 
plates on a 96-well plate (Corning). Protein assay dye reagent concentrate was diluted 1:4 in 
water and 240µL of this diluted dye reagent was added to each well. The plate was incubated 
in the dark at room temperature for 10min. The absorbance at 600nm was then determined 
using a GloMax®-Multi Microplate reader (Promega).  
The resulting data were imported into Microsoft Excel, and a standard curve of 
concentration against Abs600 was plotted. The “linear regression” function was used to 
generate a standard linear equation in the form: 
𝐴𝑏𝑠600 = (𝑚 × 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛) + 𝑏 
where m represents the slope of the line and b represents the x-intercept of the 
function. To determine protein concentration (in mg/mL) in the protein samples, the above 




) × 20 
The above equation was used to determine the concentration of all unknown 
samples, which were then diluted to 1mg/mL in leftover RPPA lysis buffer.   
2.2.3.3.3 – RPPA microarray layout 
The remaining RPPA analysis steps were performed by Kenneth MacLeod at the 
Proteomics and Metabolomics unit of the MRC Institute of Genetics and Molecular Medicine 
at the University of Edinburgh. The following protocols were provided by this facility.  
Samples were denatured by the addition of 4X sample buffer (40% Glycerol, 8% SDS, 
0.25M Tris-HCl, pH6.8; 2-mercaptoethanol was added to the buffer at 1/10 of the volume 
before use) and heated to 95°C for five minutes prior to processing.  
Following denaturation, a dilution series was prepared for each sample in PBS with 
10% glycerol. The samples were printed as a dilution series of 1.5, 0.75, 0.375 and 0.1875 
mg/mL. Samples were printed as arrays consisting of 36 x 12 spots at a 500µm spot-to-spot 
distance. Array spotting was carried out with an Aushon 1740 Arrayer Patform using 8 x 
185µM pins. Two deposition rounds were performed per feature.  
Sample dilution series were spotted in triplicate on each array, with eight arrays per 
slide, on single pad Avid Nitrocellulose slides (Grace Biolabs). Three side-by-side technical 
replicates were also set up.   
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2.2.3.3.4 – RPPA assay procedure 
 RPPA slides were washed in deionised water and incubated for 15mins in 1x Antigen 
Retrieval Reagent. This was followed by two 5min submerged washes in deionised water. The 
slides were then places in a ProPlate chamber and the wells were filled with deionised water. 
The wells were then washed twice with 1x TBST and incubated for 10mins in Superblock T20 
blocking buffer (Pierce/Thermo Scientific, cat. no. 37536). The slides were again washed 
twice in TBST before a 1h incubation in primary antibody at 1:250 dilution in blocking buffer. 
After incubation, slides were washed twice in PBS and blocked for 10mins in blocking buffer 
as before. Following two more washes, the slides were incubated for 30mins in secondary 
antibody solutions: Dylight-800-labelled anti-species antibodies diluted 1:2500 in blocking 
buffer. This was followed by two more washes in TBST and rinsed with fresh deionised water. 
The slides were allowed to dry at room temperature for 10mins prior to data acquisition; 
they were then imaged using an Innopsys 710 slide scanner.  
 Non-specific signals were determined for each slide by omitting the first incubation 
step with primary antibody on one array per secondary antibody type. Sample loading on 
arrays (for normalisation purposes) was determined by staining with fast-green dye and 
scanning at 800nm.  
2.2.3.3.5 – RPPA data analysis 
Microarray images were analysed using Mapix software (Innopsys). The spot 
diameter of the grid was set to 270 μm. Background signal intensity was determined for each 
spot individually and subtracted from the sample spot signal leading to a net signal for each 
spot. 
Data analysis was performed in a standard way: fluorescence intensity for each 
feature (spot) on the array was measured.  A test was performed for linear fit through the 
four-point dilution series for all samples on all arrays using a flag system where R2 > 0.9 was 
deemed good, >0.8 was deemed acceptable and <0.8 was poor (and may be excluded from 
data analysis). Median values from the four-point dilution series were calculated and used as 
a measure of fluorescence intensity. Raw relative fluorescence intensity (RFI) values relating 
to the abundance of total phosphorylated proteins across the sample set were calculated, 
and the expression data was normalised to total protein (as determined by a fast-green 




2.2.4 Cell culture methods 
2.2.4.1 Cell lines 
2.2.4.1.1 – Wild-type cell lines 
 Two wild-type (WT) mouse embryonic stem cell lines were used in this study. The 
first, E14TG2a, is a male clonal stem cell line derived from ES cells generated from 129/Ola 
mouse blastocysts.  They are deficient for hypoxanthine guanine phosphoribosyl transferase 
(HPRT) (Hooper et al., 1987). The second cell line, E14Ju09, is a clonal stem cell line derived 
by the transgenics service at our institute from ES cells generated from chimaeric embryos 
derived from E14TG2a ES cells. They have the same genetic background as E14TG2a cells and 
have a high propensity for germline colonisation, an observation made by the staff at the 
transgenics unit (Malaguti, 2014).  
2.2.4.1.2 – Sox1-GFP (46C) cells 
 Sox1 is a marker gene of the early neural lineage. The Sox1-GFP (Sox1+/eGFP) cell line 
has a heterozygous knock-in of eGFP into the Sox1 locus on an E14TG2a background. These 
cells are also referred to as 46C, corresponding to the clone number that was injected into 
blastocysts and passaged through the germline to generate a Sox1-GFP mouse line (Aubert 
et al., 2003).  
2.2.4.1.3 – E-cadherin knockout (EcKO) cells 
 E-cadherin knockout (Cdh1-/-) cells are negative for E-cadherin protein expression. 
They are derived from blastocysts of an E-cadherin-floxed (Cdh1fl/fl) mouse line in which 
exons 4 to 15 of the Cdh1 gene were floxed (Derksen et al., 2006). The floxed alleles were 
then Cre-excised in vitro (Pieters et al., 2016). These cells are referred to as “EcKO” 
throughout the thesis.  
2.2.4.1.4 – N-cadherin knock-in (NcKI) cells 
 N-cadherin knock-in (Cdh1Cdh2/Cdh2) cells contain a Cdh2 gene knocked in to the Cdh1 
locus; the cells are negative for E-cadherin protein expression and express N-cadherin under 
the control of the E-cadherin promoter (Kan et al., 2007). These cells are referred to as “NcKI” 
throughout the thesis. The Cdh1 gene sequence is not translated but is still present in these 
cells on the Cdh2-containing allele, leading to Ecad occasionally being detected on the mRNA 
level in the cell line by qPCR.  
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2.2.4.1.5 – A2Lox.Cre cells 
 A2Lox.Cre cells are the parental cell line of the Inducible Cassette Exchange (ICE) 
system for generating inducible murine ES cell lines (Iacovino et al., 2011). They contain an 
ICE locus targeted into the HPRT gene on the X chromosome of A17 mouse ES cells, which 
are a derivative of the E14TG2a cell line and where the reverse tetracycline-controlled 
transactivator (rtTA) has been inserted into the constitutively active Rosa26 locus. The ICE 
locus contains a Cre-recombinase site flanked by two LoxP (Locus of crossing over, P1) sites 
(a “floxed Cre”), and downstream of this is a G418 resistance gene lacking a start codon and 
promoter, which is referred to as Δneo. At this site, recombination is very high because it is 
embedded in constitutively active chromatin. Recombinant clones can be selected in G418, 
because upon recombination the Δneo gene is repaired (Iacovino et al., 2014). 
2.2.4.1.6 – Generation of the pCR Blunt II Topo-Ncad-HA plasmid 
To test the effect of N-cadherin overexpression in various cellular contexts, 
Doxycycline (Dox)-inducible mouse ES cell lines were generated using an inducible cassette 
exchange protocol developed by the Michael Kyba lab (Iacovino et al., 2009; Iacovino et al., 
2011; Iacovino et al., 2014). Primers KP03 and KP04 were designed to allow for the PCR-
amplification of a DNA fragment containing the N-cadherin gene C-terminally tagged with an 
influenza virus hemagglutinin (HA) tag, with the whole construct being flanked by XhoI and 
NotI restriction sites. This DNA fragment was generated by Q5® HotStart PCR (NEB) from 
template cDNA (reverse-transcribed from mRNA) originating from E14-JUO9 cells cultured in 
neural differentiation conditions for five days.   
The PCR product was electrophoresed in a 1% agarose gel and the band of the correct 
size (2721bp) was excised from the gel and purified using a QIAQuick Gel Extraction kit 
(Qiagen). The purified DNA was ligated into a pCR Blunt II Topo Vector (Thermo Fisher 
Scientific) using the kit provided, and the construct was then transformed into competent 
DH5α Escherichia coli cells. The transformed cells were plated onto kanamycin (Calbiochem) 
selection plates, with 0.5mg of X-gal (Promega) added per plate for blue/white screening. 
Following overnight incubation, white colonies were picked into kanamycin selection media 
and the cultures were expanded overnight. DNA was purified from the resulting cultures 
using a QIAprep Spin Miniprep Kit (Qiagen) and test-digested using EcoRI-HF restriction 
enzyme (NEB). Once the expected band size (2.8kbp) was confirmed by electrophoresis, the 
DNA sequenced using sequencing primers M13F, M13R, SL773F, SL774R, SL233F and SL234R.  
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2.2.4.1.7 – Generation of the p2Lox-Ncad-HA plasmid 
After the construct was confirmed correct by sequencing, this newly generated pCR-
BluntII-Topo-Ncad-HA plasmid and a p2Lox-eGFP plasmid (Iacovino et al., 2009) were 
digested using XhoI and NotI-HF restriction endonucleases (NEB) to generate DNA fragments 
with sticky ends. The reactions were electrophoresed, and the bands for the p2Lox backbone 
(3547bp) and Ncad-HA insert (2773bp) were excised and gel purified. The Ncad-HA insert was 
then ligated into the p2Lox backbone using T4 Ligase (NEB), treated with rAPid Alkaline 
Phosphatase (Roche) to prevent re-ligation of the backbone, and transformed into 
competent DH5α E. coli cells. The cells were plated onto ampicillin selection plates and 
cultured overnight, after which colonies were picked and expanded, and DNA was extracted 
as before. The resulting DNA was test-digested using XhoI and NotI-HF restriction 
endonucleases to confirm presence of two bands: one for the Ncad-HA insert (2772bp) and 
one for the p2Lox backbone (3548bp). Once a correct clone was identified, the DNA was 
confirmed correct by sequencing using sequencing primers SL773F, SL774R, SL233F, SL234R, 
KP05, p2LoxF and p2LoxR.  
2.2.4.1.8 – Generation of A2Lox-Ncad-HA inducible ES cell lines 
Nucleofection was performed using the P3 Primary Cell 4D-Nucleofector™ Kit (Lonza) 
as described in “ES cell transgenesis”, with 1.7µg (10µL) of p2lox-Ncad-HA plasmid 
nucleofected into 5x105 A2LoxCre cells. After 10 days of selection in G418, the surviving 
clonal colonies were picked into 96-well plates (Costar) and gradually expanded in G418 
(PAA)-supplemented medium until frozen stocks of each clone were prepared. Surviving 
clones were screened for Ncad-HA expression by ICC. Cells were fixed 24 or 48 hours after 
addition of 1µg/mL Dox and stained for N-cadherin and HA. Clones #4, #5, and #7 were 
selected for further tests.  
 
2.2.4.2 Cell culture conditions 
Mammalian cell lines were maintained and passaged according to the standard 
conditions described below. All work with live cells was performed in a biological safety 
cabinet (Esco) observing sterile practice methods and using tissue culture compatible sterile 
plastic ware (Corning). Cells were incubated in a humidified incubator (Sanyo/Panasonic) at 
37°C in 5% CO2. All centrifugation steps were performed for 2.5-3 minutes at 300g (1,300rpm) 
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in a table-top centrifuge (Eppendorf) unless otherwise stated. Where required, reagents and 
media were pre-warmed to 37°C in a 26L unstirred water bath (Grant).  
2.2.4.2.1 – Standard (mixed) pluripotent stem cell culture (Lif-serum) 
Mouse ES cells were cultured in Lif-serum media as standard, unless otherwise 
stated. The medium composition is based on that published by Smith et al. (1988), below.  
Table 2.18: Lif-serum medium composition.  
Component Volume Final Concentration 
Glasgow minimum essential medium (Sigma) 500 mL - 
Foetal calf serum (Life technologies) 51 mL 10% 
L-glutamine/sodium pyruvate solution 11 mL 2mM L-glutamine 
1mM sodium pyruvate 
MEM non-essential amino acids, 100x 
(Invitrogen) 
5.5 mL 1x 
2-mercaptoethanol, 50mM (Life technologies) 1140 µL 100nM 
Human leukaemia inhibitory factor (LIF) 550 µL 100 U/mL 
 
To passage ES cells cultured in Lif-serum, sterile cell culture dishes were coated with 
0.1% gelatin solution for at least 10 minutes before passage. Media were aspirated from cells, 
the cells were washed once in PBS (Sigma) before the addition of 1:5 trypsin solution. The 
cells were incubated at 37°C until they detached from each other and the plate (usually 
around 2-5 minutes). Next, 5-10 volumes of Lif-FCS medium were added to quench the 
trypsin. The cells were transferred to a 20mL universal tube (Sterilin) and centrifuged at 300g 
for three minutes. The supernatant was then aspirated, and the cells were resuspended in 
fresh Lif-serum medium until they formed a single-cell suspension. The cells were then 
overlaid at desired density into dishes pre-coated with gelatin solution.  
 
2.2.4.2.2 – Serum-free stem cell culture (N2B27) 
N2B27, named after the two growth factors added to this medium, was used for 
serum-free cell culture and differentiation assays as previously described (Pollard et al., 2006; 
Ying et al., 2003b).  
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Table 2.19: N2B27 medium composition.  
Component Volume Final concentration 
DMEM/F12 (Gibco) 25 mL 50% 
Neurobasal (Gibco) 25 mL 50% 
L-Glutamine, 200mM (Invitrogen) 500 µL 2mM 
2-Mercaptoethanol, 50mM (Life 
Technologies) 
100 µL 100nM 
N2 (Gibco) 250 µL 0.5x 
B27 (Gibco) 500 µL 0.5x 
 
2.2.4.2.3 – Naïve stem cell culture (2i-Lif) 
“2i” is an N2B27-based medium used to culture ES cells in a naïve pluripotent state 
(Ying et al., 2008), where 2i refers to the addition of small molecules to achieve double 
inhibition of the MEK/ERK1/2 and GSK3 pathways. The addition of Lif activates the STAT 
pathway, and this combination of pathway activation and inhibition gives rise to a stable 
naïve ES cell state that can be maintained indefinitely in vitro and that broadly corresponds 
to the E3.5 naïve epiblast (Kalkan and Smith, 2014; Ying et al., 2008).  
The composition of the medium is the same as N2B27, with three additional factors: 
1µM PD0325901 (Axon), 3µM Chiron 99021 (Axon) and 100 U/mL of human Lif (prepared in-
house). Before cell passage, dishes were treated for two hours with 0.01% poly-L-ornithine 
solution (Sigma) at room temperature, which was then replaced for two hours with 5µg/mL 
laminin coating solution at room temperature. To passage cells cultured in 2i-Lif conditions, 
the medium was removed, the cells were washed once in PBS, and then overlaid with 
Accutase solution (Sigma) and incubated at 37°C until the cells dissociated from the plate 
(about 3-5 minutes). The Accutase was then quenched in fresh medium, the cells moved to 
a universal tube (Sterilin) and centrifuged. Cells were then re-plated at a concentration 
between 1.5 – 2.0 x 104/cm2.  
To convert cells cultured in Lif-serum conditions to a more uniform and naïve-like 
state, the cells were plated as described above into 2i-Lif conditions and maintained in these 
conditions for at least three passages before further use in experimental assays.  
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2.2.4.2.4 – Epiblast stem cell culture 
Epiblast stem cells (EpiSCs) were cultured in an N2B27-based medium as previously 
described (Brons et al., 2007; Tesar et al., 2007). Minor modifications were applied in-house 
following optimisation for improved viability and proliferation; the final conditions are 
summarised below.  
Table 2.20: Epiblast stem cell culture medium composition. 
Component Volume  Final concentration 
DMEM/F12 (Gibco) 25 mL 50% 
Neurobasal (Gibco) 25 mL 50% 
L-Glutamine, 200mM (Invitrogen) 500 µL 2mM 
2-Mercaptoethanol, 50mM (Life Technologies) 100 µL 100nM 
MEM non-essential amino acids, 100x (Invitrogen) 500 µL 1x 
N2 (Gibco) 250 µL 0.5x 
B27 (Gibco) 500 µL 0.5x 
Activin A solution, 20µg/mL 50 µL 20ng/mL 
FGF2 solution, 10µg/mL 50 µL 10ng/mL 
 
The medium was prepared without the addition of Activin A and FGF2; these 
components were added to the media immediately prior to use.  
Before passage, plates were coated with 7.5µg/mL fibronectin (Sigma) in PBS for at 
least 15 minutes. Adherent EpiSCs were washed once in PBS, detached using accutase 
solution, quenched in N2B27, centrifuged, and gently resuspended in EpiSC medium to 
create a suspension of cell clumps. The fibronectin coating was removed from dishes, and 
EpiSCs were seeded at a 1:8 dilution.  
EpiSCs were derived from ES cells cultured in Lif-serum as previously described (Guo 
et al., 2009). ES cells were seeded at a density of 3 x 104 onto fibronectin-coated plates in Lif-
serum medium. After 24h, the medium was changed to EpiSC medium. The cells were 
cultured until they reached high density, when they were passaged at high density in 1:2-1:4 
dilutions. Following three passages, the cells were gradually passaged at lower-density (1:6-
1:8) dilutions.  
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2.2.4.2.5 – Neural differentiation culture (NDiff) 
For neural differentiation experiments, neural differentiation medium (NDiff) was 
used (Ying et al., 2003a). NDiff has the same composition as N2B27, but the N2 (Gibco) is 
substituted for an equal volume of home-made N2, which contains additional insulin to 
enhance the efficiency of neural differentiation.  
Figure 2.21: Home-made N2 composition. 40mL total volume. All component solutions sterile filtered 
(40nm). 
Component Volume  Concentration 
Insulin (Sigma) 4 mL 25 mg/mL in HCl 
Apo-transferrin (Sigma) 4 mL 100 mg/mL in water 
BSA (Gibco) 4 mL 75 mg/mL 
Progesterone (Sigma) 132 µL 600 µg/mL in ethanol 
Putrescine (Sigma) 400 µL 60 mg/mL 
Sodium selenite (Sigma) 40 µL 3mM 
DMEM:F12 (Gibco) 27.5 mL -  
 
2.2.4.2.6 – NMP maturation and differentiation culture 
A protocol for the generation of putative NMPs from a 2i-Lif starting population using 
an Epiblast-like cell (EpiLC) intermediate was recently developed in our lab (Watson, 2018). 
This five-day protocol was used in this thesis to study effects of cadherin switching on the 
maturation of NMPs.  
On day zero of the protocol, cells cultured in 2i-Lif were seeded in a single-cell 
suspension at a density of 4750 cells per well into plastic 12-well tissue culture plates 
(Corning) coated with fibronectin solution into EpiLC medium. This medium is identical to 
EpiSC culture medium, with the addition of 10µL/mL of KOSR (Thermo Scientific). On day two 
of the protocol (48h after seeding), the medium was changed to NMP medium. This medium 
is identical to N2B27 medium, with the addition of 0.3µl/mL Chiron (Axon, final concentration 
3µM) and 2µL/mL FGF2 (R&D, final concentration 20ng/mL) – this is double the FGF2 
concentration used for EpiSC and EpiLC culture. After 48h in this culture, the cells have been 
shown to represent putative immature NMPs, while after 72h in this culture, the cells are 
comparable to mature NMPs (Watson, 2018). On day five of the protocol (72h after the 
media change to NMP conditions), the cells are fixed for ICC. 
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2.2.4.3 ES cell transgenesis 
2.2.4.3.1 – Nucleofection 
Nucleofection was performed using the P3 Primary Cell 4D-Nucleofector™ Kit 
(Lonza). The day before nucleofection, mouse A2LoxCre targeting ES cells were induced to 
express Cre by adding 0.5µg/mL Doxycycline Hyclate (Sigma), rendering them competent for 
recombination (Iacovino et al., 2011; Iacovino et al., 2014). 24h after addition of Dox, the 
cells were treated according to kit instructions: 5x105 A2LoxCre cells were resuspended in 
82µL P3 Nucleofector Solution, and 18µL of Nucleofector supplement was added. Finally, 4µg 
(to a maximum volume of 10µL) of circular plasmid was mixed into the solution. The cell 
solution was transferred to a 100µL nucleofection cuvette (Lonza) and nucleofected in a 4D-
Nucleofector (Lonza) using the CG-104 programme. Following nucleofection, the cells were 
transferred to pre-warmed Lif-serum media in 9cm dishes pre-coated with gelatin. 5x105 
non-nucleofected cells were plated in parallel as a negative control for antibiotic selection.  
24h after nucleofection, the medium in the dishes was replaced with fresh Lif-serum 
supplemented with 400µg/mL G418 (PAA). Selection was allowed to progress for 10 days, 
with media changed every two days. After 10 days, the surviving clonal colonies were picked 
into 96-well plates (Costar) and gradually expanded in G418-supplemented medium until 
frozen stocks of each clone could be prepared.  
2.2.4.4 Cell cryopreservation 
2.2.4.4.1 – Cell freezing 
 For long-term storage of cell lines, cultured cells were dissociated from their culture 
dish with trypsin or Accutase treatment and centrifuged following routine passage protocol. 
The pellet was then resuspended in 0.5-1mL of appropriate culture medium, shown below, 
supplemented with 10% dimethyl sulphoxide (DMSO, VWR): 
 Lif-serum cultures: Lif-serum medium or FCS 
 Serum-free cultures: corresponding culture medium or KnockOutTM Serum 
Replacement (KOSR)(Thermo Scientific).  
The cell suspension was transferred to a 1.0mL CryoTubeTM vial (Thermo Scientific) 
and immediately moved to dry ice. Frozen cells were stored short-term (up to 3 months) at 
-80°C and long-term in liquid nitrogen at 180°C.  
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2.2.4.4.2 – Cell thawing 
 Before defrosting, cells were removed from the storage freezer and transferred to 
the tissue culture facility on dry ice. The cryovials were thawed at room temperature and 
immediately transferred to 2-5mL of appropriate medium, pre-warmed to 37°C. The cells 
were centrifuged, supernatant removed and the pellet resuspended in relevant medium and 
plated into pre-coated culture vessels.  
2.2.4.5 Cell line karyotyping 
The day before karyotyping, cells were passaged at high density into a T25 flask in 
standard Lif-serum conditions. The hypotonic 0.075M KCl solution and Carnoys fixative (3:1 
methanol:glacial acetic acid) were prepared fresh on the day of karyotyping. To arrest cells 
in metaphase, 100µL of KaryoMAX™ Colcemid™ Solution (Gibco) was added per 10mL of 
culture medium (final concentration 100ng/mL) 18 hours after cell splitting and the cells were 
cultured for a further 2-2.5 hours.  
 The remainder of the protocol was carried out outside the tissue culture hood. 
Culture medium was decanted into a 15mL centrifuge tube (Corning), the cells were washed 
in PBS, 500uL trypsin solution was added and the flask was incubated at 37°C for five minutes 
or until the cells lifted off. The trypsin solution was then quenched using the leftover culture 
medium and the resulting single-cell suspension was centrifuged – all the remaining 
centrifugation steps were performed at 60rcf for eight minutes at room temperature. 
Supernatant was decanted and the pellet was resuspended in the residual medium by gently 
tapping the tube. 
To gently promote cell swelling, 9mL of hypotonic 0.075M KCl solution was added 
while slowly mixing on a vortex mixer. The hypotonic cell suspension was incubated at 37°C 
for 20-25 minutes. After this time, three drops of Carnoys fixative were added using a 3.5mL 
transfer pipette (Sarstedt) while slowly mixing on a vortex mixer to gently introduce the cells 
to fixative. The cells were centrifuged, the supernatant was decanted and the pellet was 
gently resuspended in the residual medium. To fix the cells, 9mL of Carnoys fixative was 
slowly added drop-by-drop down the side of the tube while gently mixing on a vortex mixer. 
The cells were then centrifuged. The fixation step was repeated two more times with 6mL 
and 3mL of fixative. After the final centrifugation step, the cell pellet was resuspended in a 
few drops of fresh fixative.  
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A clean microscope glass slide (VWR) was polished with 100% ethanol (VWR 
Chemicals). The slide was moistened by breathing on it, and several drops (around 50µL) of 
cell suspension were dropped from a height directly onto the slide to break the cell 
membranes. After the slides had air-dried, the slides were placed in a slide chamber filled 
with Giemsa (VWR) solution diluted following manufacturer’s recommendations for 8-10 
minutes. The slides were then rinsed under running tap water and gently blotted dry with 
tissue paper. Following drying, a cover-glass (Marienfeld Superior) was mounted onto the 
slides using Pertex® mountant (HistoLab).  
The chromosome spreads were visualised under an Olympus BX61 widefield 
microscope. The number of individual chromosomes was counted at 40x magnification. A 
mouse cell line was considered to be karyotypically normal when at least 60% of 20 
chromosome spreads counted were found to contain exactly 40 chromosomes.  
 
2.2.5 Embryology 
2.2.5.1 Maintenance of mice 
WT mice were housed and bred in the Animal Unit of the MRC Centre for 
Regenerative Medicine, in accordance to the provisions of the Animals (Scientific Procedures) 
Act 1986. All work with live mice was performed by the Animal Unit staff.  
2.2.5.2 Embryo dissections 
 Pregnant female mice were culled by cervical dislocation by Animal Unit staff. All 
subsequent embryo work was performed by Rosa Portero Migueles.  
The uterus was dissected out of the abdominal cavity, and the deciduae were placed 
in M2 Medium (Sigma) at room temperature. Embryos were then isolated from the deciduae 
and the Reichert’s membrane was removed. Embryos were fixed for 30mins at room 
temperature in 4% PFA/PBST, and then incubated in 100mM glycine solution in PBS for 5mins 
at room temperature. Embryos were incubated overnight at 4°C in blocking solution (PBST 
with 5% donkey serum).  
2.2.5.3 Immunostaining and imaging of embryos 
For embryo immunostaining, the embryos were incubated overnight at room 
temperature in primary antibody diluted in blocking solution. The following day, embryos 
were washed three times for 5mins at room temperature in PBST, followed by overnight 
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incubation in secondary antibody diluted in blocking solution. The following day, embryos 
were again washed three times for 5mins in PBST at room temperature.  
After staining, the embryos were dehydrated in methanol series in PBST, as described 
previously (Becker et al., 2013). Embryos were clarified in 50/50 methanol/BABB and 
transferred into 100% BABB, and stored in borosilicate thin wall capillaries, 1.0mm x 0.78mm 
(Harvard Apparatus) for imaging. Embryos were imaged using 40x magnification on a Leica 
SP8 confocal microscope.  
2.2.6 Statistical analysis 
 Data processing and statistical analysis was performed in Microsoft Excel, R, and 
GraphPad. A student’s T-test was used to compare levels of significance between 
experimental groups, with an unpaired or paired test used depending on the experimental 
set-up. A significance threshold of p≤0.05 was used for all studies, with a result of p≤0.01 
considered highly significant. In figures, these two results are denoted with a single or double 




Chapter III – The dynamics of cadherin switching in early 
development and in pluripotent stem cells 
 
3.1 Introduction & aims 
 Expression patterns of individual cadherin species during early development are well 
characterised. E-cadherin is present in the unfertilised egg (Kemler et al., 1977; Ohsugi et al., 
1997), and continues to be expressed from the 2-cell stage through to gastrulation. E-
cadherin is essential for cell adhesion in the morula and for the formation of trophectoderm 
(Kan et al., 2007; Larue et al., 1994). At gastrulation, cells of the developing mesoderm are 
the first to lose E-cadherin expression at around the same time that they upregulate 
mesodermal markers (Larue et al., 1996). During neurulation, E-cadherin expression is 
switched off in the ectoderm, though it remains upregulated at the ectoderm-neurectoderm 
border, where studies in Xenopus have shown it to contribute to the closure of the neural 
tube (Fujimori et al., 1990).   
N-cadherin is first detected in the posterior gastrula on the mRNA level (Peng et al., 
2016), and is subsequently expressed in mesodermal and neural tissues at around E7.5 
(Kimura et al., 1995; Luo et al., 2001; Radice et al., 1997). In neurulation, during the transition 
from the neural plate stage to the neural tube, neuroepithelial cells downregulate E-
cadherin, which is then replaced by N-cadherin (Aaku-saraste et al., 1996). By E9.5, N-
cadherin is expressed in the notochord, optic vesicles and heart tubes (Radice et al., 1997). 
 The co-expression of E-cadherin and N-cadherin has been less extensively studied. In 
particular, the dynamics of the cadherin switch in relation to pluripotency and lineage 
markers are not well characterised. The timing of cadherin switching with respect to 
commitment and differentiation effects is not well understood, leaving it unclear whether 
the switch is initiated prior to, during, or after lineage commitment. This leads to the question 
of whether cadherin switching is a passive read-out of differentiation, or whether it happens 
early enough to play an active role in directing pluripotent cells towards certain fates. In 
addition, it is unclear to what extent current in vitro systems recapitulate the order of events 
of cadherin switching as they occur during development in vivo.   
 The address these questions, the aims of this chapter are to: 
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a) Characterise the co-expression patterns of E-cadherin, N-cadherin and neural lineage 
markers at various early developmental time-points in vivo. 
b) Compare expression patterns and timings of these proteins between in vivo 
embryogenesis and in vitro culture systems. 
c) Assess whether cadherin switching occurs before, during, or after loss of 
pluripotency and lineage commitment.  
3.2 Cadherin expression patterns during early embryonic 
development in the mouse 
3.2.1 Cadherin switching is initiated at E7.0-7.5 in the mouse embryo 
To assess when and in which tissues cadherin switching is occurring, mouse embryos 
of various stages of development were co-stained for E- and N-cadherin (Fig. 3.1). Staging of 
the embryos was determined according to Lawson & Wilson 2016.  
 At the pre-streak stage (E6.5), E-cadherin is highly expressed in the epiblast, and is 
most strongly expressed apically around the proamniotic cavity. No specific membrane 
staining was detected with the N-cadherin antibody (Fig. 3.1 A); some nuclear staining was 
observed at this stage, but this is likely due to background signal from the antibody, as 
observed in cultured cells where Cdh2 expression was not detected by qPCR (Appendix 1A,B). 
At the late streak stage (E7.0), E-cadherin continues to be strongly expressed in all parts of 
the embryo. For the first time, membrane-localised N-cadherin signal can be observed, which 
is the strongest at the posterior of the embryo, at the site of formation of the PS. The epiblast 
and the anterior embryo do not appear to be positive for N-cadherin at this stage (Fig. 3.1 B).  
The pre-headfold stage (E7.5) was the first stage studied where E- to N-cadherin 
switching could be clearly observed (Fig. 3.1 C). Here, the anterior pre-cardiac mesoderm was 
clearly negative for E-cadherin, and expressing high levels of N-cadherin. At the same stage, 
mesodermal tissues also express N-cadherin, while the anterior epiblast remains uniformly 
positive for E-cadherin expression. By E8.5, the neural groove is formed and clearly visible 
(Fig. 3.1 D). In a transverse section through this structure, E-cadherin and N-cadherin are both 
present at the apical edge of the neural groove, though N-cadherin appears to be the more 
dominant of the two. Cadherin switching is also noticeable in the paraxial mesoderm 
surrounding the neural groove.  
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 These results confirm that cadherin switching occurs at protein level in the embryo 
at around the pre-headfold stage (E7.5), and that it first takes place in mesoderm tissues, 
followed by ectoderm tissues. Co-expression of E- and N-cadherin was detected in the neural 
groove by E8.5.  
3.2.2 Sox1 is highly expressed in the anterior neural ectoderm at E7.5.  
 Next, E7.5 embryos were co-stained for E-cadherin, N-cadherin, and the early neural 
marker Sox1 (Fig3.2A). This time-point was chosen because it represents the first stage where 
an E- to N-cadherin switch was clearly observed in the early embryo. The anterior neural 
ectoderm was found to co-express high levels of Sox1 and E-cadherin; Sox1 was also detected 
in the extra-embryonic ectoderm. Some N-cadherin staining was visible in this Ecad+/Sox1+ 
tissue, though it appears more nuclear than membrane-bound and may therefore represent 
background signal.  
 To quantify the amount of signal in each tissue, and to determine whether the Sox1+ 
tissue also co-expressed N-cadherin, four images of E7.5 embryos were quantified using the 
image analysis software Fiji (Schindelin et al., 2012).  An area of equal size was drawn in three 
embryonic tissues: the epiblast, the precardiac mesoderm and the neurectoderm, and the 
brightness of each channel was quantified in this area using the “Measure” function in the 
software. The process was repeated in four Z-planes for four E7.5 embryos in which clear 
Sox1 staining was observed in the neurectoderm. The intensity of E-cadherin, N-cadherin and 
Sox1 was then normalised to the DAPI signal in the same tissue and the same Z-plane to 
control for differences in relative brightness of different parts of the embryo. The intensity 
for each protein was calculated, and the resulting values for each tissue were normalised to 
the epiblast (which was assigned a baseline value of 1) to obtain a measure for the expression 
of each protein in various tissues relative to the epiblast. The results of this analysis are 
summarised in Fig. 3.2 B.  
 The analysis showed that E-cadherin was expressed at the highest level in the 
posterior epiblast. N-cadherin expression was highest in the precardiac mesoderm, while 
Sox1 was most expressed in the neurectoderm. These readings correspond to signal 
intensities observed in the embryos by eye. Importantly, the analysis showed that the 
intensity of N-cadherin did not differ between the epiblast (where this protein is assumed to 
be absent) and the neurectoderm. This result shows that in vivo, neural differentiation is 





Figure 3.1: E-cadherin and N-cadherin expression in the early mouse embryo. Embryos were 
stained and imaged separately, therefore expression levels are not directly comparable between 
images. Embryo dissection, staining and imaging performed by Rosa Portero Migueles.  A-C. Sagittal 
views of embryos at different stages, left: anterior, right:posterior. Epi: epiblast; PAC: pro-amniotic 
cavity; PS: primitive streak; PCM: pre-cardiac mesoderm. D. Transverse section section through the 




3.3 Cadherin expression patterns in pluripotent cultures in vitro 
3.3.1 Heterogeneity of cadherin expression varies by culture condition 
To compare cadherin expression between embryonic development in vivo and 
embryonic stem cell culture in vitro, three widely used pluripotent culture conditions were 
used: 2i-Lif, representing naïve pluripotency comparable to the pre-implantation epiblast 
(Ying et al., 2008); Lif-serum, a mixed pluripotent condition roughly analogous to the peri-
implantation epiblast (Smith et al., 1988); and epiblast stem cell (EpiSC) culture containing 
Activin and FGF, similar to the post-implantation primed epiblast (Brons et al., 2007; Tesar et 
al., 2007). Figure 3.3 A and B shows ICC staining for Oct4, E- and N-cadherin, and the nuclear 
envelope marker LaminB1 in these cells. 
Cells in each of these culture conditions express high levels of Pou5f1 (Oct4) and Cdh1 
(E-cadherin) on both the mRNA and protein levels, though qPCR analysis at the population 
level showed that the mRNA expression of both of these genes is highest in naïve 
pluripotency (2i-Lif) and decreases progressively in Lif-serum and EpiSC cultures (Fig3.3 B). 
Flow cytometric analysis of E-cadherin protein expression at the single-cell level confirmed 
this observation, and additionally showed that cells cultured in 2i-Lif and Lif-serum express 
high, uniform levels of E-cadherin, while EpiSCs display much more heterogeneous 
expression of this protein (Fig. 3.3 C). 
 EpiSCs were the only pluripotent cells in which N-cadherin was detectable on the 
mRNA or protein levels. They were also the only cells of the three populations expressing 
Sox1. This could indicate that the EpiSC culture may contain cells that are primed for neural 
differentiation, or alternatively, that some of the cells have differentiated, and are 
committed to the neural lineage. Taken together, these observations suggest that EpiSCs 




Figure 3.2: E-cadherin, N-cadherin and Sox1 co-expression patterns in the E7.5 mouse embryo.  A. 
Sagittal sections through two E7.5 embryos. Embryo dissection, staining and imaging performed by 
Rosa Portero Migueles. ExE: extraembryonic ectoderm; NE: neural ectoderm; PcM: pre-cardiac 
mesoderm. PE: posterior epiblast. Scale bar = 50µm. B. Quantification of signal intensity of each protein 







Figure 3.3: E- and N-cadherin expression patterns in three pluripotent cultures in vitro. A-B. ICC 
of E-cadherin, N-cadherin, the pluripotency marker Oct4 and the nuclear envelope marker 
LaminB1. Scale-bar = 50µm. *2i-Lif image (A) comes from separate experiment imaged at a 
different time, so expression levels are not directly comparable to remaining images. C. Gene 
expression at the mRNA level by qPCR. Values normalised to 2i-Lif condition. Error bar = SD, N=3 
biological replicates. D. Representative plot of E-cadherin protein expression at the single cell level 
by flow cytometry. Black line depicts unstained control cells. N=3 biological replicates. 
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3.3.2 Cadherin switching is initiated prior to the loss of pluripotency marker 
expression and correlates with lineage priming in EpiSCs 
 EpiSCs were the most heterogeneous of the pluripotent populations studied with 
regards to E- and N-cadherin expression. They were also the only pluripotent state in which 
N-cadherin was detectable. To confirm that the EpiSCs expressing N-cadherin were still 
pluripotent, and not simply differentiated cell types, EpiSCs were stained for E-cadherin, N-
cadherin and Oct4, and the proportion of cells co-expressing various combinations of these 
markers were quantified on the single cell level by eye. Three biological replicates of EpiSCs 
were cultured and stained, and three fields of view were imaged in 3D by confocal 
microscopy for each replicate (Fig. 3.4 B). All cells in the images were then classified based 
on their expression of E-cadherin, N-cadherin and Oct4 by eye. This method of quantification 
was chosen because the image resolution is generally high enough for there to be a clear 
distinction between cells that are positive and negative for the proteins analysed. This makes 
it relatively straightforward to assess the cells’ protein expression profile without 
computational help. A total of 2596 cells were included in the analysis.   
 Figure 3.5 shows examples of various EpiSC identities co-expressing E-cadherin, N-
cadherin and/or Oct4, and figure 3.6 is a summary of the quantification of these identities. 
The analysis confirmed that over 90% of cells analysed expressed Oct4 and were therefore 
assumed to be undifferentiated. Within this population, the majority (81.3%) only co-
expressed E-cadherin, with the next largest population (12.4%) co-expressing both of the 
cadherins and Oct4. The four remaining populations combined made up 6.1% of the cells 
observed. These results show that in pluripotent EpiSCs cultured in FGF and Activin, E-
cadherin is the predominantly expressed cadherin, and that some of these cells additionally 
switch on N-cadherin while remaining in an undifferentiated state, as determined by the 
presence of Oct4.  
 To determine whether E- and N-cadherin expression may denote subpopulations of 
EpiSCs with distinct gene expression profiles, a sorting experiment was set up. EpiSCs were 
cultured to near-confluence, stained for E-cadherin, and sorted into the top, middle and 20% 
of cells based on E-cadherin protein expression. The three sorted populations were then 
lysed for mRNA analysis by qPCR in order to study differential gene expression. The FACS 






Figure 3.4: Cadherin and Oct4 co-expression in EpiSCs. A. Control cell populations expressing only one 






Figure 3.5: EpiSC identities of cadherin and Oct4 co-expression. Example cells indicated by white 
arrowheads. Percentages underneath images indicate the mean±SD proportion of cells observed of 
that identity by manual quantification. N=3 biological replicates, three fields of view per replicate, 2596 





Following sorting, the three subpopulations were analysed by qPCR for differences 
in gene expression of the mRNA level. The subpopulation expressing “medium” levels of E-
cadherin was used as a baseline measurement (with an assigned expression value of 1), and 
the gene expression readings for the top and bottom subpopulations were normalised to this 
value. Three independent biological replicates were performed, and a paired T-test was used 
to assess significance between the E-cadherin low and high subpopulations. The results are 
summarised in figure 3.8.  
Analysis of Cdh1 expression confirmed that the sorting had been successful, as there 
was a highly significant difference between the E-cadherin-high and -low populations. A 
reciprocal expression pattern was observed for Cdh2: the E-cadherinHigh population had 
significantly lower levels of Cdh2 than the E-cadherinLow population, and vice versa. This result 
shows that cadherin switching is taking place and is detectable at the mRNA level in EpiSCs.  
 Next, pluripotency marker expression was compared between the two populations. 
There was no significant difference in the levels of the naïve marker Klf4, general 
pluripotency markers Nanog and Pou5f1 (Oct4), and primed marker Pou3f1 (Oct6) between 
the E-cadherinHigh and E-cadherinLow populations, suggesting that cadherin switching occurs 
before the loss of pluripotency marker expression in EpiSCs.  
Figure 3.6: Percentages of EpiSCs co-
expressing E-cadherin, N-cadherin 
and/or Oct4. Summary graph of 
data from previous page. N= 3 fields 
of view each for 3 biological 





Figure 3.7: Gating strategy for sorting EpiSCs based on E-cadherin expression. A: Gating total events 
for cells (gate P1). B: E-cadherin intensity of cells in population P1. C: Gating population P1 for single 
cells (gate P2). D: Gating population P2 for live cells based on DAPI staining (gate P3). E: Gating 
population P3 for top (green), middle (pink) and bottom (purple) 20% of cells for sorting based on levels 
E-cadherin expression. N=3, representative plots shown for one experiment.  
 
 To determine whether cadherin switching correlates with a bias towards a certain 
embryonic lineage, the expression of various lineage markers was studied. The E-cadherinLow 
population was found to express significantly higher levels the neural marker gene Sox1 and 
mesoderm marker gene T (Brachyury) than the E-cadherinHigh population, while markers of 
endoderm (Sox17) and surface ectoderm (Ap2a) were expressed at comparable levels in the 
two populations. This suggests that cadherin switching correlates with priming towards the 
neural and mesodermal lineages in EpiSCs. This finding is not surprising since these are the 
two tissues where N-cadherin is first expressed in the embryo (Radice et al., 1997).  
 Finally, levels of signalling pathway readout genes were compared between the two 
sorted populations. There were no significant differences observed in the expression of the 







Figure 3.8: mRNA gene expression in EpiSCs sorted into the top and bottom 20% of cells by level 
of E-cadherin protein expression. E-cadherin- high and -low populations were normalised to the 
expression level of an E-cadherin medium population. N= three independent sorts of three biological 
replicates. Error bars = SD. *p≤0.05, paired T-test.  
108 
 
3.4 Dynamics of cadherin switching during neural differentiation 
in vitro 
 Cadherin switching was found to take place in EpiSCs. Next, to determine how this 
compares with cells exiting pluripotency, the patterns of cadherin expression were studied 
during in vitro neural differentiation. The starting population for this differentiation was a 
naïve pluripotent culture of ESCs cultured in 2i-Lif. This population was chosen as the starting 
point to produce as “clean” and reproducible of a differentiation experiment as possible.  
 Sox1-GFP cells cultured in 2i-Lif conditions were seeded onto glass coverslips on 
plastic 12-well tissue culture plates coated in poly-L-ornithine and laminin (both Sigma) at a 
density of 3000 cells per well. The cells were allowed to adhere to the matrix for 24h in 2i-Lif 
conditions, and after this period the media were changed from 2i-Lif to neural differentiation 
medium (day 0); for full details of the protocol, see Methods. Whenever the culture medium 
turned yellow, the old media were aspirated and fresh media were added.  
Sample wells were fixed on days two-to-five of the differentiation, and the process 
was repeated thrice to produce three biological replicates. Coverslips for each time point 
were then co-stained for E-cadherin, N-cadherin, the nuclear envelope marker Laminβ1, and 
either Oct4 or Sox1-GFP. The cells were then imaged in 2D on an Olympus BX61 fluorescent 
microscope. Figures 3.9-3.11 summarise the expression patterns of the different staining 
combinations.  
E-cadherin was found to be highly expressed in tightly packed 2i-Lif-cultured cells, as 
expected. At day two of neural differentiation, the cells were visibly spread apart from one 
another in a more flattened colony structure, and E-cadherin staining in the cells was much 
weaker. Days three-to-four were the first time points where N-cadherin and Sox1-GFP were 
detected, depending on the biological replicate (Figs. 3.9 and 3.11). Throughout the time-
course, E-cadherin and N-cadherin were observed in mutually exclusive regions, and Oct4 
was mostly present in cells expressing E-cadherin, while Sox1-GFP was mostly observed in 
patches of cells expressing N-cadherin. However, at the time points where cadherin switching 
was first observed, some Oct4 could be detected in cells expressing N-cadherin, and Sox1 
was also weakly expressed in cells positive for E-cadherin.  
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Figure 3.9: Co-expression of E-cadherin, N-cadherin and Sox1-GFP during neural differentiation from 
2i-Lif. Sox1-GFP cells cultured in 2i-Lif were seeded onto glass coverslips in 12-well tissue culture plates 
at a seeding density of 3,000 cells per well. The cells were cultured in 2i-Lif for 24h hours before a media 




To further study the identity of the cells co-expressing both Oct4 and N-cadherin, 
cells undergoing neural differentiation were co-stained for N-cadherin, Oct4 and Sox1-GFP. 
In this biological replicate, cadherin switching was first observed at Day four. At this time 
point, a cluster of cells positive for all three markers is clearly visible (Figure 3.11, dotted 
outline): the nuclei express low levels of Oct4 and high levels Sox1 relative to the surrounding 
cells, and are surrounded by N-cadherin positive membranes. These results suggest that N-
cadherin is switched on during neural differentiation at a time point that corresponds to 
neural priming, when cells remain undifferentiated (and express Oct4) but are becoming 
biased for the neural lineage (marked by expression of Sox1).  
It is important to note that at the later time points, Sox1-GFP expression was high, 
but in all cases some E-cadherin was still highly expressed in patches of cells, and the extent 
of E-cadherin or N-cadherin staining at each time point varied greatly between biological 
replicates. This suggests that in vitro neural differentiation is not 100% efficient and that 




Figure 3.10: Co-expression of E-cadherin, N-cadherin and Oct4 during neural differentiation from 2i-
Lif. Sox1-GFP cells cultured in 2i-Lif were seeded onto glass coverslips in 12-well tissue culture plates at 
a seeding density of 3,000 cells per well. The cells were cultured in 2i-Lif for 24h hours before a media 










Figure 3.11: Co-expression of N-cadherin, Oct4 and Sox1-GFP on Day 4 of neural differentiation from 
2i-Lif. Sox1-GFP cells cultured in 2i-Lif were seeded onto glass coverslips in 12-well tissue culture plates 
at a seeding density of 3,000 cells per well. The cells were cultured in 2i-Lif for 24h hours before a media 
change to neural differentiation medium (Day 0). White dashed outline highlights an area where all 






3.5 Discussion  
3.5.1 Differences between cadherin switching in vivo and in vitro 
 Staining early embryos for E- and N-cadherin showed that cadherin switching is 
initiated on the protein level between E7.0 and E7.5, first in mesodermal tissues and followed 
by ectodermal tissues about 24h later, as previously reported (Radice et al., 1997). The first 
full cadherin switch, consisting of strong N-cadherin staining in a tissue absent for E-cadherin, 
is seen in the pre-cardiac mesoderm. Transcriptional studies have shown that Cdh2 
transcriptional upregulation is initiated in the E6.5 gastrula (Peng et al., 2016), though N-
cadherin protein was not observed at this stage in the current study.  
 EpiSCs are a cultured stem cell population analogous to the primed epiblast at E5.5, 
which can be either derived from the post-implantation embryo or produced in culture from 
ESCs (Nichols and Smith, 2009). N-cadherin has been identified as one of the defining cell-
surface markers of this pluripotent state (Rugg-Gunn et al., 2012). EpiSCs therefore exhibit 
an earlier cadherin switching event than that observed in vivo, and highlights an important 
difference in this in vitro model of early development.  However, EpiSCs are known to be a 
highly heterogeneous population consisting of several sub-populations (Tsakiridis et al., 
2014). Additionally, previous reports have shown that while EpiSCs can be derived from the 
embryonic epiblast from E5.5 up to E8.0, their transcriptomes tend to converge in vitro, 
regardless of the age of the embryo from which they were derived (Kojima et al., 2014; 
Osorno et al., 2012).This suggests that, while EpiSCs can be a useful tool for studying early 
developmental events, they may not serve as an accurate model of a specific developmental 
time point due to their heterogeneous and dynamic gene expression resulting from in vitro 
culture.   
 It has previously been reported that N-cadherin is the predominant cadherin 
expressed by EpiSCs (Takehara et al., 2015). In the analysis shown here, only around 17% of 
all EpiSCs studied expressed N-cadherin. However, in contrast to the published EpiSC 
protocols (Brons et al., 2007; Tesar et al., 2007) the EpiSC culture used in the Takehara et al. 
(2015) study did not include the addition of Activin, therefore their findings may not be 
directly comparable to those presented in the current study.  
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3.5.2 Cadherin switching is initiated prior to the loss of pluripotency    
Co-staining for the two cadherins and the early neural marker Sox1 in the E7.5 
embryo showed that Sox1 was expressed in the anterior ectoderm by E7.5, before overt 
cadherin switching was observed in this tissue. Another study has also documented Sox1 
protein expression restricted to the neural plate of an E7.5 mouse embryo (Pevny et al., 
1998).  Expression of the pluripotency marker Oct4 has been reported in the same tissue at 
this stage (Downs, 2008; Hart et al., 2004), suggesting that the tissue may still be pluripotent 
and that the Sox1 expression pattern marks an area primed for ectodermal fate.  
Fate mapping studies on the differentiation potential of anterior ectodermal tissue 
have found that E6.5 ectoderm retains full pluripotency (Li et al., 2013). At E7.0, the anterior 
ectoderm is no longer pluripotent but is instead restricted to either epidermis or 
neurectoderm, depending on the presence or absence of BMP4, respectively. By E7.5, the 
ectoderm was found to no longer be responsive to BMP4, and is restricted either to neural 
or epidermal fate depending on the position within the embryo (Li et al., 2013). The in vivo 
data in the present study are insufficient to conclusively determine whether cadherin 
switching is initiated before, during or after the specification of the neural lineage in the 
embryo, but the two events do seem to be occurring at very similar timescales.  
However, the in vitro data are much clearer on the matter. Analyses of EpiSCs show 
that cadherin switching can be observed both at the population and single-cell level in these 
cultures, and that this switch takes place before the loss of pluripotency markers such as 
Oct4. Likewise, single cells could be identified during in vitro neural differentiation that co-
expressed Oct4, Sox1 and N-cadherin. This suggests that in vitro, cadherin switching is 
initiated prior to the loss of pluripotency markers, and coincides with neural priming. To our 
knowledge this study represents the first attempt to identify the exact temporal timeframe 
in which cadherin switching occurs in the contexts of pluripotency, priming, and 
differentiation in vitro.   
These observations prompt the question: could cadherin switching also help 
modulate this priming and subsequent differentiation? The experiments used to address this 




Chapter IV – Cadherin switching promotes neural 
differentiation 
 
4.1 Introduction & aims 
Fundamentally, cadherin switching requires two separate molecular events: the loss 
of E-cadherin, and the concomitant gain of N-cadherin. The loss of E-cadherin has been 
extensively studied in several contexts, both in the developing embryo and in ESC cultures.  
In vivo, E-cadherin knock-out mice die prior to implantation due to a failure in morula 
compaction and the inability to form functional trophectoderm caused by defective adhesion 
(Larue et al., 1994). A gene replacement knocking in Cdh2  into the Cdh1 locus (N-cadherin 
knock-in; NcKI) rescued the adhesion defect but was not enough to rescue the 
trophectoderm lethality phenotype (Kan et al., 2007). Inducing the same replacement after 
trophectoderm formation, but prior to the onset of gastrulation, allowed embryos to 
undergo gastrulation but subsequently resulted in gross morphological abnormalities and 
embryonic lethality at around E8.5 (Basilicata et al., 2016).   
Similar experiments using cells expressing a hybrid cadherin with an extracellular E-
cadherin domain and an intracellular N-cadherin domain showed that a signalling function 
involving IGF1R activation was critical for correct pre-implantation development, and was 
independent of the adhesive function of E-cadherin (Bedzhov et al., 2012). These studies 
demonstrate that E-cadherin plays important roles in both adhesion and signalling, and that 
both are critical for early embryonic development.   
E-cadherin also plays a major role in pluripotency and lineage commitment of ES 
cells. E-cadherin-null ES cells are unable to form organised structures in teratoma assays. Re-
expression of E-cadherin in these cells allows for the formation of epithelia but not other 
structures, and transfecting the E-cadherin mutants with N-cadherin resulted in the 
formation of neuroepithelium and cartilage (Larue et al., 1996). These results suggest that 
different cadherin species can promote different lineage fates. E-cadherin-null cells are also 
able to remain in an undifferentiated, proliferative state in the absence of Lif (Soncin et al., 
2009), and they can maintain Oct4 expression even after 30 days culture in embryoid body 
differentiation conditions (Pieters et al., 2016). In addition, blocking E-cadherin expression 
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compromises formation of EBs and teratomas while accelerating differentiation (Chou et al., 
2008),  and forced expression of E-cadherin can also replace Oct4 in the “Yamanaka cocktail” 
of factors supporting efficient reprogramming of cells into iPSCs (Redmer et al., 2011). These 
studies show that E-cadherin is closely linked to ES cell pluripotency.  
Transcriptome analyses have found the gene expression profile of E-cadherin-null 
ESCs to be abnormal. The cells have a similar, though not identical, transcription profile to 
EpiSCs, suggesting that E-cadherin may prevent the transition from ICM to epiblast (Soncin 
et al., 2011). They have lower levels of pluripotency markers such as Nanog and Klf4, and 
displayed a compensatory upregulation of N-cadherin in Lif/BMP conditions (Hawkins et al., 
2012).  
Gain of N-cadherin has also been studied, but to a lesser extent. The forced 
expression of N-cadherin in human squamous carcinoma cells results in a downregulation of 
endogenous E-cadherin by accelerating its degradation (Islam et al., 1996), and may be driven 
by competition for binding to p120-catenin (Maeda, 2005; Wheelock et al., 2008). However, 
this effect appears to be context-dependent: in human breast cancer cell lines the over-
expression of N-cadherin does not result in the downregulation of E-cadherin (Nieman et al., 
1999).  
The role of cadherin switching in neural differentiation has been studied to a limited 
extent. Studies from our lab have shown that blocking E-cadherin results in faster and more 
synchronous neural differentiation (Malaguti et al., 2013). N-cadherin was also found to 
promote neuronal outgrowth in foetal neural stem cells through its interaction with FGF-R1 
and through mechanical coupling of adhesion sites with acto-myosin treadmilling (Nguyen 
and Mège, 2016; Williams et al., 1994; Williams et al., 2001).  
To build on existing knowledge, this chapter explores the effects of experimentally 
controlled E- to N-cadherin switching on the neural differentiation of embryonic stem cells 
in vitro. The aim of this chapter is to answer the following questions: 
a) How does the loss of E-cadherin alone affect neural differentiation?  
b) Does forced, premature cadherin switching affect neural differentiation?  
c) How does gain of N-cadherin alone affect neural differentiation?  
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4.2 Cadherin switching promotes neural differentiation 
4.2.1 Validation of E-cadherin knock-out cells (EcKO) and N-cadherin knock-in 
(NcKI) cells 
To study the behaviour of cells lacking E-cadherin, knock-out (Cdh1-/-, referred to as 
EcKO) cells were used, which were supplied by a collaborating lab (Pieters et al., 2016). To 
complement these cells, N-cadherin knock-in cells (Cdh1Cdh2/Cdh2, referred to as NcKI) were 
supplied by a different collaborating lab (Basilicata et al., 2016; Kan et al., 2007). The NcKI 
cells have the Cdh2 gene knocked in to the Cdh1 locus, and are therefore negative for E-
cadherin protein expression. Instead, they express N-cadherin mRNA and protein in its place, 
under the control of the Cdh1 promoter. These cells therefore represent a premature and 
forced cadherin switch.  
To validate the knock-out and knock-in modifications, 5x104 cells per well were 
seeded into 2i-Lif conditions in a 12-well plate and allowed to adhere for 24h, before a media 
change to neural differentiation medium. Another 24h later the cells were fixed, co-stained 
for E- and N-cadherin, and imaged on a Leica SP8 confocal microscope (Figure 4.1). This time-
point was chosen because it represents a stage where E-cadherin, but not N-cadherin, is 
expressed during the differentiation protocol, based on previous experiments. 
Both E14-Juo9 (WT) cells and the parental control cell line for the EcKO cells (Cdh1fl/fl, 
referred to as Flox/Flox)(Derksen et al., 2006) were found to express high levels of E-cadherin 
at their cytoplasmic membranes. By contrast, both EcKO and NcKI cells were completely 
negative for E-cadherin staining. The control cell lines were found to express negligible levels 
of N-cadherin, while NcKI cells expressed high levels of N-cadherin at the membrane. 
Interestingly, EcKO cells also expressed visibly higher levels of N-cadherin than their parental 
cell line, suggesting that the loss of E-cadherin leads to a compensatory upregulation of N-
cadherin in these cells. All four cell lines robustly expressed high levels of Oct4, suggesting 




Figure 4.1: Validation of cadherin knock-out and knock-in cell lines. EcKO and NcKI cells and their 
corresponding control cell lines were seeded into 2i-Lif conditions for 24h and cultured in neural 
differentiation conditions for a further 24h. Cells were co-stained for E-cadherin (Ecad), N-cadherin 
(Ncad), Oct4 and Laminβ1. Scale bar=50µm. 
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Figure 4.2: Kayotyping WT and NcKI cells. Chromosome spreads showing a representative number 
(mode) of 40 chromosome in clonal E14-Juo9 (WT) and NcKI cells lines cultured in Lif-serum. Scale 
bar=20µm. 
  
 The Flox/Flox and EcKO cell lines were karyotyped in their lab of origin prior to 
shipping. E14-Juo9 (WT) and NcKI cells were karyotyped in-house. WT cells were found to 
have a normal karyotype, as represented by a mode of 40 chromosomes per nucleus (Fig. 
4.2), but the NcKI cells were found to have an abnormal chromosome counts in a routine 
karyotyping screen. To overcome this issue, these cells were single-cell sorted by flow 
cytometry and the resulting clones were serially passaged. These clonal cell lines were then 
karyotyped until a cell line with a chromosomal mode of 40 was identified (Fig. 4.2). This line 
was treated as karyotypically normal and was used for all experiments presented in this 
thesis.  
 
4.2.2 EcKO cells are unstable during neural differentiation 
 Previous reports from our lab showed that using a function-blocking antibody for E-
cadherin caused faster and more synchronous neural differentiation (Malaguti et al., 2013). 
To test whether this was also the case in cells null for E-cadherin, the EcKO cells were cultured 
through a six-day neural differentiation protocol, with a 24h incubation period in 2i-Lif, and 
lysed for qPCR analysis. Cells were initially seeded into 12-well plates at a density of 4,000 
cells per well. However, from day four onwards, significant cell death of the EcKO cells was 
observed (Fig 4.3), leading to insufficient mRNA yield for downstream analysis. To overcome 
this issue, the experiment was scaled up: both the parental and EcKO were seeded into 6-
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well plates (instead of 12-well plates) and seeded at a density  from 2x104 to 5x104 cells per 
well into 2i-Lif conditions, and after 24h media were changed to NDiff. Out of six biological 
replicates performed, three produced sufficient RNA yield for the EcKO cells up to day four, 
and only two produced sufficient yield for days five to six. These three replicates were used 
for qPCR analysis (Fig. 4.4).   
 qPCR analysis confirmed the deletion of E-cadherin in the mutant cells, as they 
expressed negligible levels of Cdh1 transcript compared to the parental cell line. On the 
transcript level, they did not have significantly different levels of Cdh2 compared to the 
control cells at any stage, suggesting that there was no compensatory upregulation of Cdh2 
in Cdh1-null cells: this is in contrast to the protein-level staining of EcKO cells, which displayed 
detectable N-cadherin staining after 24h in NDiff conditions, unlike WT cells  (Fig. 4.1). In 
addition, levels of Pou5f1, Sox1 and Pax6 transcript did not differ significantly between the 
control and EcKO cell lines, with the exception of the day two time-point for Pax6, which was 
significantly lower in the EcKO cells. These results suggest that the deletion of Cdh1 gene 
does not affect neural differentiation ability – the cells continue to upregulate neural markers 
to similar levels as those observed in control cells, and downregulate Pou5f1 (Oct4) at similar 
rates.  
 A major drawback of these results is that it is difficult to assess how representative 
they are of the complete cell population, as the EcKO cells displayed extensive cell death 
during neural differentiation, with few adherent cells surviving the media change and wash 
steps that occur prior to lysis for mRNA extraction, especially at later time points. This 




Figure 4.3: EcKO cells have poor survival during neural differentiation. Cells were seeded into 2i-Lif 
conditions. After 24h, media were changed to neural differentiation medium. Extensive cell death in 
EcKO cells compared to control cells is apparent from day 4 onward.  Scale bar=100µm 
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Figure 4.4: Gene expression during neural differentiation of EcKO cells. Flox/flox (parental) and EcKO 
cell lines were plated at a density of 2x104 to 5x104 cells into 2i-Lif conditions in 6-well plates. The cells 
were incubated in 2i-Lif for 24h before a media change to neural differentiation medium (Day zero). Of 
six biological replicates attempted, only three produced sufficient RNA yield up to day 4, and only two 
had sufficient yield on days 5-6. No statistical analysis was undertaken for days 5-6. N=3 up to day 4, 
and N=2 or days 5-6. Error bars show standard deviation. *p≤0.05, **p≤0.01, unpaired T-test. 
 
4.2.3 Forced cadherin switching promotes neural differentiation 
 EcKO cells displayed extensive cell death during neural differentiation, suggesting 
that E-cadherin is required for cell stability during this process. Next, NcKI cells were used to 
investigate whether replacing E-cadherin with N-cadherin could make the cells more stable, 
and whether this forced and premature cadherin switch would have an effect on the 
efficiency of neural differentiation.   
 NcKI and WT (E14-Juo9) cells were seeded into 12-well plates at a density of 4,000 
cells per well. As before, the cells were pre-incubated in 2i-Lif conditions for 24h to allow 
time for the cells to adhere to the plate, and media were then changed to NDiff (day 0), and 
dying cells were washed off and old media supplemented throughout the six-day 
differentiation.Lysates were collected for qPCR analysis on days two to six. While all cell lines 
displayed significant cell death during the differentiation protocol, substantially more NcKI 
cells survived until the later stages of neural differentiation than EcKO cells. Both NcKI and 
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the WT control cell lines yielded enough mRNA for qPCR analysis on all days analysed and in 
all three biological replicates.  
 qPCR analysis found significantly lower levels of Cdh1 transcript in the NcKI cells 
compared to WT (Fig. 4.5). However, some Cdh1 expression was still detected in the NcKI 
cells. Since the Cdh1 gene is still present behind a transcriptional termination sequence and 
not deleted from the genomic sequence of this cell line, the presence of some Cdh1 transcript 
may reflect leaky termination of transcription, or alternatively, that the qPCR primers used 
are not completely specific. NcKI cells showed significantly higher levels of Cdh2 expression 
than WT cells, as expected, though the levels of Cdh2 detected may not be as high as 
expected given that expression of this gene is driven by the Cdh1 promoter, and Cdh1 is highly 
expressed in ESCs. However, on the protein level (Fig. 4.1) these cells were found to be 
completely negative for E-cadherin protein and showed extensive N-cadherin protein 
expression, as expected.   
 NcKI cells express significantly higher levels of the early neural markers Sox1 and 
Pax6 on days two to four of neural differentiation compared to WT cells. By days five and six, 
the WT cells appear to “catch up” in their levels of expression of these genes, suggesting that 
forced cadherin switching may accelerate the process of neural induction rather than 
increasing its eventual efficiency. However, Pou5f1 (Oct4) levels were lower in NcKI cells at 
four time points, including 2i-Lif. This raises the alternative possibility that NcKI cells cultured 
in 2i-Lif may exist in a developmentally more advanced pluripotent state than WT cells, 
allowing them to differentiate more efficiently in permissive conditions. 
 To check whether the differentiation phenotype was specific to a particular lineage, 
the mesoderm marker T and endoderm marker Sox17 were assayed. The only significant 
difference observed in either of these markers was at Day three for Sox17, where NcKI cells 
showed slightly but significantly higher expression of this gene compared to WT. Since no 
other time-point was found to have significantly different levels of these two transcripts, the 
results were taken to indicate that the pro-differentiation effect of NcKI is specific to the 
neural lineage.  
Taken together, the results show that NcKI cells represent a forced, premature 
cadherin switch, and that this mutation promotes neural differentiation, an effect which was 
found to be specific for the neural lineage.   
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Figure 4.5: Gene expression during neural differentiation of NcKI cells. WT (E14-Juo9) and NcKI cell 
lines were plated at a density of 4,000 cells into 2i-Lif conditions in 12-well plates. The cells were 
incubated in 2i-Lif for 24h before a media change to neural differentiation medium (Day 0). N=3 
biological replicates. Error bars show standard deviation. *p≤0.05, **p≤0.01, unpaired T-test. 
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4.3 Overexpression of N-cadherin promotes neural fate 
4.3.1 Generation of inducible N-cadherin overexpression ES cells 
 The previous results in EcKO and NcKI cells indicated that while the deletion of E-
cadherin led to extensive cell death, the replacement of E-cadherin with N-cadherin rescued 
the cell death phenotype and additionally promoted neural differentiation. This raises the 
question of whether the pro-neural phenotype is a result of full cadherin switching, or 
whether N-cadherin alone is able to promote neural differentiation. To further investigate 
this question, an inducible N-cadherin overexpression system was developed.   
4.3.1.1 A2Lox-Ncad-HA cloning strategy 
 To study the effect of the gain of N-cadherin independently of any effects of E-
cadherin, an inducible ES cell line for N-cadherin overexpression was generated. An Inducible 
Cassette Exchange (ICE) system was chosen as this system has been developed to rapidly 
generate ES cell lines with inducible transgenes (Iacovino et al., 2011; Iacovino et al., 2014), 
and has already been successfully used by other members of the lab.  
 Briefly, the ICE system makes use of an A2Lox mES cell line. This cell line contains an 
ICE locus which encodes a doxycycline (Dox)-inducible Cre (“causes recombination”)-
recombinase flanked by two LoxP (Locus of crossing [x] over, P1) sites (the Cre is flanked by 
LoxP sites, or “floxed”)(Sternberg, 1981). Upon Dox induction, the Cre replaces itself with a 
targeted incoming gene of interest and repairs a downstream Δneo gene, rendering the 
recombinants resistant to G418 selection. The system can therefore be used to create 
transgenic cell lines that will conditionally express a gene of interest upon Dox treatment 
(Iacovino et al., 2014). This strategy was used to generate the A2Lox-Ncad-HA mES cell line. 
 For a detailed description of the cloning strategy, see Methods section 2.2.4.1. The 




Figure 4.6: Plasmid map of the p2Lox-Ncad-HA plasmid. Cdh2 and HA coding sequences labelled in 
red. Sequencing primer sites labelled in light grey (forward primers) and green (reverse primers).  
 
 Upon addition of Dox to the culture media, these cells overexpress an N-cadherin 
protein with a C-terminal influenza virus hemagglutinin (HA) tag. The tag was inserted at the 
intracellular terminus of the protein to prevent it from interfering with the adhesive function 
of N-cadherin. The drawback of this location was that the tag could not be easily used to sort 
the cells by flow cytometry for further analysis. The HA tag was chosen over a larger 
fluorescent reporter for two reasons: the small size of the tag means that it is less likely to 
interfere with the intracellular functions of the tagged protein, and the use of a non-
fluorescent tag allows for the simultaneous use of four fluorescent channels during ICC to 
visualise other proteins of interest.  
A diagram of the inducible transgene locus in the A2Lox-Ncad-HA cells is presented 
in Figure 4.7.  






SL233 Ncad Forward 2823..2842
SL234 Ncad Reverse 2897..2877
SL775 Ncad ICD Fwd 2985..3005
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Figure 4.7: Inducible Ncad-HA transgene in A2Lox-Ncad-HA cells following ICE recombination. The 
recombination site lies 5’ of the HPRT locus on the x chromosome. A doxycycline-inducible promoter 
(TRE) drives the expression of the Cdh2 transgene with a C-terminal HA tag, STOP codon and polyA 
sequence. Addition of doxycycline induces expression of the transgene. Downstream of the HPRT site, 
a PGK promoter is introduced that lies upstream of a neomycin resistance gene (Δneo) which renders 
all recombinants G418-resistant.  
 
4.3.1.2 Validation of inducible Ncad-HA cell lines 
 After cloning, electroporation, selection and expansion of recombinants was 
completed, seven surviving clonal lines were screened for Ncad-HA expression. The clones 
were cultured in Lif-serum conditions with or without 1µg/mL Dox for 24-48h, stained for HA 
expression, and imaged on an Operetta High Content Imaging System (Perkin Elmer). The 
three clones with highest HA expression (numbers 4, 5 and 7) were expanded and used in all 
subsequent experiments (Fig. 4.8).  
To confirm that the HA-tag co-localised with the expressed N-cadherin transgene, a sample 
of A2Lox-Ncad-HA cells were stained for both N-cadherin and HA and imaged on a Leica SP8 
confocal microscope in high resolution (Fig. 4.9). The images show that un-induced cells are 
negative for both N-cadherin and HA staining, and that induced cells co-express both of these 
proteins at their cytoplasmic membranes. The 24h time point of NDiff was chosen because it 




Figure 4.8: A2Lox-Ncad HA clonal cell line validation. Cells were cultured in Lif-serum with or without 
a 24h pulse of1µg/mL Dox immediately before staining, and imaged on an Operetta High Content 
Imaging System (Perkin Elmer). Images show three clones used for all remaining experiments. Scale 





Figure 4.9: The HA-tag co-localises with N-cadherin at the membrane of A2Lox-Ncad-HA cells. A2Lox-
Ncad-HA (clone 4) cells from 2i-Lif cultured in neural differentiation medium for 24h with or without 
1µg/mL Dox. Images taken on a Leica SP8 confocal microscope. Scale bar = 50µm.  
 
 Next, the induction efficiency of the inducible overexpression cell lines was 
quantified. Cells were seeded into Lif-serum conditions in a 12-well plate at a density of 5x104 
cells per well with or without Dox. The cells were analysed for gene expression by qPCR and 
for HA protein expression by cytospin-staining 24 or 48h after induction (for protocol details, 
see Methods). qPCR analysis showed that in Lif-serum conditions, the induced cells had 2-4-
fold higher Cdh2 mRNA levels than un-induced control cells when cultured in Dox for 24-48h 
(Fig. 4.10 A). Levels of Cdh1, Oct4, and Sox1 were unaffected by Ncad-HA induction at either 
time point. When the cells were fixed and stained following a cytospinning protocol and 
manually counted for Ncad-HA expression, the three clones showed between 10-20% 




Figure 4.10: Quantification of Ncad-HA induction efficiency in Lif-serum conditions. A. mRNA 
expression of A2Lox-Ncad-HA cells after 24 and 48h of induction in Lif-serum. Data normalised to ctrl 
24h condition. Bars show mean relative expression for three independent clones. Error bars = SD. 
**p<0.01, *p<0.05, paired T-test.  B. Example image of quantification of Ncad-HA induction efficiency 
in Lif-serum by cytospin. Image shows A2Lox-Ncad-HA clone 4. Cells were cultured in Lif-serum with or 
without 1µg/mL Dox or 24h before fixing and staining following a cytospinning protocol. Samples 
imaged on an Olympus IX51 fluorescent microscope.  Manual quantification found 20% induction in 







4.3.2 N-cadherin overexpression promotes anterior neural differentiation in vitro 
4.3.2.1 Optimisation of Ncad-HA induction for neural differentiation 
 To test whether induction of Ncad-HA could be improved over the levels observed in 
Lif-serum, the induction protocol was further optimised for neural differentiation conditions. 
It was hypothesised that NDiff conditions may be more permissive for N-cadherin induction 
since endogenous N-cadherin is not observed in Lif-serum (Fig. 3.3 A).  
Cells expanded in 2i-Lif were plated at a density of 2x105 cells per well in 6-well plates 
and cultured in 2i-Lif conditions overnight to allow cells to adhere to the plate, before a media 
change to NDiff (corresponding to day zero of the protocol). Ncad-HA was induced by the 
addition of Dox on days two or three of the protocol, and the cells were fixed for imaging 24h 
after addition of Dox. Manual quantification of membrane HA staining by cytospinning found 
~40% and ~20% Ncad-HA induction at the protein level when the cells were induced on days 
two and three, respectively (Figs. 4.11, 4.12). Induction at day two of NDiff therefore resulted 
in over two-fold increase in Ncad-HA expression compared to induction in Lif-serum 
conditions, confirming that NDiff conditions are more permissive for Ncad-HA expression 
(Fig. 4.12).  
Finally, the timing of Ncad-HA induction was optimised with the aim of yielding the 
highest level of transgene expression during neural differentiation. Three clones of A2Lox-
Ncad-HA cells were plated at a density of 3,000 cells per 12-well plate into 2i-Lif conditions. 
The cells were pre-incubated in 2i-Lif for 24h before a change to neural differentiation 
conditions (day zero), and Dox was added either at day zero or day two, and mRNA samples 
were collected on days two to six of NDiff. The day zero time point was chosen as a standard 
baseline, while day two was chosen because it represents a later time point where N-





Figure 4.11: Ncad-HA induction during neural differentiation. Cells were pre-incubated in 2i-Lif for 
24h before a media change do NDiff (day 0 of the protocol). 1 µg/mL Dox was added on days 2 (upper 
panels) or 3 (lower panels), and cells were fixed using a cytospinning protocol 24h after addition of 






qPCR analysis showed that Ncad-HA was robustly induced in both conditions 
following Dox treatment (Fig 4.13). When Dox was added at the beginning of the NDiff 
protocol (day zero), Cdh2 expression increased 60-fold relative to 2i-Lif. By contrast, when 
Ncad-HA was induced on day two of NDiff, Cdh2 expression increased over 120-fold relative 
to 2i-Lif, and the induced cells had between two and five-fold higher Cdh2 expression 
compared to un-induced controls throughout the time-course (Fig. 4.13). The day 2 induction 
time-point was chosen for subsequent triplicate experiments due to higher Cdh2 expression 
throughout the time-course relative to un-induced controls. The optimised experimental 
protocol is summarised in Figure 4.14. 
 
Figure 4.13: Optimisation of Ncad-HA induction during neural differentiation. A2Lox-Ncad-HA cells 
were pre-incubated for 24h in 2i-Lif before change to neural differentiation medium (day 0). 1µg/mL 
of dox was added on either day zero (A) or day two (B), and samples were collected for qPCR analysis 
on days two to six. Data normalised to Ctrl 2i-Lif condition. N=3 independent clones, error bars = SD.  
     
Figure 4.12: Manual quantification of Ncad-HA 
induction efficiency in three conditions. Ncad-
HA induction was manually quantified from 
images of cells fixed by cytospinning. Each point 
represents a single clone, lines show mean. Fixing 
and quantification was performed 24h after 





Figure 4.14: Optimised neural differentiation protocol for inducible N-cadherin overexpression cells. 
A2Lox-Ncad-HA cells are seeded into 2i-Lif conditions at a density of 3,000 cells per well in a 12-well 
plate into 2i-Lif conditions on a laminin coating. The cells are pre-incubated for 24h in 2i-Lif to allow 
proper attachment to the matrix. After 24h, media are changed to neural differentiation media. 
Doxycycline is added at 1µg/mL on day two, and continues to be replenished every time that media are 
changed. Cells are lysed for qPCR analysis on days three to six. Uninduced cells are lysed in a 2i-Lif 
control population and on days two to six. N = 3 biological replicates x 3 independent clones.  
 
4.3.2.2 N-cadherin overexpression promotes neural fate during anterior neural 
differentiation 
Once the neural differentiation protocol for the inducible N-cadherin overexpression 
cell lines was optimised, a triplicate experiment was set up. Three independent A2Lox-Ncad-
HA clonal cell lines were used in three side-by-side biological replicates. All nine replicates 
were then analysed in a single qPCR analysis, and the resulting readings were normalised to 
the geometric mean of two housekeeping genes (SDHA and TBP). To factor in the variation 
between different replicates of neural differentiation (as discussed in Chapter 3), a mean of 
the three normalised expression values for each clone was calculated. Following this, a mean 
and standard deviation were calculated for the average expression of each clone. Finally, the 
2i-Lif reading for each gene was set as 1, and all other readings were set relative to the 2i-Lif 
expression value.  
To assess significance between control and experimental conditions, an unpaired T-
test was performed on the mean expression values of the three clones used. Therefore, while 
the data are representative of a total of nine samples (three biological replicates of three 
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independent clones), the sample size for the significance calculations, and for the mRNA 
expression data summarised in Figure 4.15, is formally three.   
The qPCR analysis showed that inducing the expression of Ncad-HA on day two of 
the protocol produced a significant and robust upregulation of Cdh2 within 24h in the 
induced cells compared to uninduced cells, and this overexpression lasted for the remaining 
duration of the time course. Next, the effect of Cdh2 overexpression on the levels of other 
genes of interest was investigated.  
Levels of both Cdh1 and Pou5f1 decreased in response to Cdh2 overexpression. 
Within 48h of Ncad-HA induction this decrease was significant, and remained so until the end 
of the experiment on day six. The drop in levels of Pou5f1 suggests that the induced cells are 
exiting pluripotency faster or more efficiently than the un-induced controls. The drop in 
levels of Cdh1 occurred in synchrony with that of Pou5f1, as previously observed (Malaguti 
et al., 2013).  
Next, two early neural markers, Sox1 and Pax6, were assayed to investigate the role 
of N-cadherin overexpression on neural differentiation. Both of these markers were 
significantly upregulated within 24h of N-cadherin induction compared to un-induced 
controls, and remained that way up to day five of the time-course. These results show that 
the overexpression of N-cadherin either promotes or accelerates the expression of early 
neural markers during anterior neural differentiation, suggesting that N-cadherin may play a 
role in promoting neural fate during this process.  
To investigate whether this effect was specific to the neural lineage, marker genes 
for other germ layers were assayed – T for mesoderm, Dlx5 for surface ectoderm, and Sox17 
for endoderm. No significant differences were observed in the levels of these genes in the 
induced cells compared to their un-induced controls, suggesting that the effect of N-cadherin 
is specific to the neural lineage in this experimental system.  
Finally, the expression levels of marker genes of two signalling pathways were 
assayed to investigate whether these pathways may play a mechanistic role in the pro-neural 
effect of N-cadherin. Levels of Axin2, a key readout gene of the canonical WNT pathway, 
were not found to differ significantly between induced and un-induced cells. Next, levels of 
Egr1 and Dusp4, early and late targets of the FGF pathway, respectively (according to 
unpublished data from Tilo Kunath), were assayed.  On day three, levels of Egr1 were slightly 
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but significantly higher in induced cells, while on day four the levels of this gene were 
significantly lower in these cells, suggesting fluctuations in FGF signalling as a result of N-
cadherin overexpression. Levels of Dusp4 were reduced in induced cells on days four to six, 
and this downregulation was statistically significant on days four and six, suggesting that N-
cadherin may cause a dampening of FGF responsiveness.  
Taken together, the results of the triplicate qPCR analysis of N-cadherin 
overexpression during monolayer neural differentiation suggest that N-cadherin alone is able 
to promote neural induction, and that this effect is specific to the neural lineage. Analysis of 
signalling readout genes showed that overexpression of N-cadherin may lead to changes in 
FGF signalling.  
4.3.3 N-cadherin overexpression promotes neural specification in neuro-
mesodermal progenitors (NMPs) 
4.3.3.1 Protocol for generation and analysis of NMPs from ES cells cultured in 2i-Lif 
 Previous results suggested that the overexpression of N-cadherin promotes 
induction into the neural lineage during anterior neural differentiation. Next, the ability of N-
cadherin to influence lineage choice during another developmental process was investigated. 
A system for the generation and maturation of putative neuro-mesodermal progenitors 
(NMPs) was recently developed in the lab (Watson, 2018), and this system was used to 
investigate whether the overexpression of N-cadherin could also promote neural fate in this 
developmental context.  
 NMPs are bipotent progenitor cells that can give rise to either neural or mesodermal 
cells (Gouti et al., 2014; Tzouanacou et al., 2009). In vivo, they are a transient population 
emerging between E8.5-E13.5 that enables the elongation of axial tissues (Cambray and 
Wilson, 2002; Cambray and Wilson, 2007; Gouti et al., 2017; Wymeersch et al., 2016). 
Importantly for this study, the maturation of NMPs (occurring between E8.5 and E9.5) is 
accompanied by an E- to N-cadherin switch (Gouti et al., 2017). This led to the question of 






Figure 4.15 (pages 137-138): Changes in gene expression during neural differentiation in response 
to N-cadherin overexpression. A2Lox-Ncad-HA cells were used to induce N-cadherin overexpression 
according to an optimised neural differentiation protocol. Dox was added at 1µg/mL on day two. N=3 
mean readings covering biological replicates of three independent clones. Data normalised to Ctrl 2i-
Lif condition. Error bars = SD, **p<0.01, *p<0.05, unpaired T-test. 
 
Several in vitro protocols have been developed to study the maturation and 
differentiation of NMPs for both mouse and human systems (Gouti et al., 2014; Tsakiridis and 
Wilson, 2015; Turner et al., 2014). They involve the use of an EpiSC population as a “proxy” 
for the embryonic epiblast, followed by exposure to FGF2 and Chiron (a GSK3B inhibitor) to 
generate NMPs (Gouti et al., 2014; Henrique et al., 2015). More recently, a protocol for 
generating putative NMPs has been developed in our lab by Julia Watson which uses an Epi-
like stem-cell (EpiLSC) population generated from 2i-Lif cells as the epiblast-like starting 
population (Watson, 2018). I adapted this protocol for use with A2Lox-Ncad-HA cells to 
investigate how N-cadherin overexpression in early NMPs affects their maturation and 
commitment to the two daughter lineages. It was hypothesised that N-cadherin 
overexpression may promote the bi-potent NMP state, since cadherin switching 
accompanies the maturation on NMPs in vivo (Gouti et al., 2017). Alternatively, N-cadherin 




 Briefly, A2Lox-Ncad-HA cells cultured in 2i-Lif are seeded onto fibronectin at a density 
of 4,750 cells per well of a 12-well plate into EpiLC medium containing KOSR, FGF2 and 
Activin. After 48h, the cells have matured into EpiLCs, and the medium is change to NMP 
medium containing double the amount of FGF2 and additional Chiron. Culture for 48h in this 
medium generate immature NMPs- at this point, Dox is added to induce the overexpression 
of N-cadherin. After 24h of induction, the cells correspond to mature NMPs, and are fixed 
and stained for two markers of NMP lineage fate: T and Sox2. Double-positive cells 
correspond to bi-potent putative NMPs, while cells that are single-positive for T and Sox2 are 
assumed to have committed to mesoderm or neural fate, respectively. The protocol is 
summarised in Figure 4.16. 
 
Figure 4.16: Protocol for generation and maturation of NMPs. A2Lox-NCad-HA cells cultured in 2i-Lif 
were seeded onto fibronectin in EpiLC conditions containing FGF2, Activin and KOSR. On day two, media 
are changed to NMP medium containing double the dose of FGF2 and Chiron. On day four, Dox is added 
at 1µg/mL to induce the expression of Ncad-HA. Cells are fixed on day five and stained for ICC analysis.  
  
Following fixation, the cells were stained for T, Sox2, HA and DAPI, and were analysed 
using an Operetta high content imaging system and analysed using the corresponding 
Columbus® image analysis software (Perkin Elmer). Twelve fields of view were imaged and 
analysed per well. The design of the nuclear intensity analysis pipeline is described in 
Methods. The pipeline includes a nuclear segmentation module that assigns individual DAPI-
stained nuclei and is designed to filter out regions where segmentation quality is poor (Fig. 
4.18). After segmentation, Brachyury and Sox2 intensity thresholds were set empirically for 
each experiment by using internal controls in the stained samples- these were cells that were 




Figure 4.17: Example nuclear segmentation on Columbus® software. A. DAPI staining of A2Lox-Ncad-
HA cells cultured following the optimised NMP protocol. B. Segmentation performed by Columbus 
software. Incorrectly segmented nuclei were rejected based on size, roundness, and DAPI intensity. 
Scale bar = 100µm. 
 
Figure 4.18: Mature NMPs generated from A2Lox-Ncad-HA cells co-stained for T, Sox2 and HA. 
Images show cells from clone 5 with or without Dox induction (top and bottom panels, respectively). 




 Brachyury, Sox2, and HA co-staining showed that at day five of the NMP protocol, 
cells heterogeneously expressed Brachyury and Sox2 (Fig. 4.18, top right panel). Many cells 
also co-expressed these two proteins, suggesting that they had a bi-potent NMP identity. 
Induced cells were found to express high levels of HA at their membranes within 24h of 
addition of Dox (Fig. 4.18, bottom right panel).  
 Next, to investigate whether N-cadherin overexpression led to lineage bias in 
maturing NMPs, single and double expression of Brachyury and Sox2 was quantified in 
Columbus and compared between induced and un-induced samples. Three A2Lox-Ncad-HA 
clones were used in each biological replicate. A total of seven independent biological 
replicates were performed and analysed, yielding 21 independent data points for each 
condition. These data are summarised in Figure 4.19.  
 
Figure 4.19: Change in Bra and Sox2 co-
expression in response to N-cadherin 
over-expression during maturation of 
NMPs.  Points show enrichment of the 
given Bra/Sox2 identity in N-cadherin 
over-expressing condition compared to 
un-induced control. Data show seven 
biological replicates of three independent 
clones. N=21, **p≤0.01, unpaired T-test.  
  
 
The results showed that there was no significant change in the number of double 
positive or double negative cells following the N-cadherin overexpression. However, the 
induced cell populations were found to contain significantly fewer Brachyury single-positive 
cells and significantly more Sox2 single-positive cells than the un-induced wells. These results 
suggest that overexpression of N-cadherin during the maturation of NMPs biases cell fate 
towards the neural lineage, at the expense of the mesodermal lineage.  
However, it should be noted that a significant amount of variability in protein 
expression was observed between individual biological replicates. Additionally, some of the 
un-induced samples had very low levels of double-positive cells, suggesting that there may 
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have been a problem with the NMP induction protocol, or the thresholds used for analyses, 
in these replicates. Additionally, the number of cells expressing Brachyury appears to be low 
compared to previously optimised protocols (Gouti et al., 2014). In general, a trend for fewer 
double-positive cells in the induced samples can be observed, however this negative trend is 
non-significant due to a few large outliers. Overall, the results suggest that overexpression 
of N-cadherin leads to a bias in the neural lineage over the mesodermal lineage, though a 
different or more optimised system may have to be used to generate a more reliable and 
reproducible dataset in order to confirm these findings.  
4.4 Discussion 
4.4.1 Loss of E-cadherin leads to instability during neural differentiation 
 Previous studies in our lab have showed that blocking E-cadherin leads to faster, 
more synchronous neural differentiation from a Lif-serum starting population (Malaguti et 
al., 2013). This led us to hypothesise that deleting E-cadherin in ES cells would also promote 
neural differentiation.  
 The EcKO cells generated by collaborators (Pieters et al., 2016) were found to be 
stable in pluripotent cultures, both in Lif-serum and 2i-Lif conditions and could self-renew 
over several passages. In ICC validation of the cells, the EcKO cells appear to upregulate 
endogenous N-cadherin to a higher level than their parental cell line- this is an effect 
previously reported in ES cells lacking E-cadherin (Hawkins et al., 2012). 
When the EcKO cells were cultured from 2i-Lif through a neural differentiation 
protocol, they showed very poor survival (Fig. 4.3), and the protocol had to be scaled up and 
repeated multiple times to yield enough mRNA for robust qPCR analysis. The analysis found 
that the surviving cells could upregulate Cdh2 and the neural marker Sox1, and downregulate 
the pluripotency marker Pou5f1, but these changes occurred at similar levels to parental 
control cells (Fig. 4.4). These results showed that in the experimental system used, while loss 
of E-cadherin caused cells to become extremely unstable during neural differentiation, the 
mutation did not appear to either promote or inhibit commitment to the neural lineage. 
 Similarly, studies in vivo have also shown that a loss of E-cadherin leads to instability 
at several stages during early development, from the pre-implantation stages and beyond 
gastrulation; these phenotypes appear to involve both adhesive and signalling functions, as 
rescuing adhesion by knocking in other cadherin species rescues some adhesive functionality 
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but ultimately still leads to embryonic lethality at several stages in early development 
(Basilicata et al., 2016; Bedzhov et al., 2012; Bedzhov et al., 2013; Kan et al., 2007; Larue et 
al., 1994; Larue et al., 1996). These reports support the view that E-cadherin is necessary for 
tissue stability, and the current results suggest that loss of E-cadherin leads to poor cell 
survival during neural differentiation.  
 However, in vitro studies of the role of E-cadherin in the maintenance of and exit 
from pluripotency offer contradictory results. In particular, one study found that the same E-
cadherin-null cells used here can retain Pou5f1 expression even after 30 days of culture as 
EBs in differentiation conditions, and fail to upregulate lineage markers (Pieters et al., 2016). 
In contrast, our findings show that under certain conditions, these cells are able to 
downregulate Pou5f1 and upregulate neural markers at a similar rate to control cells. 
However in the present study, cellular survival was the limiting factor for this differentiation.  
 Taken together, the findings of the current study and previous reports paint a 
muddled picture for the role of E-cadherin during neural differentiation, with some 
identifying it as an inhibitor, and others, as a promotor of the process. Since the survival issue 
presented an obstacle for neural differentiation of these cells, we shifted our focus to 
studying the NcKI cells. The cell death phenotype observed in EcKO cells is rescued in NcKI 
cells, allowing for the investigation of any differentiation bias in these cells in the absence of 
the confounding effect of the apoptosis phenotype.  
4.4.2 Cadherin replacement rescues cell stability and promotes neural 
differentiation 
 NcKI cells have been previously studied at pre-implantation and post-gastrulation 
stages in vivo, and were used to show that E-cadherin is critical for trophectoderm formation 
and necessary for germ layer maturation at E8.5 (Basilicata et al., 2016; Kan et al., 2007). 
However, they have not previously been used in the context of in vitro neural differentiation, 
and they were an attractive model for the current study as they represent a forced, 
premature cadherin switch, similar to that observed in neural differentiation and the E8.5 
neural tube (Chapter 3).  
 During neural differentiation, NcKI cells expressed significantly higher mRNA levels 
of early neural markers at the earliest time-points of the differentiation protocol, without a 
major effect on markers of other lineages. They also expressed consistently lower levels of 
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Pou5f1 throughout the time-course, from 2i-Lif up to day five of the protocol. There are two 
mechanistic explanations for this observation: first, that the NcKI mutation may accelerate 
the process of lineage priming and subsequent differentiation; and second, that the NcKI 
mutation causes cells to exist in developmentally later stage than WT cells cultured in the 
same pluripotent condition. A combination of these causes may also be plausible. 
Indeed, it has been reported that cells lacking E-cadherin have a more EpiSC-like gene 
expression profile (Soncin et al., 2011), supporting the second mechanism. This explanation 
is additionally supported by the fact that NcKI cells already express significantly lower levels 
of Pou5f1 in 2i-Lif conditions (Fig. 4.5), suggesting that they may be more “poised” for 
differentiation than WT cells.  
The fact that EcKO cells did not display an overt differentiation bias while NcKI cells 
did suggests that the gain of N-cadherin is the main contributing factor for the observed 
phenotype. However, it is also plausible that knock-in N-cadherin may be rescuing cell 
stability during differentiation, while the loss of E-cadherin may be a contributing factor to a 
pro-neural effect, as seen in Malaguti et al. 2013. Indeed, numerous studies have shown that 
N-cadherin plays an important role in the suppression of apoptosis in various cancer cells  
(Wheelock et al., 2008). To attempt to uncouple these two possible mechanisms, the N-
cadherin overexpression cell line was generated to examine the effects of N-cadherin gain-
of-function without changing endogenous levels of E-cadherin.   
4.4.3 N-cadherin overexpression biases differentiation towards the neural 
lineage in two developmental contexts 
 The development of the A2Lox-Ncad-HA cell line allowed for the study of the effects 
of N-cadherin overexpression at a precise experimental time-point. In Lif-serum conditions, 
a minority of induced cells expressed N-cadherin at the protein level, which corresponded to 
a roughly four-fold increase in mRNA expression (Figs. 4.10-12). This overexpression did not 
give rise to changes the expression of other genes, including Pou5f1 and Cdh1, as reported 
previously (Takehara et al., 2015). This result suggests that any pro-differentiation effect of 
N-cadherin is not strong enough to affect the pluripotent gene regulatory network in ES cells 
cultured in Lif-serum.  
By contrast, within 48h of N-cadherin induction in neural differentiation conditons, 
Cdh1 and Pou5f1 expression was significantly reduced in the induced cells (Fig. 4.15). It is 
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unclear whether the downregulation of Cdh1 is a direct effect of N-cadherin, as observed in 
human squamous carcinoma cells (Islam et al., 1996), or whether it simply accompanies the 
loss of Pou5f1 as the cells exit pluripotency (Malaguti et al., 2013). In other contexts, such as 
human breast cancer cell lines, overexpression of N-cadherin does not always lead to 
downregulation of E-cadherin (Hazan et al., 2000; Nieman et al., 1999).  
 In addition to the downregulation of pluripotency markers, N-cadherin induction was 
also found to cause the upregulation of early neural markers, but not markers of other 
lineages, showing that N-cadherin alone can promote neural fate in permissive conditions. 
N-cadherin is known to play an important role in the development of the nervous system by 
promoting the growth of neurons, a mechanism that has been linked to N-cadherin coupling 
with FGF receptors (Doherty et al., 2000; Nguyen and Mège, 2016; Williams et al., 2001). 
Indeed, significant changes were observed in two FGF pathway readout genes in the N-
cadherin overexpression time-course, suggesting that FGF signalling may play a role in this 
context. In the following chapter, the mechanism behind the pro-neural effect of N-cadherin 
during monolayer neural differentiation is investigated in greater detail.  
 In addition to EMT and early neural differentiation, cadherin switching is also 
reported to occur in embryonic development during the maturation of NMPs (Gouti et al., 
2017). Since a system for the studying NMP maturation in vitro had been recently optimised 
by a current lab member (Watson, 2018), N-cadherin overexpression was additionally 
investigated in this context. The analysis found that induction of N-cadherin during NMP 
maturation caused a significant drop in the numbers of cells single-positive for Brachyury, 
and a significant increase in the proportion of cells single-positive for Sox2 (Fig 4.19). The 
trends in the data imply that fewer cells express Brachyury as a result of N-cadherin 
induction, either alone or in combination with Sox2. This result suggests that N-cadherin 
promotes induction into the neural lineage during NMP maturation and differentiation.  
 The mechanism for this NMP fate bias remains was not further investigated. The fate 
decisions of NMPs are delicately balanced in vivo by complex gene regulatory network (Gouti 
et al., 2017), and it is possible that an overexpression of N-cadherin may tip this balance in 
favour of the neural lineage, or perhaps accelerate neural differentiation at the expense of 
mesodermal differentiation. A study in chick embryos found that FGFR1 promoted the 
elongation of the anterior nervous system (Mathis et al., 2001); since N-cadherin is known to 
interact with FGFR1 in other contexts relating to pluripotency and nervous development 
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(Takehara et al., 2015; Williams et al., 2001), it is plausible that an interaction between N-
cadherin and this receptor may be driving the neural bias in NMPs observed in the current 
study.  
 However, there were some caveats in the experimental set-up that would have to be 
addressed to further analyse the mechanism behind this phenotype. Specifically, the number 
of cells expressing Brachyury is lower than expected in the NMPs, either on its own or in 
combination with Sox2. The published protocol for in vitro derivation of NMPs from EpiSCs 
yields a very high proportion (nearly 100%) of double-positive cells (Gouti et al., 2014), while 
the protocol used here gave rise to fewer Brachyury-expressing cells: in some experimental 
replicates, the total percentage of cells expressing Brachyury, either alone or in combination 
with Sox2, was below 10%. Furthermore, the extent of variation in the proportion of cellular 
identities between experiments suggests that the experiment could be optimised further to 
yield more consistent cell populations. In addition, the putative NMPs generated from an 
EpiLC intermediate through this protocol have not been validated in vivo, and therefore 
cannot be confidently deemed to be true bipotent progenitors.  
In conclusion, the overexpression of N-cadherin was found to have significant pro-
neural effects in vitro, both during anterior neural differentiation and during the maturation 
of putative NMPs generated from an EpiLC intermediate. These results show that in 
permissive conditions, N-cadherin alone is able to promote neural fate in two developmental 
contexts. However, due to the combination of experimental shortcomings around the NMP 
protocol used here, the mechanisms behind the pro-neural effect of N-cadherin in NMPs 
were not studied further. In the following chapter, the signalling effects of N-cadherin during 
neural differentiation will be investigated.  
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Chapter V – Effects of cadherin switching on signalling 
 
5.1 Introduction & aims 
 In the previous chapter, it was established that both full cadherin switching, and the 
gain of N-cadherin on its own, are able to promote induction into the neural lineage during 
neural differentiation in vitro. Cadherins are traditionally regarded as  cell-cell adhesion 
molecules, but a growing body of evidence is showing that they can also perform signalling 
functions in addition to – and independently of – their role in adhesion. Is the pro-neural 
effect of cadherin switching therefore a result of changes in adhesion or signalling?  
 Both the adhesive and signalling functions of E-cadherin have been shown to be 
critical for early embryonic development, as mutations targeting either function result in 
gross morphological disruption, developmental defects, and embryonic lethality (Basilicata 
et al., 2016; Bedzhov et al., 2012; Larue et al., 1994; Larue et al., 1996). E-cadherin has been 
linked to signalling through the IGF and EGF pathways by forming complexes with their 
receptors (Bedzhov et al., 2012; Pece and Gutkind, 2000).  E-cadherin has also been linked to 
the WNT pathway through its association with and release of β-catenin at the cytoplasmic 
membrane, allowing this protein to perform nuclear signalling functions (Gottardi et al., 
2001; Howard et al., 2011).  
 However, since both NcKI cells and N-cadherin overexpressing cells display a pro-
neural effect, the focus shifts to the role of N-cadherin in producing this phenotype. Embryos 
lacking N-cadherin die by E10 due to developmental defects of the heart, but also display 
malformed somites and yolk sac deformities. The lethality is mostly ascribed to adhesion 
defects in the heart, where cardiac myocytes dissociate from one another and the heart tube 
fails to develop normally (Radice et al., 1997). This lethality can be rescued by knocking in E-
cadherin, supporting the view that impaired adhesion, and not an N-cadherin specific 
signalling function, is responsible for the phenotype (Luo et al., 2001). 
 Nevertheless, N-cadherin also has functions in signalling. N-cadherin has been shown 
to interact with the FGF receptor and promote signal transduction through it, in contrast to 
E-cadherin which signals through the EGF receptor (Fedor-Chaiken et al., 2003; Hazan and 
Norton, 1998; Hoschuetzky et al., 1994; Williams et al., 1994). N-cadherin can also regulate 
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WNT/β-catenin signalling in neural precursor cells through an Akt-dependent mechanism 
(Zhang et al., 2010). These signalling interactions have been linked to several physiological 
processes, including neuronal growth and differentiation (Nguyen and Mège, 2016; Williams 
et al., 2001; Zhang et al., 2010). Additionally, N-cadherin activation and use of N-cadherin-
coated surfaces has been linked to reduction in Rho/ROCK signalling, leading to reduced 
apoptosis and increased neurite outgrowth in neural precursor cells (Haque et al., 2015). 
 In summary, there are several putative mechanisms that may be causing the pro-
neural effect observed in cells undergoing cadherin switching. This raises several questions: 
is the neural bias mainly caused by the adhesive or signalling functions of the cadherins, or 
are these two mechanisms acting co-operatively? If the phenotype is caused by changes in 
signalling, what are the pathways involved? To answer these questions, the aims of this 
chapter are to: 
a) Assess and quantify changes in adhesion caused by cadherin switching; 
b) Investigate changes in signalling pathways caused by cadherin switching; 
c) Determine whether the pro-neural effect of cadherin switching can be rescued by 
manipulating these signalling pathways. 
5.2 Quantification of clustering in cells with cadherin 
manipulations 
5.2.1 Nuclear segmentation of confocal images using NESSys 
 In order to determine whether the pro-neural phenotype caused by cadherin 
switching was caused by changes in the way cells adhere to one another, a quantitative image 
analysis strategy was developed to assess differences in cellular adhesion between different 
cell populations. The strategy involved the nuclear segmentation of 3D confocal images and 
measurement of distances between the nuclear edges in the different cell types used.  These 
values were used as a measure of cellular clustering, which would serve as an indirect 
readout of changes in cellular adhesion.  
 The quantitative image analysis software PickCells, developed in our lab by postdoc 
Guillaume Blin, was used for this quantification. The software includes a nuclear 
segmentation module (Nuclear Envelope Segmentation System – NESSys) which was used for 
the analysis. The system segments nuclei based on nuclear envelope staining and makes use 
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of a combination of manual and machine learning systems to generate an automated nuclear 
segmentation pipeline. For a detailed description of the workflow pipeline, see Methods, 
(section 2.2.3.1.9).  
Examples of high and lower-quality segmentations based on nuclear envelope 
staining are shown in Figure 5.1. Panel C shows a high quality segmentation where nearly 
100% or nuclei are accurately segmented. The bottom-left corner of panel D shows an 
example of a high-density area where segmentation is more inaccurate, with some omissions 
and merges of individual nuclei. In general, certain conditions, such as culture with Wnt3a 
(pictured) or later-stage neural differentiation led to areas of higher cellular density, which 
were more challenging for the segmentation software. To improve on this, the software uses 
3D Z-stacks of the samples to match individual nuclei between Z-planes, improving 
segmentation quality for the sample in general. Samples for quantification were therefore 
always imaged as 3D Z-stacks and the analysis pipeline was empirically optimised for each 
dataset to yield the highest quality segmentation possible. It was deemed that this 
segmentation quality was accurate enough for downstream applications. 
5.2.2 Loss of E-cadherin leads to clustering defects 
Cells with E-cadherin knock-out and N-cadherin knock-in mutations were cultured in 
2i-Lif, and then seeded at a density of 5x104 cell per well in 12-well plates onto glass coverslips 
into 2i-Lif conditions. After a 24h pre-incubation to allow better adhesion to the culture 
surface, media were changed to NDiff for a further 24h. For A2Lox-Ncad-HA cells, Dox was 
added at the time of the media change. After one day of culture in neural conditions, all cells 
were fixed and stained for the nuclear envelope marker Laminβ1. The 24h time point was 
chosen since many, but not all, of the cell lines formed tight, compact dome-shape colonies 
in 2i-Lif conditions, and 24h of culture in NDiff conditions cause them to flatten out with 
surprising consistency. It was therefore hypothesised that 24h NDiff conditions would allow 
for the most consistent comparison of cellular clustering, and an accurate quantification of 
adhesive differences between cell lines, at a time point when the cells retained Oct4 






Figure 5.1: Example nuclear segmentation in NESSys. Cells were seeded at a density 5x104 cells per 
well in a 12-well plate onto glass coverslips into 2i-Lif conditions. After 24h, media were changed to 
NDiff for a further 24h. Cells were then stained for the nuclear envelope marker Laminβ1. A-B: Nuclear 
envelope staining for cells cultured with or without Wnt3a. C-D: Corresponding nuclear segmentation. 
Images show one Z-plane of a larger 3D Z-stack. Scale bar = 50µm. 
 
Once the cells were stained, imaged, and segmented in NESSys, the PickCells 
software was used to calculate the distances between nuclear edges of neighbouring cells up 
to a 40µm radius. The analysis module employs Delaunay triangulation to identify the nearest 
neighbours of each individual nucleus, and these were the nuclei for which edge distances 
were calculated. In practice, this method results in the calculation of edge distances only 
between the nearest neighbours of individual nuclei, up to a distance of 40µm. A graphical 




This analysis resulted in several edge distance measurements for each nucleus 
analysed per image, corresponding to the number of immediate neighbours that each 
nucleus had. To illustrate the spread of these data, density plots for one biological replicate 
are displayed in Figure 5.3, where each curve represents 1054 individual distance 
measurements from a single stained sample. The trends in these density plots show that 
parental control cells and WT cells tend to mostly have inter-nuclear edge distances below 
10 microns. By contrast, both the EcKO cells and NcKI cells display a much larger spread of 
inter-nuclear edge distance measurements, showing that these cells are spread further apart 
from one another than the control cells.  
Figure 5.3: Example density plots of inter-nuclear edge distances in cadherin mutant cells. N=1054 
individual edge-distance measurements.  
 
Figure 5.2: Methodology for measuring inter-
nuclear edge distances in stained and 
segmented nuclei. Delaunay triangulation 
was used to identify the nearest neighbours 
for each nucleus (solid white line), and the 
inter-nuclear distances were calculated for 
these cells (grey dotted lines). The maximum 
radius for neighbour detection was set at 
40µm (white dotted outline). Scale bar = 
20µm, diagram to scale. 
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In total, three biological replicates were plated and analysed for each condition 
studied, and a minimum of three fields of view were imaged for each replicate. For the A2Lox-
Ncad-HA cells, one biological replicate and three independent clones were used for bot the 
un-induced and induced conditions. The outcomes of the analysis are summarised in Figure 
5.4. By eye, the nuclei of cells lacking E-cadherin (EcKO and NcKI) appear to be spread further 
apart from one another than their control cell lines (Fig. 5.4 A). The inter-nuclear edge 
distance analysis confirms that these cadherin mutant cells have significantly greater inter-
nuclear edge distances than their control cell lines, suggesting that loss of E-cadherin leads 
to defective adhesion (Fig. 5.4 B). In addition, the EcKO and NcKI cells have nearly identical 
mean inter-nuclear edge distance values, showing that knocking-in N-cadherin is not enough 
to rescue the defective clustering of E-cadherin null cells. A2Lox-Ncad-HA cell nuclei are 
shown to spread slightly but significantly further apart from one another following Dox 
treatment, suggesting that overexpression of N-cadherin may loosen cell-cell contacts or 
push cells further apart. 
To ensure that the differences observed in cell clustering were not simply an 
outcome of differences in cell number or survival, the total number of cells per analysis was 
also recorded (Fig. 5.4 C). Cell numbers between comparable replicates did not differ 
significantly, supporting the idea that the differences in inter-nuclear edge distances are a 
result of the cadherin mutations.  
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Figure 5.4: Clustering analysis of E-cadherin knock-out and N-cadherin knock-in cell lines. A. Example 
images used in the analysis. All images show Laminβ1 nuclear envelope staining. Scale bar = 50µm.  B. 
Summary of inter-nuclear edge distance analysis. C. Total cell number analysed in each biological 
replicate. For B and C, each point represents a mean of all cells from three fields of view of each 






 Taken together, the results show that the loss of E-cadherin leads to significant 
changes in cell clustering which cannot be rescued by knocking-in N-cadherin. Additionally, 
N-cadherin overexpression caused a slight but significant increase in inter-nuclear distances 
compared to control cells. These results were interpreted as showing that cadherin switching 
causes changes in cellular adhesion, with loss of E-cadherin especially resulting in a failure of 
cells to properly adhere to one another.  
It should be noted that this approach for measuring cellular clustering has a few 
significant limitations. While the changes in inter-nuclear distance are presumed to be due 
to defective adhesion, they could also be explained by other cellular processes, such as 
differences in migration, survival, or changes in cell morphology or cytoplasmic volume. 
Additionally, the data uses distances between nuclei because this was the cellular 
compartment for which a robust segmentation and analysis pipeline was available; 
membrane segmentation and analysis could give a more informative view of changes in 
cellular adhesion. However, the tools for such an analysis were not available for the current 
study.   
 Interestingly, the cells in which a pro-neural effect was observed (NcKI and Dox-
induced A2Lox-Ncad-HA cells) show very different clustering profiles to one another. 
Additionally, the populations with the most disrupted clustering (EcKO and NcKI) displayed 
different behaviours in neural differentiation assays, with EcKO cells behaving similarly to 
control cells while NcKI cells underwent more efficient neural differentiation. This suggests 
adhesion may not be the main driver behind the pro-neural phenotype observed, raising the 
possibility that cadherin switching may influence differentiation via some other mechanism, 





5.3 The relationship between E-cadherin, β-catenin and canonical 
Wnt signalling 
5.3.1 Loss of E-cadherin leads to a global loss of β-catenin 
 In the previous section, it was proposed that changes in adhesion cannot fully explain 
the pro-neural effect of cadherin switching, since levels of nuclear clustering did not correlate 
with the cell lines and conditions exhibiting a neural bias. As such, it was hypothesised that 
cadherin switching may modulate cellular signalling.  
 To test this hypothesis, a reverse-phase protein array (RPPA) was used to measure 
the strength of various signalling pathways. In this method, cellular lysates are prepared at a 
fixed concentration and printed onto a microarray slide in a dilution series, incubated with 
specific fluorescent antibodies, and imaged in an analyser. The fluorescence of each sample 
is then quantified to determine the relative expression of a specific protein or phospho-
protein species in a given sample (Spurrier et al., 2008). In this project, RPPA was used to 
quantify levels of protein and phosphor-protein species involved in signal transduction in 
various pathways.  
 For the RPPA, EcKO and NcKI cells, their respective control cell lines, and A2Lox-Ncad-
HA cells were used. The cells were plated at a density of 1.5x106 cells into 10cm dishes into 
2i-Lif conditions and incubated for 24h to allow for proper adhesion to the dish. Media were 
then changed to neural differentiation medium. For A2Lox-Ncad-HA cells, Dox was added at 
the time of this medium change. After 24h of culture in neural differentiation conditions, the 
cells were lysed for protein content, normalised to a standard concentration and shipped to 
an external facility where RPPA analysis was performed. The 24h time-point was chosen 
because it was hypothesised that any signalling changes occurring due to cadherin switching 
would be occurring early on, as differences in gene expression can already be observed 
within 48h of neural differentiation in the cadherin mutant cells. Three independent 
biological replicates were performed. For A2Lox-Ncad-HA cells, a different clone was used in 
each biological replicate.   
 Figure 5.5 shows the full results of the RPPA experiment, with each value 
corresponding to mean enrichment relative to the relevant control cell line. Each (phospo-) 
protein species was manually classified into the signalling pathway that it is most commonly 
associated with based on entries in the GeneCards.org online database. 
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Overall, EcKO cells tended to have lower levels of most proteins compared to the 
parental cell line, but only three protein species were significantly lower: E-cadherin, β-
catenin and Tsc2 phosphorylated at Thr1462.  By contrast, NcKI cells were found upregulate 
many proteins compared to WT cells across various signalling pathways, many of them 
significantly. Finally, no significant change in protein levels was observed in the induced 
A2Lox-Ncad-HA cells compared to un-induced cells. Interestingly, EcKO cells also displayed 
higher levels of cleaved caspase-3, suggesting an elevated rate of apoptosis in these cells 
(Walters et al., 2009), and lending additional support to the idea that loss of E-cadherin 
causes cellular instability and increased cell death.  
After E-cadherin, the protein with the greatest magnitude of change in expression 
was un-phosphorylated β-catenin, which was highly downregulated in both EcKO and NcKI 
cells, similarly to previous reports (Soncin et al., 2011). This result shows that the loss of E-
cadherin leads to a significant drop in levels of β-catenin, which cannot be rescued by 
knocking-in N-cadherin. Two phosphorylated forms of β-catenin were also assayed, but no 
significant difference was detected in their levels compared to control cells (Fig. 5.6). Since 
β-catenin is an important player in WNT signalling, the results raised the possibility that 





Figure 5.5 (pages 157-158): RPPA protein expression heat-map for 24h in neural differentiation 
conditions. Values correspond to mean relative enrichment compared to the relevant control: 
EcKO/Parental, NcKI/WT, A2Lox-Ncad-HA induced/un-induced. Approximate signalling pathway 
identity selected manually from GeneCards.org online database. N=3 biological replicates, *p≤0.05, 






5.3.2 Quantification of nuclear β-catenin in cadherin mutant cells  
 β-catenin is a central component of the canonical WNT signalling pathway; when the 
pathway is activated, translation of β-catenin protein is activated, and its un-phosphorylated 
form translocates to the nucleus where it activates transcription of WNT target genes 
(Clevers, 2006). Studies in ESCs have shown that activation of WNT signalling promotes self-
renewal (Sato et al., 2004; ten Berge et al., 2011) and inhibits neural differentiation (Faunes 
et al., 2013; Haegele et al., 2003). In the previous section, the loss of E-cadherin was linked 
to a significant drop in global levels of β-catenin. This raised the possibility that the pro-neural 
effect observed in NcKI cells may be due to reduced WNT signalling in these cells, assuming 
that the drop in β-catenin levels also occurs in the nucleus. To further explore this possibility, 
the nuclear levels of β-catenin were studied in the cadherin mutant cells, and the cells’ 
responsiveness to external WNT signals was explored.   
 EcKO, NcKI and their relevant control cell lines were plated onto glass coverslips at a 
density of 5x104 cells per well in a 12-well plate in 2i-Lif conditions. After a 24h-incubation in 
2i-Lif, media were changed to NDiff, and parallel wells were set up with three concentrations 
of Wnt3a: 0, 25 and 100ng/mL. After 24h of neural differentiation with or without 
supplemented Wnt3a, the cells were fixed and stained for Laminβ1, E-cadherin, Oct4, and an 
active (dephosphorylated) form of β-catenin. The samples were then imaged as 3D Z-stacks 
on a Leica SP8 confocal microscope, with at least three fields of view imaged per sample. 
Figures 5.7 and 5.8 show example images of representative samples.  
Figure 5.6: Mean expression 
values for three phosphorylation 
states of β-catenin in cadherin 
mutant cell lines. Values 
obtained from RPPA analysis. 
N=3 biological replicates, 













Figure 5.7 (page 160): Example ICC of parental (A) and EcKO (B) cells after 24h of neural 
differentiation in increasing concentrations of Wnt3a. Samples images on a Leica SP8 confocal 
microscope. Scale bar =50µm.  
 
Figure 5.8 (page 161): Example ICC of WT (A) and NcKI (B) cells after 24h of neural differentiation in 
increasing concentrations of Wnt3a. Samples images on a Leica SP8 confocal microscope. Scale bar 
=50µm.  
 
 By eye, it is evident that both cell lines lacking E-cadherin display substantially lower 
levels of β-catenin, both at their cytoplasmic membrane and within the nucleus, confirming 
observations from the RPPA data. Increasing concentrations of Wnt3a appear to yield higher 
nuclear β-catenin staining, which is most evident in the Flox/Flox cells (Fig. 5.7 A). By eye, 
nuclear Oct4 intensity appears comparable between the different mutants and varying 
concentrations of Wnt3a.  
5.3.2.1 Optimisation of β-catenin nuclear quantification 
 Next, the nuclear intensity of β-catenin in the samples was quantified using PickCells. 
Nuclear segmentation was performed on Laminβ1 signal using the NESSys module as before. 
The “Intrinsic Features” module in PickCells quantifies several nuclear properties. Here, this 
module was used to quantify mean intensity of the β-catenin staining in the nuclei, which 
produced a mean value for each nucleus based on all Z-planes of the 3D Z-stack in which a 
given nucleus was detected. A visual representation of this quantification is presented in 
Figure 5.9, showing that the loss of E-cadherin leads to lower nuclear β-catenin signal, and 




Figure 5.9: PickCells quantification of nuclear signal intensity in cells stained for active β-catenin. 
Cells cultured for 24h in neural differentiation conditions with or without a high dose of Wnt3a.  
 
 The nuclear β-catenin quantification experiment was optimised by using two 
different β-catenin antibodies: one, raised in rabbit, which detects all β-catenin; and a 
second, raised in mouse, which detects the active form of the protein that is 
dephosphorylated at both Ser37 and Thr41. Samples of EcKO, NcKI and the relevant control 
cell lines (cultured as before) were stained with both of these antibodies, and the intensity 
profiles of their nuclei were investigated using PickCells analysis. Figures 5.10 and 5.11 
compare density plots produced by these two antibodies at different concentrations of 
Wnt3a. It was concluded that the two antibodies produced very similar quantitative results, 
and in following experiments, the β-catenin antibody was selected that would better match 
a given panel of other antibodies based on the animal species they were raised in.  
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Figure 5.10: Comparison of nuclear β-catenin intensity by two antibodies in EcKO cells. Flox/Flox 
(parental) and EcKO cells were cultured for 24h in neural differentiation conditions in varying 
concentrations of Wnt3a, fixed, and stained with one of two β-catenin antibodies, specific for total (A) 
and unphosphorylated (B) β-catenin. Samples were imaged on a Leica SP8 confocal microscope. 
Nuclear intensity of the antibody signal was quantified using PickCells software. Each curve represents 




Figure 5.11: Comparison of nuclear β-catenin intensity by two antibodies in NcKI cells. WT and NcKI 
cells were cultured for 24h in neural differentiation conditions in varying concentrations of Wnt3a, 
fixed, and stained with one of two β-catenin antibodies, specific for total (A) and unphosphorylated (B) 
β-catenin. Samples were imaged on a Leica SP8 confocal microscope. Nuclear intensity of the antibody 
signal was quantified using PickCells software. Each curve represents one biological replicate including 
at least three fields of view. N=162 nuclei per sample.  
 
5.3.2.2 Loss of E-cadherin leads to a loss of nuclear β-catenin 
 A previous study showed that E-cadherin and Oct4 are downregulated in synchrony 
during neural differentiation (Malaguti et al., 2013), while another study has proposed the 
existence of a membrane-bound E-cadherin/β-catenin/Oct4 complex that is involved in 
regulating pluripotency (Faunes et al., 2013). To investigate the relationship between E-
cadherin, β-catenin and Oct4, the cells in the current experiment were additionally stained 
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for Oct4, and the nuclear levels of this transcription factor were quantified in PickCells. 
Example density of Oct4 intensity distributions in the different cell lines and at various 
concentrations of Wnt3a are shown in Figure 5.12.  
 Once the staining protocol and analysis pipeline for the experiment were optimised, 
four biological replicates were performed, and samples were collected for both ICC and qPCR 
for protein and mRNA-level analysis, respectively. The results for nuclear active β-catenin and 
Oct4 are summarised in figure 5.13. These results show that the loss of E-cadherin leads to a 
significant drop in levels of nuclear un-phosphorylated β-catenin, and that this effect cannot 
be rescued by knocking in N-cadherin. In addition, increased concentrations of Wnt3a led to 
higher levels of nuclear β-catenin staining in all cell lines studied, but these increases were 
much less pronounced in the two cell lines lacking E-cadherin. This result suggests that E-
cadherin is required for the maintenance of global and nuclear levels of β-catenin in the 
earliest stages of in vitro neural differentiation. In the absence of E-cadherin, even high doses 
of Wnt ligand are unable to rescue WT levels of nuclear β-catenin.    
 By contrast, analysis of Oct4 levels in the cadherin mutants showed that neither the 
loss of E-cadherin nor the compensatory knock-in of N-cadherin had an effect on the levels 
of Oct4 protein in the cells studied at this time point. However, higher concentrations of 
Wnt3a correlated with higher levels of Oct4, supporting previous reports that in neural 
differentiation conditions, Wnt3a promotes, and is sufficient to maintain, a pluripotent state 
(Faunes et al., 2013). This effect was observed to some extent in all the cell lines studied, 
suggesting that while the cadherin mutant cells exhibit lower levels of nuclear β-catenin, they 
may still retain WNT-responsiveness. This possibility is investigated further in the next 




Figure 5.12: Example quantification of nuclear Oct4 intensity in cadherin mutant cells. Cadherin 
mutant cells and their relevant control cell lines were cultured for 24h in neural differentiation 
conditions in varying concentrations of Wnt3a, fixed, and stained for Oct4. Samples were imaged on a 
Leica SP8 confocal microscope. Nuclear intensity of the antibody signal was quantified using PickCells 
software. Each curve represents one biological replicate including at least three fields of view. N=162 




Figure 5.13: Nuclear levels of active β-catenin and Oct4 in cadherin mutant cells. EcKO and NcKI cells, 
and their relevant control cell lines, were cultured in neural differentiation conditions for 24h in varying 
concentrations of Wnt3a, stained for active β-catenin and Oct4, and imaged on a Leica SP8 confocal 
microscope. The nuclear intensity of these proteins was quantified using PickCells software. Each point 
represents the mean of hundreds of cells from one biological replicate and at least three fields of view. 




5.3.3 Forced cadherin switching allows cells to overcome the inhibitory effects of 
Wnt on neural differentiation 
 In the last section, cells lacking E-cadherin were shown to have reduced nuclear β-
catenin levels, but the impact of this phenotype on WNT signalling remained unclear. WNT 
signalling is generally regarded as an inhibitor of neural differentiation (Haegele et al., 2003), 
and it represses anterior epiblast and early neural features in EpiSCs (Tsakiridis et al., 2014). 
Therefore, the next step of this study was to investigate whether changes in WNT signalling 
played a role in the pro-neural effect of cells undergoing cadherin switching.  
 The previous experiment was repeated, but the cells were plated into 2i-Lif 
conditions at a lower density (5x103 cells per well in a 12-well plate) and were subsequently 
cultured in neural differentiation conditions for three to four days, with Wnt3a added on day 
zero at the same doses as before. Cells were then either lysed for qPCR analysis or fixed for 
ICC and PickCells quantification. The fixed cells were stained for Laminβ1, E-cadherin, Sox1 
and β-catenin; since the Sox1 antibody was raised in mouse, an antibody for total β-catenin 
was used as this was raised in rabbit, and therefore was a more practical option for the 
selected antibody panel. Three biological replicates were analysed for each condition. 
Example samples stained and imaged by confocal microscopy are shown in figures 5.14 and 
5.15.  
 The confocal images show a varying amount of E-cadherin expression in WT and 
Flox/Flox cells at different concentrations of Wnt3a, and no staining in the EcKO and NcKI 
cells, as expected. Nuclear β-catenin staining at varying intensities is visible in all samples. 
Sox1 staining is visible in all cell lines in the samples cultured without Wnt3a, but is mostly 
absent in cells cultured with Wnt3a, with the exception of NcKI cells, especially at day four. 
To further investigate the relationship between cadherin switching, WNT signalling and 
neural differentiation, the nuclear intensities of Sox1 total β-catenin were quantified using 
















Figure 5.14 (pages 170-171):  Example ICC of parental (Flox/flox) and EcKO cells after three (A,B) and 
four (C,D) days of neural differentiation in increasing concentrations of Wnt3a. Samples imaged on 
a Leica SP8 confocal microscope. Scale bar =50µm. 
 
Figure 5.15 (pages 172-173):  Example ICC of WT and NcKI cells after three (A,B) and four (C,D) days 
of neural differentiation in increasing concentrations of Wnt3a. Samples imaged on a Leica SP8 
confocal microscope. Scale bar =50µm. 
  
 Nuclear intensity of β-catenin at days three and four of neural differentiation showed 
considerable variability between experiments. In general, nuclear β-catenin signal was 
reduced in EcKO and NcKI cells compared to control cells, with this reduction found to be 
significant between WT and NcKI cells on day four in cultures with added Wnt3a.  In EcKO 
cells, a spike in Sox1 intensity was observed at day four in the absence of Wnt3a; all other 
conditions were found to have similar Sox1 levels between EcKO and Flox/Flox cells. Some 
replicates of NcKI cells showed a very high increase in Sox1 levels compared to WT cells, 
especially at day 4, and even in high concentrations of Wnt3a. However, due to extensive 
variability of the data, none of the results for Sox1 were found to be statistically significant.  
 To try to get a better understanding of the effect of cadherin switching and WNT 
signalling on neural differentiation, the day one, day three and day four time-points were 
also analysed by qPCR. It should be noted that cells used for the day one analysis were plated 
at a 10x greater seeding density than those analysed at days three to four in order to produce 
high enough RNA yield for downstream qPCR analysis. The results of the qPCR gene 
expression analysis are presented in Figure 5.17. 
 Gene expression analysis by qPCR found negligible levels of Cdh1 transcript in both 
cadherin mutant cell lines, as expected. Levels of Cdh2 were significantly elevated in both cell 







Figure 5.16: Nuclear levels of β-catenin and Sox1 in cadherin mutant cells during neural 
differentiation. EcKO and NcKI cells, and their relevant control cell lines, were cultured in neural 
differentiation conditions for 3-4 days in varying concentrations of Wnt3a, stained for total β-catenin 
and Sox1, and imaged on a Leica SP8 confocal microscope. The nuclear intensity of these proteins was 
quantified using PickCells software. Each point represents the mean of hundreds of cells from one 
biological replicate and at least three fields of view. N=3 biological replicates. *p≤0.05, **p≤0.01, 
paired T-test.  
  









Figure 5.17 (pages 176-178): Gene expression in cadherin mutant cell lines during neural 
differentiation in varying concentrations of Wnt3a. EcKO, NcKI and relevant control cell lines were 
cultured from 2i-Lif in neural differentiation conditions for one, three or four in varying concentrations 
of Wnt3a. Mean gene expression values were normalised to day one expression in the relevant control 
cell line. N=3, error bars = SD. Asterisks refer to significant difference compared to control cell line in 
the same condition, *p≤0.05, **p≤0.01, unpaired T-test.   
 
Next, the expression of neural marker genes was studied. In the control cell lines, the 
later time-points had high levels of Sox1 and Pax6 transcript in the absence of Wnt3a, but 
these levels dropped severely with the addition of Wnt3a. This result shows that Wnt3a is a 
potent inhibitor of neural differentiation, as reported previously (Faunes et al., 2013). 
 In EcKO cells, Sox1 was significantly elevated in all Wnt3a concentrations on days 
one and three compared to the parental cell line, though levels of a second neural marker, 
Pax6, were not found to be significantly different. In NcKI cells however, both of these genes 
were highly upregulated at days three and four of the protocol, even in high doses of Wnt3a. 
This result suggests that forced cadherin switching, and specifically the gain of N-cadherin, 
promotes neural differentiation even in the presence of the anti-neural factor Wnt3a.   
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Next, the levels of WNT pathway target genes were investigated. Given that both of 
the cell lines lacking E-cadherin displayed lower levels of nuclear β-catenin during early 
neural differentiation, it was expected that these cells would have reduced levels of WNT 
signal responsiveness. In the control cell lines, there was a dose-response relationship 
between Wnt3a concentration and the levels of activation of Axin2 and T within 24h after 
the addition of the ligand, as expected.  This relationship was much less pronounced at later 
time-points, suggesting that the Wnt3a was degraded, metabolised or otherwise lost its 
activity after 72-96h in culture.  
Surprisingly, the cadherin mutations seemed to have a minimal effect on WNT 
responsiveness: at day one, the EcKO and NcKI cells displayed no significant change in their 
levels of Axin2 or T compared to control cell lines. A few differences in the levels of these 
genes were observed at later time points, but they did not correlate with one another, 
suggesting that the changes may not be functionally significant. Taken together, these results 
show that despite a significant drop in global and nuclear levels of β-catenin in cells lacking 
E-cadherin, these cells appear to maintain comparable levels of WNT responsiveness to 
control cells. Additionally, since the NcKI cells did not display an obvious WNT signalling 
phenotype, this result also suggests that this signalling pathway is not responsible for the 
pro-neural effect previously observed in these cells.  
This raises the question of whether another pathway may be responsible for the pro-
neural effect of cadherin switching. The FGF pathway has previously been associated with N-
cadherin and is known to modulate neural differentiation (Williams et al., 2001). Two 
readouts of this pathway were assayed in the current analysis: the later FGF target gene 
Dusp4, and the early target Etv4 (based on unpublished microarray data from Tilo Kunath). 
In EcKO cells, the levels of these genes differed significantly from parental cells at various 
time-points and concentrations of Wtn3a, suggesting that loss of E-cadherin has an effect on 
FGF signalling. The direction of this change was also variable in EcKO cells, perhaps implying 
that any effect of E-cadherin deletion on FGF signalling may be very time-dependent. In NcKI 
cells, several significant differences in transcript levels were also observed, and in these cells, 
the levels of the FGF readout genes were always found to be lower than in WT cells.  
Taken together, the results of the WNT experiments showed that WNT signalling 
inhibits neural differentiation, and that this effect is retained even when levels of global and 
nuclear β-catenin are significantly reduced. The analyses also showed that forced, premature 
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cadherin switching allows cells to overcome this WNT-based inhibition, as these cells are able 
to upregulate neural genes even in high concentrations of Wnt3a. The gene expression 
analysis also revealed an effect of cadherin switching on FGF signalling. This effect is 
investigated further in the next section.  
5.4 N-cadherin promotes neural differentiation by dampening 
FGF signalling 
5.4.1 Nanostring analysis implicates N-cadherin in the dampening of FGF 
signalling 
 In the previous section, NcKI cells were shown to upregulate neural genes even in 
the presence of high levels of Wnt3a, in contrast to WT or EcKO cells. In addition, the NcKI 
cells displayed lower levels of FGF readouts than control cells. This raised the possibility that 
N-cadherin may play a role in modulating FGF signalling, allowing the cells to switch on neural 
genes even in suboptimal conditions. Additionally, the neural differentiation experiments 
using the N-cadherin overexpression cell line showed that N-cadherin alone was able to have 
a pro-neural effect, but the mechanism behind this phenotype remained elusive.  
 To study the effect of N-cadherin alone on signalling during neural differentiation, 
A2Lox-Ncad-HA cells were cultured through the same neural differentiation protocol as in 
Chapter 4, with Dox added to induce N-cadherin overexpression at day two of the protocol. 
RNA samples were collected 24h and 48h after Dox induction, and the samples were then 
shipped to an external facility for Nanostring analysis. These time-points were chosen 
because N-cadherin overexpression was previously shown to cause a significant upregulation 
of neural markers at these times (Fig. 4.15).  
Nanostring analysis tests a given RNA sample against a panel of 770 genes selected 
for their involvement in key cellular signalling pathways. The output is a microarray showing 
changes in gene expression between control and experimental samples, giving information 
on which signalling pathways are up- or downregulated in response to the experimental 
treatment. The standard sample number for one Nanostring analysis is 12 samples. 
Therefore, one biological replicate of three A2Lox-Ncad-HA clones was performed. The 
samples were analysed using a mouse nCounter® PanCancer Immune Profiling Panel 
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containing 770 genes. Enrichment calculations and clustering were performed using the 
associated nSolver 4.0 software.  
 A dendrogram for the relationships in gene expression in the analysed samples is 
shown in Figure 5.18. The clustering shows that the greatest changes in gene expression are 
between days three and four of neural differentiation. On day three, further clustering is 
specific to the clone analysed, irrespective of N-cadherin overexpression. On day four 
however, the cells clearly cluster by presence or absence of Dox, suggesting that the 
overexpression of N-cadherin has a significant effect on gene expression.  
Next, the enrichment of each Dox-induced sample relative to the relevant un-
induced control was calculated for each day, and a mean of these relative enrichment scores 
was obtained based on the three clones. Statistical significance was then calculated using a 
paired T-test. These mean enrichment scores of all significantly changing genes are ranked in 
figures 5.19 and 5.20. 
Figure 5.18: Gene expression clustering in A2Lox-Ncad-HA cells during neural differentiation. A2Lox-
Ncad cells were plated into 2i-Lif conditions for 24h before a medium change to NDiff. Dox was added 
to induce Ncad-HA expression on day two of neural differentiation, and the cells were lysed 24-48h 
after Dox induction. RNA samples were analysed by Nanostring. 
 









Figure 5.19 (page 182): Mean relative expression of significantly changing genes between induced 
and un-induced A2Lox-Ncad-HA cells on day three of neural differentiation. Dox was added on day 
two of the protocol. Gene expression was quantified using Nanostring analysis. Values are a mean of 
three independent clones from one biological replicate.  
Figure 5.20 (page 183): Mean relative expression of significantly changing genes between induced 
and un-induced A2Lox-Ncad-HA cells on day four of neural differentiation. Dox was added on day 
two of the protocol. Gene expression was quantified using Nanostring analysis. Values are a mean of 
three independent clones from one biological replicate.  
 
On both days, the most upregulated gene in the induced cells is Hprt: this result is 
explained by the fact that the Hprt locus is the constitutively active site where the 
overexpression construct is located. Within the set of significantly changing genes, most were 
found to be downregulated in response to N-cadherin overexpression, and many more genes 
displayed a significant change in response to N-cadherin overexpression on day four 
compared to day three of the protocol.  
To determine which signalling pathways were most represented in this dataset, the 
DAVID Functional Annotation Analysis Wizard was used (Huang et al., 2008; Huang et al., 
2009). This is an online bioinformatics tool that allows users to input any list of genes and 
compare them to a custom genetic background. For this analysis, all the significantly changing 
genes were used as an input gene list, while all 770 genes assayed in the Nanostring panel 
were input as the background. The output of the analysis is a list of signalling pathways and 
a corresponding number of input genes involved in that pathway accompanied by a p-value. 
This approach generates a list of pathways by number of affected genes, but not necessarily 
by the magnitude or direction of the change in expression of particular genes. The results of 




Figure 5.21: Top ten pathways represented by significantly changing genes in response N-cadherin 
overexpression during neural differentiation. Significantly changing genes identified by Nanostring 
RNA analysis were classified by the DAVID functional annotation tool. Significance was calculated by 
paired T-test on three clonal replicates. Graphs show the number of significantly changing genes (125 








The results of the Nanostring and DAVID analyses show that after 24h of N-cadherin 
overexpression during neural differentiation, genes involved in cell cycle are most affected. 
Of the top four pathways responding to N-cadherin overexpression at this time-point, two 
(PI3K-Akt and MAPK) represent components of the FGF pathway. After 48h of N-cadherin 
overexpression, the top three pathways are components of the FGF pathway. These results 
imply that FGF signalling is significantly affected by the gain of N-cadherin. In addition, since 
the majority of significantly changing genes following Dox-induction were downregulated 
(Figs 5.19, 5.20), the analysis suggests that a gain of N-cadherin during neural differentiation 
results in the dampening of FGF signalling. To follow up this finding, the mechanism behind 
this effect was investigated.   
5.4.2 Modulating FGF signalling rescues the pro-neural effect of NcKI cells and 
replicates it in WT cells 
 To establish how FGF signalling affects gene expression in cadherin mutant cells 
undergoing neural differentiation, the cells were cultured through a neural differentiation 
protocol in the presence of an agonist or inhibitor of the FGF signalling pathway. WT, NcKI 
and A2Lox-Ncad-HA cells were seeded at a density of 5,000 cells per well into 12-well plates 
in 2i-Lif conditions. After 24h, media were changed to NDiff. On day two of the protocol (48h 
after media change) 20ng/mL of FGF2, a ligand for the FGF pathway, or 100ng/mL of 
PD173074 (abbreviated to PD17), a specific inhibitor of FGFR1, was added. Dox was also 
added to the A2Lox-Ncad-HA cells at this time point. On days three and four, the cells were 
lysed for qPCR analysis. This experimental protocol is depicted in Figure 5.22. The results of 
the qPCR analysis are shown in Figures 5.23 and 5.24.   
 In NcKI cells, Cdh2 was upregulated compared to WT cells at both time-points and in 
most conditions, as expected. Addition of FGF2 caused a spike in the FGF target genes Dusp4 
and Etv4, while addition of the FGFR1 inhibitor PD17 caused the levels of both of these genes 
to drop to near-zero levels in all cell lines studied. Interestingly, NcKI cells showed reduced 
levels of FGF target genes, both when no ligands were added, and when the medium was 
supplemented with FGF2. This result strongly suggests that forced, premature cadherin 
switching causes cells to dampen their endogenous FGF output, and to also lose their 




Figure 5.22: Experimental protocol for testing the effect of modulating FGF on neural differentiation 
during cadherin switching. WT, NcKI and A2Lox-Ncad-HA cells were seeded at a concentration of 5,000 
cells per well into 12-well plates. Ligands added were either FGF2 (at 20ng/mL) or PD17 (at 100ng/mL). 
Dox added at 1µg/mL as before. Cells were lysed for qPCR analysis on days three and four.  
 
How does this change in FGF responsiveness affect neural differentiation? Neural 
marker genes (Sox1 and Pax6) were upregulated in untreated NcKI cells compared to WT 
cells, as previously shown. Importantly, FGF2 treatment was found to predominantly reduce 
the expression of these genes, while the FGFR inhibitor generally elevated their levels in both 
WT and NcKI cells. These results suggest that FGF signalling inhibits neural differentiation. 
Importantly, promoting FGF signalling reduced the level of Sox1 to similar levels as those 
observed in WT cells, while inhibiting FGF signalling in WT cells raised Sox1 expression to a 
similar level observed in untreated NcKI cells. The effect was also present but not as 
pronounced for Pax6, where levels of this gene were consistently higher in NcKI cells 
compared to WT cells in all conditions. This partial rescue suggests that FGF signalling plays 
a role in the pro-neural effect observed in NcKI cells.  
Perhaps surprisingly, a similar rescue was not observed in A2Lox-Ncad-HA cells. As 
expected, addition of Dox to these cells caused a significant upregulation of Cdh2. 
Interestingly, the addition of PD17 caused a significant spike in the levels of Cdh2 transcript 
in both induced and un-induced cells, especially at day four of the protocol, or 48h after the 
addition of the inhibitor. This result may point towards a role of FGFR1, or FGF signalling as 




Figure 5.23: Gene expression in WT and NcKI cells on days three and four of neural differentiation 
with activators and inhibitors of FGF signalling. Ligands were added on day two of neural 
differentiation at a concentration of 20ng/mL for FGF2 and 100ng/mL for PD17. N=3 biological 
replicates, all replicates shown. Lines connect values for each biological replicate.  
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Figure 5.24: Gene expression in A2Lox-Ncad-HA cells on days three and four of neural differentiation 
with activators and inhibitors of FGF signalling. Ligands and Dox were added on day two of neural 
differentiation at a concentration of 20ng/mL for FGF2, 100ng/mL for PD17 and 1µg/mL of Dox. N=3 







As with the NcKI cells, addition of FGF2 and PD17 had a similar effect of reducing or 
promoting the expression of neural markers, respectively. These results yield further 
evidence that at this time-point in early neural differentiation, activation of FGF signalling 
inhibits neural specification.  
However, no significant differences were observed in the expression of the two 
neural markers or the FGF target genes between control and N-cadherin overexpressing cells 
in any of the conditions tested. This suggests that the gain of N-cadherin was not enough to 
promote upregulation of neural genes, and did not have a significant effect on the FGF 
signalling profile of the cells. This result was unexpected, as the large-scale neural 
differentiation experiment with three independent clones in Chapter 4 showed that 
overexpression of N-cadherin led to increased expression of neural markers (Fig. 4.15), while 
the Nanostring experiment implicated the gain of N-cadherin in a dampening of FGF 
signalling.  
Taken together, the results of this study yield a number of conclusions.  First, the 
results clearly indicate that FGF signalling inhibits early neural differentiation, and conversely, 
inhibition of FGF signalling promotes this process. Second, forced and premature cadherin 
switching causes a drop in FGF signalling: adding FGF2 to NcKI cells increases Dusp4 transcript 
to similar levels as those observed in WT cells, and causes the levels of Sox1 and Pax6 to drop 
in NcKI cells. Conversely, adding an FGFR1 inhibitor to WT cells causes their levels of FGF 
target transcript to plummet, and increases Sox1 and Pax6 transcripts to a similar level as 
those observed in untreated NcKI cells. Surprisingly, overexpression of N-cadherin alone was 
unable to produce a similar effect.  
These results indicate that cadherin switching promotes early neural differentiation 






5.5.1 Cell clustering is altered during cadherin switching, but this does not fully 
explain the pro-neural phenotype of NcKI cells 
 Since adhesion is a key function of cadherin proteins, it was important to determine 
whether the pro-neural effect in cadherin mutant cells observed during neural differentiation 
was caused by changes in adhesion. In order to achieve this, a system for the quantification 
of nuclear clustering was devised by measuring inter-nuclear distances, as an indirect readout 
of cellular adhesion.  
 The analysis of inter-nuclear edge distances in EcKO, NcKI and A2Lox-Ncad-HA cells 
showed that the loss of E-cadherin resulted in a pronounced clustering defect, where the 
nuclei were visibly further apart from one another. Moreover, this effect could not be 
rescued by the knock-in of N-cadherin (Fig. 5.4). This phenotype is similar to that observed in 
vivo, where E-cadherin-null embryos die at pre-implantation stages due to failure in morula 
compaction due to adhesive defects (Larue et al., 1994). Knocking in N-cadherin can initially 
rescue morula compaction, but the embryos subsequently die due to a failure in the 
generation of polarised trophectoderm (Kan et al., 2007). Even when the NcKI mutation is 
induced after gastrulation, the embryos die at around E8.5 due to gross morphological 
defects, including massive cell detachment from the ectoderm (Basilicata et al., 2016). These 
studies identify a specific and critical role for E-cadherin in cell adhesion and highlight its 
importance at multiple stages of development; the results from the clustering analysis 
presented here confirm that E-cadherin also plays a specific role in cell-cell adhesion in vitro.  
 The clustering analysis also showed that overexpression of N-cadherin led to a small 
but significant increase in inter-nuclear edge distance (Fig 5.4). This may be explained by N-
cadherin’s reduced adhesive capacity compared to E-cadherin: atomic force microscopy 
studies have shown that E-cadherin has three to four times the adhesive strength of N-
cadherin (Chu et al., 2004; Chu et al., 2006). Additionally, levels of Cdh1 transcript were found 
to drop in response to Dox in the inducible cells (Fig 4.15), suggesting that the change in 
adhesion profile from E- to N-cadherin may be promoting looser adhesion in these cells.  
 Importantly, the changes in clustering were not sufficient to fully explain the pro-
neural phenotype observed in cells undergoing cadherin switching. The mean inter-nuclear 
distance of cells over-expressing N-cadherin, though significantly higher from un-induced 
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cells, was still similar to that of WT cells. The fact that the N-cadherin overexpressing cells 
display a pro-neural phenotype in contrast to the three control cell lines suggests that an 
alternative mechanism may be responsible for the effect, which enables the cells to have a 
neural bias even when they maintain a WT-like clustering profile. Additionally, the analysis 
found that EcKO and NcKI cells share an almost identical inter-nuclear clustering profile, but 
these cells behave very differently in neural differentiation conditions, with EcKO cells 
showing poor long-term survival while NcKI cells show exhibit normal survival and a bias for 
the neural lineage.  
 These results showed that while cadherin switching affects cellular clustering, the 
observed changes in adhesion cannot fully explain the pro-neural phenotype of cells 
undergoing cadherin switching. This in turn raises the possibility that a signalling effect may 
be responsible for the neural bias observed in these cells.  
5.5.2 Cells lacking E-cadherin lose β-catenin, but retain Wnt responsiveness 
during early neural differentiation 
Since adhesive changes were eliminated as the main mechanism behind the pro-
neural effect in cells undergoing cadherin switching, attention was turned to signalling 
changes in these cells. RPPA protein analysis revealed a significant drop in the level of global 
β-catenin in cells lacking E-cadherin, an effect previously reported in various E-cadherin-null 
cell types (Hendriksen et al., 2008; Orsulic et al., 1999; Wetering et al., 2001). However, the 
levels of two phosphorylated forms of β-catenin were not found to change significantly in 
the cadherin mutant cells (Figs. 5.5 and 5.6). 
Cadherins have traditionally been viewed as negative regulators of WNT signalling, 
because they sequester newly synthesised cytoplasmic β-catenin to the outer cell 
membrane, protecting the protein from degradation but also preventing it from being 
translocated to the nucleus to promote transcription of target genes (discussed in Howard et 
al 2011). The un-phosphorylated form of β-catenin can be found in three cellular 
compartments: in an E-cadherin-associated complex at the cytoplasmic membrane, as a 
newly synthesised form in the cytoplasm, and as the transcriptionally active form in the 
nucleus; phosphorylation marks the protein for degradation by the cytoplasmic β-catenin 
destruction complex (Clevers, 2006). The significant drop in the un-phosphorylated form in 
the cells lacking E-cadherin points towards a global loss of β-catenin. ICC staining of E-
cadherin-null cells suggests that all of these compartments are affected (Figs. 5.7 and 5.8) 
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and PickCells analysis additionally confirms a drop in nuclear levels of β-catenin in these cells 
(Fig. 5.13).  
However, the RPPA analysis also showed that there was no change in the levels of 
two phosphorylated forms of β-catenin after 24h of neural differentiation. This result could 
indicate that there is no change in the levels of free cytoplasmic β-catenin marked for 
degradation, perhaps suggesting that the rate of translation of nascent β-catenin is low at 
this time-point, and stays that way in cells lacking E-cadherin. This idea is supported by the 
fact that there is an absence of Wnt ligands in the anterior neurectoderm during 
development (Arnold and Robertson, 2009), implying that this pathway is not involved in 
neural specification and that WNT signalling is inactive in the cells studied.  
 While the exact mechanism behind the changes in β-catenin and its subcellular 
localisation lends itself to further discussion, its relevance to this study hinges on whether 
this phenotype has an effect on WNT signalling or neural differentiation. Therefore, the WNT 
signalling response of the cells undergoing cadherin switching was investigated further.  
5.5.2.1 Reasons for high variation in nuclear β-catenin in later neural differentiation 
At days three and four of the neural differentiation protocol (and in contrast to day 
one), the levels of nuclear β-catenin and Sox1 quantified by PickCells analysis varied 
significantly even in identical experimental conditions (Fig. 5.16). There were also notable 
differences in trends in protein expression observed between control and cadherin mutant 
cells. There are a number of possible reasons for this high level of variation.  
As noted in Chapter 3, the in vitro neural differentiation protocol from 2i-Lif used 
throughout this thesis shows around a day’s worth of variation in the timing of Sox1 
upregulation and endogenous cadherin switching, and patches of Oct4 and E-cadherin 
expression remain even after five days of neural differentiation. Since the experiments were 
performed with related but independent cell lines acting as controls, this variation in the 
speed of neural differentiation may have contributed to the large differences observed in the 
behaviour of biological replicates.  
The image analysis pipeline for the quantification of nuclear protein signal relies on 
accurate nuclear segmentation. As mentioned earlier (and illustrated in Fig. 5.1), the later 
days of the neural differentiation protocol can give rise to areas of high cellular density, 
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leading to poorer-quality nuclear segmentation. This may have contributed to the increased 
variation observed in the data at days three and four of neural differentiation.  
 In addition, cells undergoing neural differentiation tend to lift off at the latter stages 
of this protocol; to try to avoid this, the cells are seeded onto laminin in 2i-Lif conditions for 
24h to allow better cell adhesion to the matrix. The cells were found to exhibit weaker 
adhesion to the glass coverslips than to the underlying tissue culture plastic, and tend to 
detach during the various media change or washes, even after sample fixation in 
formaldehyde. The ICC staining protocol also involves a number of wash steps, leading to 
more cell detachment. As such, the cells that were finally imaged and analysed for nuclear 
signal intensity may reflect just those cells that were able to survive and adhere to the glass 
for the duration of the differentiation and staining protocols, and may therefore not be an 
accurate or reliable representation of all differentiating cells.  
5.5.2.2 Cells with depleted β-catenin retain WNT responsiveness 
 To determine whether the significant changes in levels of β-catenin caused 
differences in WNT signalling responsiveness, or contributed to the pro-neural phenotype 
observed during cadherin switching, EcKO and NcKI cells were tested for their WNT 
responsiveness during neural differentiation. A dose-response effect to the addition of 
Wnt3a on WNT target genes was observed on day one of the protocol in all cell lines tested 
(Fig. 5.17). The same effect was also observed to a lesser extent at later time-points, but not 
for both of the genes tested and not in all conditions. This results showed that within 24h of 
pathway stimulation, cadherin mutant cells retain WNT responsiveness to comparable levels 
as those observed in WT cells. This result was confirmed by the behaviour of neural marker 
genes. Wnt3a was found to significantly inhibit neural differentiation, as previously reported 
(Faunes et al., 2013), and both control and EcKO cells treated with Wnt3a had significantly 
lower levels of Sox1 and Pax6 on days three and four of the neural differentiation protocol. 
The fact that cells lacking E-cadherin have reduced levels of β-catenin, but retain the 
ability to activate transcriptional targets of this protein, has been previously reported in 
various cell types (Hendriksen et al., 2008; Wetering et al., 2001), including mES cells (Orsulic 
et al., 1999). These findings suggest that levels of either global or nuclear β-catenin do not 
directly correlate with WNT signalling activity. There are several possible explanations for 
this: first, it is plausible that even low levels of nuclear β-catenin are sufficient to activate 
WNT target genes. Second, a non-canonical WNT pathway that does not require β-catenin 
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could be responsible for the upregulation of WNT targets. Finally, it is plausible that newly 
synthesised β-catenin translocates directly to the nucleus, thus bypassing sequestration by 
E-cadherin at the membrane and resulting in lower global levels of the protein; however this 
mechanism seems unlikely as nuclear β-catenin levels are also significantly reduced in cells 
lacking E-cadherin; moreover, it has been reported that the β-catenin/E-cadherin interaction 
at the membrane “primes” β-catenin for enhanced transcriptional activity (Howard et al., 
2011), suggesting that in the absence of E-cadherin at the membrane, β-catenin is less 
transcriptionally potent.  
In addition to showing that cells lacking E-cadherin can retain WNT responsiveness, 
this experiment also confirmed the pro-neural effect previously observed in NcKI cells. 
Surprisingly, Sox1 was also significantly upregulated in some conditions in EcKO cells, perhaps 
indicating a marginal role for the loss of E-cadherin in promoting neural differentiation.  
Addition of Wnt3a correlated with a notable improvement in cell survival of EcKO cells, 
supporting the idea that their instability is the reason that these cells fail to replicate previous 
reports of improved neural differentiation (Malaguti et al., 2013). 
Interestingly, NcKI cells were able to upregulate neural genes even in the presence 
of high doses of Wnt3a. In particular, the levels of Sox1 at day four were near-identical 
irrespective of the Wnt3a concentration that they were exposed to earlier on. This result 
highlights that NcKI cells exhibit a strong pro-neural phenotype, even in suboptimal 
differentiation conditions. Since EcKO and NcKI cells have similar adhesion, β-catenin, and 
WNT responsiveness profiles, yet exhibit markedly different behaviour during neural 
differentiation, it is likely that the pro-neural phenotype is not primarily caused by the 
aforementioned factors. It also implies that N-cadherin is an important contributor to this 
phenotype. This raised the possibility that a signalling pathway other than the WNT pathway 
is modulated by N-cadherin to promote neural fate.  
5.5.3 N-cadherin overexpression dampens FGF signalling during neural 
differentiation 
  To determine whether the overexpression of N-cadherin alone could modulate 
signalling during neural differentiation, Nanostring analysis was used to measure mRNA-level 
signalling pathway activity in N-cadherin overexpressing cells. Clustering analysis 24h after 
the addition of Dox to induce N-cadherin overexpression found more differences in gene 
expression between individual clones than between induced and un-induced samples, while 
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after 48h, the induced samples clustered separately to un-induced samples (Fig. 5.18). This 
result suggests that major changes in the expression of genes related to cellular signalling 
occur in response to N-cadherin overexpression within 48h of induction.  
  A striking feature of the trends in gene expression following N-cadherin 
overexpression is that the majority of significantly changing genes are downregulated (Figs 
5.19 and 5.20). At 48h post-induction, functional annotation analysis shows that the most 
represented pathways amongst these significantly changing genes are PI3K-Akt, Ras and 
MAPK, which all represent major branches in the FGF signalling pathway that lie downstream 
of FGF receptors (Lanner and Rossant, 2010). These results suggest that overexpression of N-
cadherin alone is able to cause significant downregulation of the FGF pathway during neural 
differentiation.  
5.5.3.1 Cadherin switching promotes neural differentiation by dampening FGF signalling 
 In order to determine whether increasing FGF activity could supress the pro-neural 
effect of N-cadherin, a rescue experiment was designed (Fig 5.22).  
 First, it was confirmed that N-cadherin knock-in does dampen FGF responsiveness, 
since NcKI cells displayed significantly lower levels of FGF readouts compared to WT cells (Fig. 
5.23). Next, it was confirmed that FGF signalling suppresses neural differentiation: addition 
of an FGF ligand inhibited the expression of neural genes, while the use of an FGFR1 inhibitor 
caused the levels of these genes to increase in all cell lines studied. Finally, we asked whether 
increasing FGF can rescue the pro-neural effect of N-cadherin. Strikingly, addition of the FGF 
receptor inhibitor to WT cells raised their levels of Sox1 to similar levels as those seen in 
untreated NcKI cells, while the addition of an FGF agonist to NcKI cells reduced levels of this 
gene to similar levels as those observed in untreated WT cells. Similar trends were observed 
for a second neural marker, Pax6. These results strongly suggest that FGF signalling inhibits 
neural differentiation, and that a dampening of this pathway in NcKI cells allows them to 
undergo more efficient neural induction compared to WT cells.  
 However, there is a limitation to this model – RPPA analysis of cells after 24h in neural 
differentiation conditions showed that NcKI cells displayed higher, not lower levels of most 
PI3K/Akt and MAPK/ERK components of the FGF pathway (Fig 5.5). In many cases, these 
increases were statistically significant. This is in contrast to the lowered level of FGF signalling 
documented in the Nanostring and FGF rescue experiments, which were performed at days 
3-4 of neural differentiation. These result suggests that the effect of cadherin switching on 
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FGF signalling is highly dependent on context and timing.  This is discussed in greater detail 
in Chapter 6.  
5.5.3.2 Reasons or a lack neural bias in N-cadherin overexpressing cells in the FGF 
response study 
In contrast to the previous experiment on neural differentiation of N-cadherin 
overexpressing cells described in this thesis (Fig 4.15), no pro-neural effect was observed in 
these cells in the final FGF-response experiment (Fig. 5.24). There are several possible 
reasons for this lack of response. First, the original N-cadherin overexpression experiment in 
neural differentiation (described in Chapter 4) included three biological replicates of three 
independent A2Lox-Ncad-HA clonal cell lines, enabling more robust statistical analysis and 
the detection of smaller significant changes in gene expression due to a larger sample size. 
Second, perhaps the level of Cdh2 upregulation in this experiment was not strong enough to 
have a robust effect on neural differentiation or FGF signalling, or the particular clone chosen 
may be more recalcitrant to neural differentiation than the two other clones used throughout 
the rest of the thesis. These limitations may be resolved by repeating the experiment with 
three independent clonal cell lines and three biological replicates.  
It is also unclear why the N-cadherin overexpressing cells do not phenocopy NcKI 
cells in the FGF response study, with respect to both upregulation of neural markers and 
downregulation of FGF target genes. One explanation may be that full cadherin switching, or 
a pronounced drop in the levels of E-cadherin, may be required for the full pro-neural effect.  
5.5.4 Summary 
In conclusion, the studies described in this chapter have investigated the 
mechanisms behind the pro-neural effect observed in cells with forced, premature cadherin 
switching (NcKI cells), and cells with induced N-cadherin overexpression. Cellular clustering 
was found to be affected by cadherin switching, but these adhesive defects did not correlate 
with more efficient neural differentiation. Loss of E-cadherin resulted in significant reduction 
in levels of global and nuclear β-catenin, but this did not affect WNT responsiveness of E-
cadherin null cells. Interestingly, NcKI cells displayed efficient neural induction even in 
suboptimal differentiation conditions with added Wnt3a. Finally, N-cadherin was found to 
modulate FGF signalling during neural differentiation, and FGF rescue experiments 
demonstrated that changes in FGF signalling can explain the differences in the rates of neural 
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induction between WT and NcKI cells. Taken together, these results show that cadherin 




Chapter VI – General Discussion 
 
6.1 Differences between the timing of cadherin switching in vitro and in vivo 
 Cadherin switching is a process occurring at a number of developmental stages, in 
diverse cell types, and in various tissues. A growing body of evidence implicates the cadherins 
in playing important roles not only in adhesion, but also in various cellular signalling 
pathways. The main focus of this project was therefore to assess whether cadherin switching 
can influence differentiation competence of pluripotent stem cells, and if so, to investigate 
the molecular mechanisms behind this effect. The anterior neurectoderm was selected since 
this is a tissue where cadherin switching is observed relatively early in embryogenesis and 
reproducible protocols for its differentiation have been established in vitro (Pollard et al., 
2006; Ying et al., 2003a).  Additionally, neurectodermal competence has been proposed as 
the fate that pluripotent cells adopt in the absence of other instructive signals (Muñoz-
Sanjuán and Brivanlou, 2002), making it a model system with few external inputs, and that is 
therefore relatively simple to study.  
 First, the timing of cadherin switching was investigated: if the switch was found to 
occur after overt neural specification, it would be unlikely to play a role in the induction of 
this process. Results presented in this thesis showed that in EpiSCs in vitro, cadherin 
switching is initiated at the transcriptional level in cells that continue to express pluripotency 
markers (Figs. 3.5, 3.6 & 3.8), and that this switch coincides with the expression of early 
neural and mesodermal markers, suggesting that it may be tied to priming towards these 
lineages (Fig. 3.8). Additionally, studies of neural differentiation in vitro showed that for a 
brief time around day three to four of differentiation from 2i-Lif, a subset of cells co-express 
N-cadherin, Oct4 and Sox1, again suggesting that cadherin switching may coincide with 
neural priming (Fig. 3.11). These findings showed that in vitro, cadherin switching is initiated 
prior to the loss of pluripotency, prompting the theory that the switch may be occurring early 
enough to play an instructive role in lineage commitment.  
However, in vivo gene expression data presented in this thesis and elsewhere have 
shown that the earliest protein level E- to N-cadherin switch in the developing mouse embryo 
takes place in nascent mesoderm at around E7.5, followed by ectodermal tissues about a day 
later (Figs. 3.1, 3.2, and Radice et al., 1997). Other studies have shown that at E7.0, the 
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anterior ectoderm is no longer pluripotent and is primed for epidermal or neurectodermal 
fate depending on the presence or absence of BMP4, respectively. By E7.5, the ectoderm was 
shown to be restricted to either neural or epidermal fate depending on its positioning in the 
embryo (Li et al., 2013).  
These studies imply that cadherin switching is initiated at subtly different 
developmental time-points in vivo than in analogous in vitro systems, raising questions about 
the validity of in vitro findings if they do not match the events observed during embryonic 
development. For example, N-cadherin protein has been widely reported to be expressed in 
EpiSCs (Rugg-Gunn et al., 2012; Takehara et al., 2015), but has not been observed in the 
primed epiblast in vivo – its earliest detection on the transcript level is in the posterior of the 
E6.5 gastrula (Peng et al., 2016). It is therefore unclear whether the findings on cadherin 
switching in EpiSCs are directly applicable to in vivo development. Further studies are 
required to determine why some in vitro conditions are more permissive to the expression 
of certain proteins than the analogous stages of embryonic development in vivo.  
A second population in which cadherin switching is observed are bi-potent NMPs, 
which can give rise to either neural or mesodermal derivatives. Microarray data from NMPs 
show that their maturation, occurring between E8.5 and E9.5, is accompanied by an E- to N-
cadherin switch (Gouti et al., 2017).  Results presented in this thesis showed that N-cadherin 
overexpression during an in vitro NMP maturation protocol biased lineage choice in these 
cells (Fig. 4.19), suggesting that cadherin switching may play a role in cell fate decisions in 
this developmental context as well.  
For all the developmental contexts in which cadherin switching was studied – EpiSCs, 
anterior neural differentiation, and NMP maturation – it would be highly informative to test 
how the in vitro findings presented in this thesis hold up when tested in the analogous 
context in vivo. For example, induction of the NcKI mutation in vivo has been attempted 
previously in both the pre- and post-implantation embryo, and in both contexts the mutation 
resulted in embryonic lethality (Basilicata et al., 2016; Kan et al., 2007). Interestingly, when 
the mutation was induced post-implantation, it resulted in cell detachment from the E7.5 
ectoderm, in addition to several gross embryonic malformations (Basilicata et al., 2016). 
These findings suggest that forced, premature cadherin switching in this embryonic tissue 
results in adhesive defects that prohibit normal neurectodermal development, in contrast to 
the in vitro findings presented in this thesis, which found that the mutation promotes neural 
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differentiation despite adhesive defects. As an alternative approach, a less severe mutation 
could be studied in vivo by electroporating the inducible N-cadherin overexpression 
constructs into the relevant embryonic compartments, and testing their contribution to 
various lineages.  
In conclusion, the results presented in this thesis show that in vitro, cadherin 
switching occurs early enough to play a role in directing pluripotent cells towards certain 
lineages, and correlates with lineage priming. However, given in vivo expression data 
presented here and prior fate mapping studies (Li et al., 2013), it is not possible to conclude 
whether cadherin switching may have the same effect during in vivo development. We 
propose that cadherin switching is unlikely to be a critical instructive signal for neurectoderm 
specification in vivo, but may rather be contributing a secondary signal that gives the system 
additional robustness during embryonic development (discussed in more detail below).  
 
6.2 The role of cadherin switching in neural differentiation 
6.2.1 Loss of E-cadherin causes cellular instability during neural differentiation 
Previous studies have shown that blocking E-cadherin can lead to faster, more 
synchronous neural differentiation (Malaguti et al., 2013). It was therefore surprising that 
populations of EcKO cells did not differ from control cells in their expression of neural marker 
genes during neural differentiation from 2i-Lif (Fig. 4.4). Instead, the EcKO cells displayed a 
profound cell death phenotype in the later stages of this process, leading to the necessity of 
upscaling the experimental protocol just to yield enough sample for qPCR analysis (Fig. 4.3), 
and suggesting that E-cadherin is necessary to maintain cellular stability during neural 
differentiation. RPPA analysis also showed that EcKO cells at 24h of differentiation exhibit 
increased levels of cleaved caspase-3 (Fig. 5.5), a marker of cell death, supporting the notion 
that these cells have higher levels of apoptosis than parental control cells.  
Indeed, E-cadherin has previously been linked to cell survival in other contexts. hESCs 
do not tolerate single-cell culture, a phenomenon that has been linked to the loss of E-
cadherin mediated adhesion. Attenuation of this adhesion by chelation of calcium ions, 
blocking antibodies or RNAi leads to apoptosis in hESCs, and has been linked to Rho-ROCK 
signalling (Ohgushi and Sasai, 2011; Ohgushi et al., 2010; Xu et al., 2010). Interestingly, the 
same effect is observed in dissociated mEpiSCs but not in mESCs, and has been ascribed to 
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pluripotency state-dependent ROCK/myosin hyper-activation (Ohgushi et al., 2010); this may 
explain why EcKO cells appear healthy in the first 24h of neural differentiation from 2i-Lif 
conditions, but become increasingly sparse with further culture (Figs. 5.7, 5.14).  
However, additional experiments described in this thesis showed that occasionally, 
surviving EcKO cells could indeed exhibit higher levels of Sox1 mRNA or protein in neural 
differentiation conditions than control cells, sometimes significantly (Figs. 5.16, 5.17). The 
evidence is therefore mixed as to whether the loss of E-cadherin can have an effect on neural 
differentiation- is conceivable that the cell death phenotype of EcKO cells is so extreme that 
it masks any significant pro-neural effect that this mutation could have. The NcKI mutation 
was shown to rescue the cell death phenotype, allowing cells to survive the neural 
differentiation protocol in high numbers. Since NcKI cells have been reported to rescue 
cadherin-based adhesion during pre-implantation development (Kan et al., 2007), it is 
possible that the severe and extensive adhesion phenotype of EcKO cells is responsible for 
their elevated rate of apoptosis.  
In subsequent experiments, the NcKI mutation was also found to promote neural 
differentiation, however it is unclear whether this was due to a pro-neural effect of knocking-
in N-cadherin, a synergistic effect of simultaneous loss of E-cadherin and gain of N-cadherin, 
or even an isolated effect of loss of E-cadherin, with N-cadherin rescuing the cells from 
apoptosis. The latter effect seems unlikely, as subsequent tests that overexpression of N-
cadherin alone could also have a pro-neural effect. In summary, loss of E-cadherin led to 
significant cell death during neural differentiation, which could be rescued by knocking in N-
cadherin; these results, in combination with previously published findings, may implicate a 
critical role for cadherin-based adhesion during neural differentiation.  
6.2.2 E-cadherin is not required for neural lineage commitment in mESCs 
A previous report using EcKO cells in embryoid body differentiation culture found 
that these cells maintain expression of pluripotency genes and fail to upregulate lineage 
markers even after 30 days in differentiation conditions, and the authors conclude that E-
cadherin is required for the lineage commitment of mESCs (Pieters et al., 2016). The results 
presented here dispute that conclusion, as a small subset of the EcKO cells that survived to 
the later stages of the neural differentiation protocol were able to upregulate the neural 
lineage marker Sox1, and were not found to differ significantly from control cells in gene 
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expression (Fig. 4.4). Subsequent protein-level analysis confirmed that EcKO cells can 
upregulate Sox1 protein in permissive conditions (Figs. 5.14, 5.15, 5.17).   
In addition, NcKI cells lacking E-cadherin but expressing N-cadherin in its place are 
also able to robustly upregulate neural lineage markers in permissive conditions, providing 
further evidence that E-cadherin is not required for lineage commitment. All differentiation 
experiments presented in this thesis were initiated from a 2i-Lif starting population, 
corresponding to a state of naïve pluripotency, suggesting that cells lacking E-cadherin are 
indeed able to pass through all stages of lineage priming, commitment, exit from 
pluripotency and subsequent differentiation, without the need for this protein. These 
findings robustly refute the claim proposed by Pieters et al. (2016) that E-cadherin is required 
for lineage commitment in mESCs.  
6.2.3 Gain of N-cadherin biases lineage choice in three in vitro contexts 
 The results summarised in this thesis have shown that in vitro, cadherin switching 
appears to predict or bias lineage choice in three conditions analogous to three different 
stages of early development: epiblast priming, anterior neuroepithelial differentiation, and 
maturation of NMPs.  
6.2.3.1 Epiblast stem cells (EpiSCs) 
 In EpiSCs, cadherin switching was found to be initiated prior to the loss of expression 
of pluripotency markers such as Oct4 (Figs. 3.5, 3.6, and 3.8). This result could indicate that 
cadherin switching occurs early enough to affect lineage decisions of pluripotent cells. In 
addition, FACS-sorted EpiSCs with low levels of E-cadherin (and reciprocally high N-cadherin) 
were also shown to have higher levels of neural and mesodermal markers Sox1 and T, 
respectively (Fig. 3.8), showing that cadherin switching can predict lineage bias in these cells 
and may be involved in priming towards these lineages.  
In the embryo however, N-cadherin is first detected at the transcript level in the 
posterior of the gastrula (Peng et al., 2016), perhaps indicating that EpiSC culture is more 
permissive of cadherin switching than the primed epiblast in vivo. This also suggests that the 
findings summarised here – showing that cadherin switching identifies a bias in neural and 
mesodermal priming in EpiSCs – may not be directly applicable to in vivo development. 
However, they do highlight that in conditions permissive to N-cadherin expression, this 
protein identifies a cellular population that appears to be primed for commitment to specific 
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lineages, highlighting that cadherin switching may play a role in differentiation towards these 
lineages.  
A study by Takehara et al. (2015) identified N-cadherin to be the predominantly 
expressed cadherin species in EpiSCs, and proposed that it stabilises FGFR1 to contribute to 
primed-state pluripotency in these cells. These results differ from the results obtained during 
the current study, where E-cadherin was found to be the predominantly expressed cadherin 
in EpiSCs, with N-cadherin was expressed only by around 13% of EpiSCs (Fig. 3.6). However, 
Takehara et al. cultured their EpiSCs in a medium without supplemented Activin, in contrast 
to previously published protocols (Brons et al., 2007; Tesar et al., 2007), making their findings 
not directly comparable to those presented here.  
6.2.3.2 Anterior neural differentiation 
 In Chapter 4, two independent approaches – gene replacement and inducible protein 
overexpression – were used to show that a gain of N-cadherin can promote neural 
differentiation in permissive in vitro conditions; both NcKI cells and N-cadherin 
overexpressing cells displayed a drop in the expression of pluripotency marker Pou5f1 and 
an increase in the levels of neural markers Sox1 and Pax6 (Figs. 4.5, 4.15). This is in 
accordance with reports by Larue et al. (1996) who found that E-cadherin-null cells 
transfected with N-cadherin show a bias for differentiation towards neuroepithelial and 
cartilage structures.  
It should be noted that since NcKI cells lack E-cadherin, and that N-cadherin 
overexpressing cells displayed significantly lower levels of Cdh1 within 48h of N-cadherin 
induction, the possibility exists that an indirect loss of E-cadherin may be contributing to the 
pro-neural effect observed in these cells. However, this is unlikely since N-cadherin 
overexpressing cells displayed significantly higher levels of neural markers within 24h of 
induction (Fig. 4.15), before a significant drop in Cdh1, suggesting that N-cadherin alone can 
play a direct role in promoting neural differentiation.  
E-cadherin and N-cadherin share very similar domain architecture, homophilic 
adhesive function, and binding partners such as β-catenin, but their expression tends to be 
mutually exclusive in tissues where they are stably expressed (Bedzhov et al., 2013). 
However, a major difference between the two proteins is in their ability to bind and interact 
with specific growth factor receptors: E-cadherin is known to bind IGF1R (Bedzhov et al., 
2012) and EGF receptors (Hoschuetzky et al., 1994), while N-cadherin has been identified to 
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have specific signalling roles mediated by FGF receptor binding (Nguyen and Mège, 2016; 
Takehara et al., 2015; Williams et al., 1994). These differential receptor interactions raise the 
possibility that cadherin switching may be providing a subtle signalling cue, helping to push 
cells towards the neural lineage.  
6.2.3.3 Neuro-mesodermal progenitors (NMPs)  
 Recently, a single-cell transcriptomics approach was used to analyse changes in gene 
expression during the maturation of NMPs (Gouti et al., 2017). The dataset revealed that 
NMP maturation between E8.5 and E9.5 is accompanied by a switch from E- to N-cadherin, 
presenting a novel context for the study of the effects of cadherin switching. From this point 
of view, NMPs are an especially interesting progenitor population since they can give rise to 
both neural and mesodermal progeny cells, and both of these tissues are known to express 
N-cadherin during development (Radice et al., 1997).  
To further study the role of cadherin switching in the context of NMP maturation and 
lineage choice, N-cadherin overexpression cell line was used in a newly developed protocol 
that uses 2i-Lif cells as the starting population, and an EpiLSC intermediate (Watson, 2018), 
to investigate how the overexpression of N-cadherin affects lineage choice in NMPs. The 
results of these experiments showed that N-cadherin overexpression during NMP maturation 
caused a significant reduction in the number of single-positive cells expressing the mesoderm 
marker Brachyury, and a significant increase in cells single-positive for the neural lineage 
marker Sox2. These populations are taken to be cells committed to either the mesodermal 
or neural lineages, respectively. There was also a non-significant decrease in the number of 
cells co-expressing these two markers, and these cells were taken to be a putative bi-potent 
NMPs (Fig. 4.19).  
These results suggested that N-cadherin can have a pro-neural effect even in NMPs. 
However, due to several technical issues with the in vitro protocol used, this result was not 
pursued further. This finding would benefit from in vivo validation, where the inducible N-
cadherin cells could for example be electroporated into CLE of developing embryos to check 
whether N-cadherin could cause also bias lineage choice in this context.  
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6.3 The effect of cadherin switching on signalling during neural differentiation 
6.3.1 Uncoupling the roles of adhesion and signalling in cadherin switching 
 An important aspect of the project described in this thesis was to assess whether any 
changes in differentiation patterns caused by cadherins were attributable to the adhesive or 
to the signalling functions of these proteins. Previous studies investigating the adhesion 
functions of cadherins have adopted diverse strategies for modulating cadherin-mediated 
adhesion: from mutating the protein by truncations (Nagafuchi and Takeichi, 1988), deletions 
(Larue et al., 1994; Radice et al., 1997), domain substitutions (Bedzhov et al., 2012), or point 
mutagenesis (Tamura et al., 1998), to disturbing cadherin function by blocking antibodies 
(Malaguti et al., 2013), shRNAs (Onder et al., 2008), or preventing calcium-dependent binding 
by the addition of chelating agents (Zhang et al., 2010). While these experimental approaches 
result in changes in adhesion, very few strategies exist to objectively and accurately measure 
those changes, and many authors have simply relied on observing cells by eye and reporting 
gross adhesive defects.  
 In planning the current project, it was hypothesised that using the NcKI cell line 
would rescue the adhesion defects observed in E-cadherin-null cells, as reported in the pre-
implantation embryo (Kan et al., 2007);  this would allow for the uncoupling of any signalling 
effects of cadherin switching from its adhesive effects. In addition, the inter-nuclear edge 
distance analysis was developed as a strategy to quantitatively monitor differences in cellular 
adhesion, with the goal of having a more objective method than simply assessing adhesive 
changes by eye. To our knowledge, this is the first fully quantitative image-analysis technique 
developed to assess changes in inter-nuclear clustering as an indirect readout of cellular 
adhesion. The technique could be further strengthened by the development of a cytoplasmic 
segmentation technique, but this was unavailable at the time of the study.   
 Surprisingly, the inter-nuclear edge distance analysis found that after 24h in neural 
differentiation conditions (from a 2i-lif starting population), NcKI cells display a significant 
clustering defect that is comparable to that seen in EcKO cells (Fig. 5.4). Nevertheless, despite 
displaying an almost identical clustering profile, these two cell lines exhibited different 
behaviours during neural differentiation. This suggests that adhesive changes are not the 
main cause for the pro-neural phenotype observed in NcKI cells, which may instead be better 
explained by differences in cellular signalling, as described in Chapter 5.  
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In addition, the inter-nuclear edge distance analysis showed that N-cadherin 
overexpression contributed to a slight but significant increase in inter-nuclear distances. 
However, since the cells overexpressing N-cadherin were still found to have comparable 
clustering profiles to two control cell lines used in the study, it was assumed that any 
adhesive changes are negligible, and are not likely to be the main cause for the pro-neural 
effect of N-cadherin overexpression observed in these cells.  
In summary, quantifying inter-nuclear edge distances using PickCells software 
provides an estimate of differences in cellular adhesion between given samples. While it does 
not allow for the direct uncoupling of adhesion and signalling effects in cells with cadherin 
mutations, it provides a method to objectively measure and control for changes in cellular 
clustering, allowing for greater insight on the effects of a particular treatment or condition 
on cellular adhesion. For the current study, this method proved to be much more useful than 
subjective estimation of cellular adhesion by eye, and strongly suggested that changes in 
differentiation were not directly caused by an adhesive effect of cadherin switching. This 
allowed for the focus of the research to shift from cell-cell adhesion to the interrogation of 
changes in cellular signalling pathways.  
6.3.2 Loss of E-cadherin leads to a significant reduction in levels of β-catenin, but does 
not perturb WNT signalling 
 The WNT signalling pathway is involved in pluripotency and development, and the 
canonical branch of this pathway relies on signal transduction via β-catenin, which is also a 
key binding partner of cadherins (Clevers, 2006). Both E- and N-cadherin are able to modulate 
WNT-dependent transcription in certain contexts (Howard et al., 2011), making WNT 
signalling a possible candidate mechanism for the pro-neural effect observed in response to 
cadherin switching.   
 RPPA analysis, ICC and quantitative image analysis all demonstrated a significant loss 
of β-catenin globally and in the nuclei of cells lacking E-cadherin within 24h of the 
commencement of neural differentiation (Figs 5.5, 5.13). Similar results have been reported 
previously upon the loss of E-cadherin in other contexts and in diverse cell types (Hendriksen 
et al., 2008; Orsulic et al., 1999; Wetering et al., 2001).  
 The cadherin-catenin interaction has previously been found to act as a positive 
stimulus for the transcriptional activity of β-catenin, perhaps priming β-catenin for this 
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function (Howard et al., 2011). Others have proposed that the cadherin/catenin complex 
binds Oct4 at the membrane, titrating the nuclear concentration of this transcription factor 
to optimal levels for the maintenance of pluripotency (Faunes et al., 2013).  
 In the experiments presented in this thesis, it was found that both EcKO and NcKI 
cells maintained nearly identical levels of Oct4 expression in their nuclei compared to control 
cells at the 24h time-point of neural differentiation, despite the loss of nuclear β-catenin 
observed in both cell lines. This result suggested that at early stages of differentiation, levels 
of E-cadherin or β-catenin do not appear to have a significant effect on the nuclear 
abundance of Oct4 (Fig. 5.13). Levels of nuclear Oct4 were found to increase slightly in 
response to Wnt3a treatment, an effect that was observed at near identical levels between 
the cadherin mutant cell lines and their relevant control lines. This result points to two 
conclusions: that Wnt3a may inhibit either exit from pluripotency or the onset of neural 
differentiation, as previously reported (Faunes et al., 2013), and that both EcKO and NcKI 
cells are able to respond to such WNT signals despite their global loss of β-catenin at this 
time-point, suggesting that neither E-cadherin nor high levels of β-catenin are required for 
WNT-induced elevation of Oct4.  
 At later time-points of neural differentiation, Wnt3a treatment was also found to 
have an inhibitory effect on the expression of neural genes (Fig. 5.17). However, both EcKO 
and NcKI cell lines upregulated WNT-target genes to comparable levels to those seen control 
cell lines when cultured with Wnt3a, suggesting that cells lacking E-cadheirn retain WNT-
responsiveness even when β-catenin levels are significantly reduced. Similar findings have 
been reported previously (Hendriksen et al., 2008; Wetering et al., 2001), showing that levels 
of global or nuclear β-catenin are not an accurate readout of WNT responsiveness or pathway 
activation.  
 The Wnt3a experiments also confirmed the pro-neural effect observed in NcKI cells: 
these cells exhibited significantly higher levels of Sox1 and Pax6 compared to WT controls, 
and were able to upregulate these early neural markers even when exposed to high doses of 
Wnt3a earlier during the differentiation protocol. These results showed that NcKI cells can 
promote neural differentiation even in the presence of the anti-neural factor Wnt3a, 
suggesting that cadherin switching may play a role in ensuring that neural differentiation is a 
robust and replicable process even in the presence of inhibitory signals. Additionally, the 
cadherin mutant cells were found to have different FGF signalling profiles during neural 
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differentiation than their control cell lines, raising the possibility that FGF signalling may be 
behind the pro-neural behaviour observed in the cadherin mutant cells. 
 In summary, the experiments on Wnt3a supplementation in cadherin mutant cell 
lines during neural differentiation showed that WNT signalling profiles did not differ 
significantly between NcKI cells, which were previously shown to exhibit a pro-neural 
phenotype, and control cells, despite the two lines having different expression profiles of β-
catenin. These results suggest that WNT/β-catenin signalling is not the primary cause of the 
pro-neural effect observed in NcKI cells.  
6.3.3 Cadherin switching promotes neural differentiation by dampening FGF 
responsiveness 
 Since WNT signalling was eliminated as the primary candidate driving the pro-neural 
effect observed in NcKI cells, attention was turned to the effects of FGF signalling, following 
Nanostring mRNA analysis results showing that FGF signalling components were significantly 
downregulated in induced A2Lox-Ncad-HA cells during neural differentiation (Fig. 5.21).  
 FGF signalling plays diverse and context-dependent roles in the maintenance of and 
exit from pluripotency, as well as in subsequent differentiation. Inhibition of FGF signalling 
promotes self-renewal of ESCs (Guo et al., 2009; Hamilton and Brickman, 2014; Hamilton et 
al., 2013), while stimulation of the pathway promotes their progression into EpiSCs and the 
maintenance of that state (Lanner and Rossant, 2010; Sterneckert et al., 2010; Takehara et 
al., 2015).  The role of FGF signalling in neural differentiation is somewhat controversial: 
some studies show that is it required for and promotes neural differentiation of ES cells 
cultured in Lif-serum (Lowell et al., 2006; Song et al., 2018; Ying et al., 2003a). However, other 
studies have shown that FGF signalling inhibits differentiation from the primed EpiSC state 
to the neural lineage (Greber et al., 2010; Jaeger et al., 2011; Stavridis et al., 2010; 
Sterneckert et al., 2010). Nevertheless, it is possible to reconcile these conflicting findings by 
viewing neural specification as a two-step process: the first stage being the conversion from 
naïve to primed pluripotency, which requires FGF, and the second stage being differentiation, 
which occurs in the absence of FGF signalling and is inhibited by this pathway.  
The results of an FGF rescue experiment performed for this thesis showed that 
stimulating FGF signalling at day two of neural differentiation (from a 2i-Lif starting 
population) inhibited neural differentiation, and conversely, FGFR1 inhibition at the same 
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time-point promoted neural marker expression (Fig. 5.23). While the cells used in the study 
were not EpiSCs, it is likely that after two days of differentiation from 2i-Lif conditions, the 
cells either resemble or have already passed the stage of primed pluripotency. These results 
are in accordance with the studies mentioned previously, which showed that FGF signalling 
inhibits neural differentiation from a primed state.  
The FGF rescue experiment confirmed our previous observations that at days three 
and four of in vitro neural differentiation, NcKI cells express lower levels of FGF target genes 
such as Dusp4 and Etv4 than WT cells, and confirmed the pro-neural phenotype observed 
previously in NcKI cells. Importantly, the high levels of Sox1 and Pax6 detected in NcKI cells 
could be lowered to near-WT levels by the addition of FGF2 to the NcKI cells. Conversely, 
adding PD17, an FGFR1 inhibitor, to WT cells raised their expression of neural marker genes 
to similar levels as those observed in untreated NcKI cells, demonstrating that the 
modulation of FGF signalling could replicate the pro-neural effect observed in NcKI cells (Fig. 
5.23).  
Surprisingly, the induction of N-cadherin overexpression was not found to have a 
similar effect on FGF dampening as the NcKI mutation. As discussed in Chapter 5, a larger 
sample size with three independent clones is recommended to confirm this result with 
greater confidence. The current data showing that N-cadherin overexpression alone does not 
have the same weakened FGF signalling profile as NcKI cells suggests that full cadherin 
switching is required for this phenotype to have a greater effect on FGF dampening. 
However, since the N-cadherin overexpressing cells in this experiment do not replicate the 
pro-neural effect observed in the larger-scale study performed in Chapter 4, the effect may 
be very subtle. Nanostring analysis showed that a decrease in FGF targets was the most 
significant change in gene expression as a result of N-cadherin overexpression (Fig. 5.21), 
suggesting that the pro-neural effect of induced A2Lox-Ncad-HA cells may still be ascribable 
to this pathway. Further studies are needed to confirm this hypothesis.  
Taken together, these results provide evidence that forced, premature and complete 
cadherin switching promotes neural differentiation by dampening FGF responsiveness. 
However, RPPA data from 24h of neural differentiation showed a contrasting result, where 
the levels of most phospho-protein species associated with different branches of the FGF 
pathway were higher in NcKI cells compared to WT cells at this time point (Fig. 5.5). This 
result suggests that in the first 24h of differentiation from naïve pluripotency, NcKI cells 
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exhibit higher FGF signalling compared to WT cells, perhaps promoting a faster transition 
towards the primed EpiSC state.  
In a model where FGF signalling first promotes priming of ESCs into EpiSCs, and its 
subsequent inhibition allows cells to differentiate towards the neural lineage, the forced, 
premature and complete cadherin switching represented by NcKI cells may accelerate the 
progression of these cells through the early stages of differentiation. The molecular 
interactions for this effect were not investigated in this project, but a candidate mechanism 
could be that the prematurely expressed N-cadherin binds and stabilises FGFR1, possibly 
leading to a faster progression into and out of the EpiSC state (Takehara et al., 2015). 
However, since the effects of cadherin switching in the context of transitions between early 
pluripotent states was not studied in this thesis, this hypothesis remains untested.  
 
6.4 Working model 
 
Figure 6.1: Working model. In vitro, cadherin switching is initiated at the EpiSC stage, prior to the loss 
of pluripotency, and coincides with lineage priming. In vivo, the switch occurs later, at around the time 
of late gastrulation. FGF signalling peaks at the EpiSC stage, when it is required for the maintenance 
of the primed pluripotent state. Cadherin switching promotes neural differentiation by dampening FGF 
signalling during exit from pluripotency and subsequent neural induction. The molecular interactions 





 The experiments described in this thesis have shown that in vitro, cadherin switching 
occurs prior to the loss of pluripotency and coincides with lineage priming towards the neural 
and mesodermal fates. In vitro, this transition appears to take place earlier than in vivo, 
where its earliest signs are observed at the time of gastrulation (Peng et al., 2016).  
During in vitro assays from a 2i-Lif starting population, cadherin switching was found 
to promote neural differentiation, both through forced, premature cadherin switching using 
the NcKI cell line, and through the induction of N-cadherin alone using an inducible 
overexpression cell line, A2Lox-Ncad-HA. Cadherin switching at days three and four of neural 
differentiation was found to correlate with significant dampening of FGF responsiveness. 
Since FGF signalling is involved in the induction and maintenance of the primed pluripotent 
state (Lanner and Rossant, 2010; Sterneckert et al., 2010), we propose that cadherin 
switching dampens FGF responsiveness to allow exit from the pluripotent state and guiding 
differentiating cells towards the neural lineage, potentially through an interaction with 
FGFR1.  
We do not believe that cadherin switching provides the decisive instructive cue that 
forces cells to adopt a neural fate. Rather, we propose that cadherin switching makes the 
process more robust and replicable, allowing cells to resist inappropriate signalling cues, such 
as Wnt ligands, and allows for replicable neural induction in the anterior embryo even in 










Appendix 1: Non-specific N-cadherin background staining in ICC. A. Example nuclear background 
signal from N-cadherin antibody staining in cells negative (Lif-serum) and positive (EpiSC) for N-
cadherin. Scale bar=50µm. F. qPCR data for Cdh2 (N-cadherin) expression at different stages of 
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